10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-40829

Sterling Check Corp.

(Exact name of registrant as specified in its charter)

Delaware	37-1784336
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
6150 Oak Tree Boulevard, Suite 490
Independence, Ohio	44131
(Address of principal executive offices)	(Zip Code)

1 (800) 853-3228

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value	STER	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated

filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The total number of outstanding shares of the registrant’s common stock, $0.01 par value per share, as of November 1, 2023 was 94,285,105 (excluding treasury shares of 5,610,661).

1

STERLING CHECK CORP. AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

TABLE OF CONTENTS

	PART I—FINANCIAL INFORMATION
Item 1.	Financial Statements	5
	Unaudited Condensed Consolidated Balance Sheets	5
	Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income	6
	Unaudited Condensed Consolidated Statements of Stockholders’ Equity	7
	Unaudited Condensed Consolidated Statements of Cash Flows	9
	Notes to Unaudited Condensed Consolidated Financial Statements	11
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	48
Item 4.	Controls and Procedures	49
	PART II—OTHER INFORMATION
Item 1.	Legal Proceedings	50
Item 1A.	Risk Factors	50
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	50
Item 3.	Defaults Upon Senior Securities	51
Item 4.	Mine Safety Disclosures	51
Item 5.	Other Information	51
Item 6.	Exhibits	51
Signatures		52

2

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend that all forward-looking statements that we make will be subject to the safe harbor protections created thereby. You can generally identify forward-looking statements by our use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “playbook,” “potential,” “predict,” “projection,” “seek,” “should,” “will” or “would,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements that address market trends, and statements regarding our expectations, beliefs, plans, strategies, objectives, prospects or assumptions, or statements regarding future events or performance contained in this Quarterly Report on Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements.

We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed in this Quarterly Report on Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” may cause our actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements, or could affect our share price. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include:

•changes in economic, political and market conditions, including bank failures and concerns of a potential economic downturn or recession, and the impact of these changes on our clients’ hiring trends;

•the sufficiency of our cash to meet our liquidity needs;

•the possibility of cyber-attacks, security vulnerabilities and internet disruptions, including breaches of data security and privacy leaks, data loss and business interruptions;

•our ability to comply with the extensive United States (“U.S.”) and foreign laws, regulations and policies applicable to our industry, and changes in such laws, regulations and policies;

•our compliance with data privacy laws and regulations;

•potential liability for failures to provide accurate information to our clients, which may not be covered, or may be only partially covered, by insurance;

•the possible effects of negative publicity on our reputation and the value of our brand;

•our failure to compete successfully;

•our ability to keep pace with changes in technology and to provide timely enhancements to our products and services;

•the continued impact of COVID-19 on global markets, economic conditions and the response by governments and third parties;

•our ability to cost-effectively attract new clients and retain our existing clients;

•our ability to grow our Identity-as-a-Service offerings;

•our success in new product introductions and adjacent market penetrations;

•our ability to expand into new geographies;

•our ability to pursue and integrate strategic mergers and acquisitions;

•design defects, errors, failures or delays with our products and services;

•systems failures, interruptions, delays in services, catastrophic events and resulting interruptions;

•natural or man-made disasters including pandemics and other significant public health emergencies, outbreaks of hostilities or effects of climate change and our ability to deal effectively with damage or disruption caused by the foregoing;

•our ability to implement our business strategies profitably;

•our ability to retain the services of certain members of our management;

•our ability to adequately protect our intellectual property;

•our ability to implement, maintain and improve effective internal controls;

3

•our ability to comply with public company requirements in a timely and cost-effective manner, and expense strain on our resources and diversion of our management’s attention resulting from public company compliance requirements; and

•the other risks described in Item 1A. “Risk Factors” in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 2, 2023 and in this Quarterly Report on Form 10-Q.

Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q are not guarantees of future performance and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. In addition, even if our results of operations, financial condition, and liquidity, and events in the industry in which we operate, are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, they may not be predictive of results or developments in future periods.

Any forward-looking statement that we make in this Quarterly Report on Form 10-Q speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this Quarterly Report on Form 10-Q.

Investors and others should note that we announce material financial and operational information using our investor relations website, press releases, SEC filings and public conference calls and webcasts. Information about Sterling Check Corp. (“Sterling”), our business, and our results of operations may also be announced by posts on our accounts on social media channels, including the following: Instagram, Facebook, LinkedIn and Twitter. The information contained on, or that can be accessed through, our social media channels and on our website is deemed not to be incorporated in this Quarterly Report on Form 10-Q or to be a part of this Quarterly Report on Form 10-Q. The information that we post through these social media channels and on our website may be deemed material. As a result, we encourage investors, the media and others interested in Sterling to monitor these social media channels in addition to following our investor relations website, press releases, SEC filings and public conference calls and webcasts. The list of social media channels we use may be updated from time to time on our investor relations website.

4

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)	September 30, 2023		December 31, 2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	49,877	$	103,095
Accounts receivable (net of allowance for credit losses of $2,670 and $2,304 at September 30, 2023 and December 31, 2022, respectively)	151,935		139,579
Insurance receivable	4,689		921
Prepaid expenses	8,595		13,433
Other current assets	23,770		13,654
Total current assets	238,866		270,682
Property and equipment, net	7,330		10,341
Goodwill	878,390		849,609
Intangible assets, net	240,482		241,036
Deferred tax assets	4,328		4,452
Operating leases right-of-use asset	7,020		20,084
Other noncurrent assets, net	10,499		11,050
TOTAL ASSETS	$	1,386,915	$	1,407,254
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	39,327	$	38,372
Litigation settlement obligation	7,178		4,165
Accrued expenses	60,387		67,047
Current portion of long-term debt	13,125		7,500
Operating leases liability, current portion	4,233		3,717
Other current liabilities	14,435		12,939
Total current liabilities	138,685		133,740
Long-term debt, net	483,334		493,990
Deferred tax liabilities	31,584		23,707
Long-term operating leases liability, net of current portion	8,834		16,835
Other liabilities	3,737		2,336
Total liabilities	666,174		670,608
COMMITMENTS AND CONTINGENCIES (NOTE 13)
STOCKHOLDERS’ EQUITY:
Preferred stock ($0.01 par value; 100,000,000 shares authorized; no shares issued or outstanding)	—		—
Common stock ($0.01 par value; 1,000,000,000 shares authorized; 99,889,227 shares issued and 95,045,289 shares outstanding at September 30, 2023; 97,765,120 shares issued and 96,717,883 shares outstanding at December 31, 2022)	97		76
Additional paid-in capital	971,950		942,789
Common stock held in treasury (4,843,938 and 1,047,237 shares at September 30, 2023 and December 31, 2022, respectively)	(64,499)		(14,859)
Accumulated deficit	(183,180)		(186,448)
Accumulated other comprehensive loss	(3,627)		(4,912)
Total stockholders’ equity	720,741		736,646
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,386,915	$	1,407,254

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except share and per share data)	2023		2022		2023		2022
REVENUES	$	180,566	$	199,299	$	550,224	$	596,862
OPERATING EXPENSES:
Cost of revenues (exclusive of depreciation and amortization below)	95,882		106,422		292,692		314,954
Corporate technology and production systems	11,329		13,715		34,709		38,806
Selling, general and administrative	42,382		42,411		134,743		126,630
Depreciation and amortization	15,875		16,570		47,117		56,598
Impairments and disposals of long-lived assets	48		193		7,193		805
Total operating expenses	165,516		179,311		516,454		537,793
OPERATING INCOME	15,050		19,988		33,770		59,069
OTHER EXPENSE (INCOME):
Interest expense, net	9,305		7,764		26,903		20,719
Gain on interest rate swaps	—		—		—		(296)
Other income	(561)		(560)		(1,370)		(1,422)
Total other expense, net	8,744		7,204		25,533		19,001
INCOME BEFORE INCOME TAXES	6,306		12,784		8,237		40,068
Income tax provision	3,952		3,481		4,969		12,958
NET INCOME	$	2,354	$	9,303	$	3,268	$	27,110
Unrealized gain on hedged transactions, net of tax expense of $1,188, $0, $1,044 and $0, respectively	1,962		—		1,554		—
Foreign currency translation adjustments, net of tax of $0, $0, $0 and $0, respectively	(1,906)		(4,790)		(269)		(7,990)
Total other comprehensive income (loss)	56		(4,790)		1,285		(7,990)
COMPREHENSIVE INCOME	$	2,410	$	4,513	$	4,553	$	19,120
Net income per share attributable to stockholders
Basic	$	0.03	$	0.10	$	0.04	$	0.29
Diluted	$	0.03	$	0.09	$	0.03	$	0.27
Weighted average number of shares outstanding
Basic	90,972,009		94,134,690		92,184,159		94,043,105
Diluted	93,651,691		99,118,521		94,493,254		99,217,125

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)	Shares Outstanding	Par Value		Additional Paid-In Capital		Common Shares Held in Treasury	Common Stock Held in Treasury		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total
BALANCE at December 31, 2022	96,717,883	$	76	$	942,789	1,047,237	$	(14,859)	$	(186,448)	$	(4,912)	$	736,646
Issuance of common stock	4,567	—		—		—	—		—		—		—
Repurchases of common stock	(493,926)	—		—		493,926	(7,712)		—		—		(7,712)
Issuance of restricted shares, net of forfeitures	1,894,310	19		(19)		—	—		—		—		—
Shares withheld to cover restricted share vesting tax	(37,128)	—		—		37,128	(487)		—		—		(487)
Stock-based compensation	—	—		8,043		—	—		—		—		8,043
Net income	—	—		—		—	—		591		—		591
Unrealized loss on hedged transactions, net of tax	—	—		—		—	—		—		(5,159)		(5,159)
Foreign currency translation adjustment, net of tax	—	—		—		—	—		—		682		682
BALANCE at March 31, 2023	98,085,706	95		950,813		1,578,291	(23,058)		(185,857)		(9,389)		732,604
Issuance of common stock	2,363	—		—		—	—		—		—		—
Repurchases of common stock	(1,465,893)	—		—		1,465,893	(17,630)		—		—		(17,630)
Common stock issued for exercise of employee stock options	63,336	—		611		—	—		—		—		611
Issuance of restricted shares, net of forfeitures	80,331	1		(1)		—	—		—		—		—
Shares withheld to cover restricted share vesting tax	(7,181)	—		—		7,181	(85)		—		—		(85)
Stock-based compensation	—	—		9,358		—	—		—		—		9,358
Net income	—	—		—		—	—		323		—		323
Unrealized gain on hedged transactions, net of tax	—	—		—		—	—		—		4,751		4,751
Foreign currency translation adjustment, net of tax	—	—		—		—	—		—		955		955
BALANCE at June 30, 2023	96,758,662	96		960,781		3,051,365	(40,773)		(185,534)		(3,683)		730,887
Repurchases of common stock	(1,564,019)	—		—		1,564,019	(20,701)		—		—		(20,701)
Common stock issued for exercise of employee stock options	165,422	2		1,385		—	—		—		—		1,387
Issuance of restricted shares, net of forfeitures	(86,222)	(1)		1		—	—		—		—		—
Shares withheld to cover restricted share vesting tax	(228,554)	—		—		228,554	(3,025)		—		—		(3,025)
Stock-based compensation	—	—		9,783		—	—		—		—		9,783
Net income	—	—		—		—	—		2,354		—		2,354
Unrealized gain on hedged transactions, net of tax	—	—		—		—	—		—		1,962		1,962
Foreign currency translation adjustment, net of tax	—	—		—		—	—		—		(1,906)		(1,906)
BALANCE at September 30, 2023	95,045,289	$	97	$	971,950	4,843,938	$	(64,499)	$	(183,180)	$	(3,627)	$	720,741

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Continued)

(in thousands, except share amounts)	Shares Outstanding	Par Value		Additional Paid-In Capital		Common Shares Held in Treasury	Common Stock Held in Treasury		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total
BALANCE at December 31, 2021	95,746,975	$	68	$	916,578	107,820	$	(897)	$	(206,218)	$	93	$	709,624
Issuance of common stock	1,112	—		—		—	—		—		—		—
Common stock issued for exercise of employee stock options	8,486	—		80		—	—		—		—		80
Issuance of restricted shares, net of forfeitures	533,095	5		(5)		—	—		—		—		—
Stock-based compensation	—	—		5,108		—	—		—		—		5,108
Net income	—	—		—		—	—		6,236		—		6,236
Cumulative effect adjustment for adoption of CECL, net of tax of $56	—	—		—		—	—		(198)		—		(198)
Foreign currency translation adjustment, net of tax	—	—		(8)		—	—		—		283		275
BALANCE at March 31, 2022	96,289,668	73		921,753		107,820	(897)		(200,180)		376		721,125
Issuance of common stock	1,812	—		—		—	—		—		—		—
Common stock issued for exercise of employee stock options	76,399	—		734		—	—		—		—		734
Issuance of restricted shares, net of forfeitures	42,388	—		—		—	—		—		—		—
Stock-based compensation	—	—		6,023		—	—		—		—		6,023
Net income	—	—		—		—	—		11,571		—		11,571
Foreign currency translation adjustment, net of tax	—	—		(24)		—	—		—		(3,483)		(3,507)
BALANCE at June 30, 2022	96,410,267	73		928,486		107,820	(897)		(188,609)		(3,107)		735,946
Issuance of common stock	1,604	—		—		—	—		—		—		—
Common stock issued for exercise of employee stock options	159,350	2		1,477		—	—		—		—		1,479
Issuance of restricted shares, net of forfeitures	(23,155)	—		—		—	—		—		—		—
Stock-based compensation	—	—		6,293		—	—		—		—		6,293
Net income	—	—		—		—	—		9,303		—		9,303
Unrealized gain on hedged transactions, net of tax	—	—		—		—	—		—		—		—
Foreign currency translation adjustment, net of tax	—	—		(17)		—	—		—		(4,790)		(4,807)
BALANCE at September 30, 2022	96,548,066	$	75	$	936,239	107,820	$	(897)	$	(179,306)	$	(7,897)	$	748,214

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months Ended September 30,
(in thousands)	2023		2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	3,268	$	27,110
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	47,117		56,598
Deferred income taxes	(200)		4,885
Stock-based compensation	27,184		17,424
Impairments and disposals of long-lived assets	7,193		805
Provision for bad debts	556		1,016
Amortization of financing fees	808		327
Amortization of debt discount	594		1,444
Deferred rent	383		(170)
Unrealized translation loss (gain) on investment in foreign subsidiaries	94		(1,838)
Changes in fair value of derivatives	—		(4,102)
Change in fair value of contingent consideration, net	(686)		—
Interest rate swap settlements	1,323		—
Changes in operating assets and liabilities
Accounts receivable	(8,699)		(33,145)
Insurance receivable	(3,768)		—
Prepaid expenses	5,849		3,579
Other assets	(6,493)		(2,097)
Accounts payable	757		6,546
Litigation settlement obligation	3,013		—
Accrued expenses	(7,982)		84
Other liabilities	(4,635)		(4,868)
Net cash provided by operating activities	65,676		73,598
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(1,377)		(3,978)
Purchases of intangible assets and capitalized software	(13,364)		(11,719)
Acquisitions, net of cash acquired	(49,210)		—
Proceeds from disposition of property and equipment	121		25
Net cash used in investing activities	(63,830)		(15,672)
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock	1,998		2,291
Repurchases of common stock	(46,043)		—
Payments of initial public offering issuance costs	—		(225)
Cash paid for tax withholding on vesting of restricted shares	(3,597)		—
Payments of long-term debt	(5,625)		(4,846)
Payment of contingent consideration for acquisition	(305)		(226)
Payments of finance lease obligations	—		(3)
Net cash used in financing activities	(53,572)		(3,009)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(1,492)		(3,725)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(53,218)		51,192
CASH AND CASH EQUIVALENTS
Beginning of period	103,095		47,998
Cash and cash equivalents at end of period	$	49,877	$	99,190

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

9

STERLING CHECK CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

	Nine Months Ended September 30,
(in thousands)	2023		2022
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for
Interest, net of capitalized amounts of $308 and $245 for the nine months ended September 30, 2023 and 2022, respectively	$	29,006	$	24,277
Income taxes	13,219		11,513
Noncash investing activities
Purchases of property and equipment in accounts payable and accrued expenses	$	400	$	8
Noncash purchase price of business combinations	4,706		—

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

10

STERLING CHECK CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.    Description of Business

Sterling Check Corp. (the “Company”), a Delaware corporation headquartered in Independence, Ohio, is a global provider of technology-enabled background and identity verification services. The Company provides the foundation of trust and safety its clients need to create effective environments for their most essential resource—people. The Company offers a comprehensive hiring and risk management solution that begins with identity verification, followed by criminal background screening, credential verification, drug and health screening, employee onboarding document processing and ongoing risk monitoring.

As of September 30, 2023, the Company is 52.4% owned by an investment group consisting of entities advised by or affiliated with The Goldman Sachs Group, Inc. (“Goldman Sachs”) and Caisse de dépôt et placement du Québec (“CDPQ” and, together with Goldman Sachs, our “Sponsor”). CDPQ owns its equity interest in the Company indirectly through a limited partnership controlled by Goldman Sachs.

2.    Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

These unaudited condensed consolidated financial statements are unaudited; however, in the opinion of management, they reflect all adjustments consisting only of normal recurring adjustments necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with GAAP applicable to interim periods. The results of operations for the interim periods presented are not necessarily indicative of results for the full year or future periods. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of December 31, 2022 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2023.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that can affect the reported amount of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Significant estimates include the impairment of long-lived assets, goodwill impairment, the determination of the fair value of acquired assets and liabilities, collectability of receivables, the valuation of stock-based awards and stock-based compensation and sales and income tax liabilities. The Company also applies an estimated useful life of three years to internally developed software assets. This is based on the historical observed pace of change in the Company’s delivery, technology, and product offerings as well as market competition. The Company believes that the estimates used in the preparation of these unaudited condensed consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.

Segment Information

The Company has one operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance.

Cash and Cash Equivalents

Cash and cash equivalents of $49.9 million and $103.1 million as of September 30, 2023 and December 31, 2022, respectively, include money market instruments with maturities of three months or less. The Company maintained cash outside the U.S. as of September 30, 2023 of $33.4 million with the largest deposits being held in India and Canada, with balances of $4.1 million and $6.0 million, respectively. Cash outside the U.S. was $28.0 million as of December 31, 2022, with the largest deposits being held in Canada and India, with balances of $9.2 million and $5.1 million, respectively.

11

Foreign Currency

Assets and liabilities of operations having non-USD functional currencies are translated at period-end exchange rates, and income statement accounts are translated at weighted average exchange rates for the period. Gains or losses resulting from translating foreign currency financial statements, net of any related tax effects, are reflected in Accumulated Other Comprehensive Income or Loss (“OCI”), a separate component of stockholders’ equity on the unaudited condensed consolidated balance sheets. Gains or losses resulting from foreign currency transactions incurred in currencies other than the local functional currency are included in other income in the unaudited condensed consolidated statements of operations and comprehensive income. The cumulative translation adjustment resulted in losses of $5.5 million and $5.6 million as of September 30, 2023 and December 31, 2022, respectively.

Accounts Receivable and Allowance for Credit Losses

Accounts receivable balances consist of trade receivables that are recorded at the invoiced amount, net of allowances for expected credit losses and for potential sales credits and reserves. Sales credits and reserves were $0.7 million and $0.9 million as of September 30, 2023 and December 31, 2022, respectively.

The Company adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 326, Financial Instruments—Credit Losses (“CECL”) on January 1, 2022. The adoption of CECL resulted in a $0.3 million cumulative effect adjustment recorded in retained earnings as of January 1, 2022.

CECL requires an entity to utilize an impairment model to estimate its lifetime expected credit losses and record an allowance that, when deducted from the amortized cost basis of a financial asset, presents the net amount expected to be collected on the financial asset.

The Company maintains an allowance for expected credit losses in order to record accounts receivable at their net realizable value. Inherent in the assessment of the allowance for expected credit losses are certain judgments and estimates relating to, among other things, the Company’s customers’ access to capital, customers’ willingness and ability to pay, general economic conditions and the ongoing relationship with customers. Allowances have been recorded for receivables believed to be uncollectible, including amounts for the resolution of potential credit and other collection issues such as disputed invoices. The allowance for expected credit losses is determined by analyzing the Company’s historical write-offs, the current aging of receivables, the financial condition of customers and the general economic climate. Adjustments to the allowance may be required in future periods depending on how such potential issues are resolved or if the financial condition of the Company’s customers were to deteriorate resulting in an impairment of their ability to make payments. The Company has not historically had material write-offs due to uncollectible accounts receivable.

Allowances for expected credit losses were $2.7 million and $2.3 million as of September 30, 2023 and December 31, 2022, respectively. The following table summarizes changes in the allowance for expected credit losses for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Balance at beginning of period	$	2,658	$	2,161	$	2,304	$	2,949
Cumulative effect of accounting change upon adoption of CECL	—		—		—		254
Additions	97		351		556		1,010
Write-offs, net of recoveries	(82)		(36)		(190)		(1,727)
Foreign currency translation adjustment	(3)		(14)		—		(24)
Balance at end of period	$	2,670	$	2,462	$	2,670	$	2,462

Corporate Technology and Production Systems

Corporate technology and production systems includes costs related to maintaining the Company’s corporate information technology infrastructure and non-capitalizable costs to develop and maintain its production systems.

12

The following table sets forth expenses included in each category of corporate technology and production systems for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Corporate information technology	$	4,665	$	7,012	$	14,854	$	19,425
Development of platform and product initiatives	4,371		4,433		13,065		12,797
Production support and maintenance	2,293		2,270		6,790		6,584
Total production systems	6,664		6,703		19,855		19,381
Total corporate technology and production systems	$	11,329	$	13,715	$	34,709	$	38,806

Corporate information technology consists of salaries and benefits of personnel (including stock-based compensation expense) supporting internal operations such as information technology support and the maintenance of information security and business continuity functions. Also included are third-party costs including cloud computing costs that support the Company’s corporate internal systems, software licensing and maintenance, telecommunications and other technology infrastructure costs.

Production systems costs consist of non-capitalizable personnel costs including contractor costs incurred for the development of platform and product initiatives and production support and maintenance. Platform and product initiatives facilitate the development of the Company’s technology platform and the launch of new screening products. Production support and maintenance includes costs to support and maintain the technology underlying the Company’s existing screening products and to enhance the ease of use of the Company’s cloud applications. Certain personnel costs related to new products and features are capitalized and amortized to depreciation and amortization.

Included within corporate technology and production systems are non-capitalizable production system and corporate information technology expenses related to Project Ignite, a three-phase strategic investment initiative. Phase one of Project Ignite modernized client and candidate experiences and is complete. Phase two of Project Ignite focused on decommissioning the Company’s on-premises data centers and migrating the Company’s production systems and corporate information technological infrastructure to a managed service provider in the cloud. During the first half of 2021, the Company completed phase two initiatives related to the migration of its production and fulfillment systems to the cloud, and as a result, approximately 98% of revenue is processed through platforms hosted in the cloud. The Company incurred expenses related to phase two to complete the decommissioning of on-premises data centers for internal corporate technology infrastructure and migration to the cloud which was completed as of September 30, 2022. Phase three of Project Ignite was decommissioning of the platforms purchased over the prior ten years and the migration of the clients to one global platform. This third and final phase, which was completed in the first quarter of 2023, unified clients onto a single global platform. The Company’s core platform now processes approximately 80% of its global revenue.

3.    Recent Accounting Standards Updates

The Company qualifies as an emerging growth company under the Jumpstart Our Business Startups Act (the “JOBS Act”). The JOBS Act permits extended transition periods for complying with new or revised accounting standards affecting public companies. The Company has elected to use the extended transition periods and is adopting new or revised accounting standards on the FASB’s non-public company timeline. As such, the Company’s financial statements may not be comparable to financial statements of public entities that comply with new or revised accounting standards on a non-delayed basis.

The Company will cease to be an emerging growth company upon the earliest of (a) the last day of the fiscal year in which it has total annual gross revenues of $1.235 billion or more; (b) the last day of its fiscal year following the fifth anniversary of the date of its initial public offering (“IPO”); (c) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years; or (d) the date on which it is deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur as of the last day of a fiscal year in which the market value of its common stock held by non-affiliates equals or exceeds $700 million as of the last business day of the second fiscal quarter of such fiscal year, which threshold was not exceeded as of June 30, 2023.

13

4.    Acquisitions

Socrates and A-Check Acquisitions

On January 4, 2023, the Company acquired all of the outstanding shares of Socrates Limited and its affiliates (“Socrates”), a screening company in Latin America, pursuant to a share purchase agreement. The Socrates acquisition expands the Company’s global presence into Latin America to serve the rapidly growing regional hiring needs of both multi-national and local clients. On March 1, 2023, the Company acquired all of the outstanding shares of A-Check Global (“A-Check”), a U.S.-based employment screening organization, pursuant to a share purchase agreement. The A-Check acquisition provides the Company access to a high quality, enterprise-focused customer base diversified across verticals including healthcare and telecom. The aggregate purchase price for the acquisitions totaled approximately $66.2 million, was funded with available cash on hand and is subject to certain closing adjustments specified in the share purchase agreements and includes initial contingent consideration related to the A-Check acquisition of $4.7 million recorded at fair value. The contingent consideration will be determined based on actual future results. The initial fair value of the contingent consideration consisted of $2.6 million for an earn-out payable one year after the acquisition based upon revenue retention and a $2.1 million payable throughout the second and third year following the acquisition based on revenue retention and referral revenue. The Company recorded a preliminary allocation of the purchase price to assets acquired and liabilities assumed based on their estimated fair values as of their respective purchase dates. Additionally, in connection with the Socrates acquisition, $5.0 million is payable to certain senior employees two years after the acquisition date based on certain retention requirements.

The Company incurred approximately $2.0 million of transaction expenses related to the acquisitions during the nine months ended September 30, 2023.

The preliminary allocation of the purchase price is based on the fair value of assets acquired and liabilities assumed as of the applicable acquisition date. The following table summarizes the consideration paid and the amounts recognized for the assets acquired and liabilities assumed:

	Preliminary Purchase Price Allocation				Adjusted Purchase Price Allocation
(in thousands)	March 31, 2023		Purchase Price Adjustments		September 30, 2023
Consideration
Cash	$	11,935	$	—	$	11,935
Other current assets
Accounts receivable	4,279		(3)		4,276
Other current assets	805		447		1,252
Property and equipment	177		(1)		176
Intangible assets	32,141		(1,268)		30,873
Other long-term assets	6		—		6
Total assets acquired	$	49,343	$	(825)	$	48,518
Accounts payable and accrued expenses	1,156		94		1,250
Other current liabilities	1,291		(72)		1,219
Deferred tax liability	8,388		77		8,465
Other liabilities	2		—		2
Total liabilities assumed	$	10,837	$	99	$	10,936
Total identifiable net assets	38,506		(924)		37,582
Goodwill	27,352		1,218		28,570
Total consideration	$	65,858	$	294	$	66,152

Goodwill recognized is primarily attributable to assembled workforce and expected synergies and is not tax deductible in future years. Intangible assets acquired consist largely of customer lists in the amount of $28.0 million to be amortized over 15 years. The remaining intangible assets include trade names, developed technology and a non-compete agreement, which will be amortized over two years, eight years, and five years, respectively.

14

The acquisitions are not material to the Company's financial position as of September 30, 2023 or results of operations for the three and nine months ended September 30, 2023, and therefore, pro forma operating results and other disclosures for the acquisitions are not presented.

EBI Acquisition

On November 30, 2021, the Company acquired all of the outstanding shares of Employment Background Investigations, Inc. (“EBI”) for a purchase price of $67.8 million, consisting of $66.3 million of cash and $1.5 million of contingent consideration recorded at fair value. As of December 31, 2022, the purchase price was reduced by $0.3 million reflecting the final determination of the post-closing adjustment of the purchase price in accordance with the purchase agreement with EBI, resulting in an adjusted purchase price of $67.5 million. The receivable related to this adjustment was collected in February 2023.

5.    Property and Equipment, Net

(in thousands)	September 30, 2023		December 31, 2022
Furniture and fixtures	$	1,621	$	2,568
Computers and equipment	37,763		41,084
Leasehold improvements	2,048		6,565
	41,432		50,217
Less: Accumulated depreciation	(34,102)		(39,876)
Total property and equipment, net	$	7,330	$	10,341

Depreciation expense on property and equipment was $0.8 million and $1.1 million during the three months ended September 30, 2023 and 2022, respectively, and $2.8 million and $3.3 million for the nine months ended September 30, 2023 and 2022, respectively. Write down of abandoned property and equipment no longer in use totaled less than $0.1 million and $1.7 million during the three and nine months ended September 30, 2023, respectively. Write down of abandoned property and equipment no longer in use was $0.2 million and $0.8 million for the three and nine months ended September 30, 2022, respectively.

6.    Goodwill and Intangible Assets

Goodwill

The changes in the carrying amount of goodwill for the periods presented were as follows:

(in thousands)
Goodwill at December 31, 2022	$	849,609
Acquisitions	28,570
Foreign currency translation adjustment	211
Goodwill at September 30, 2023	$	878,390

Intangible Assets

Intangible assets, net consisted of the following for the periods presented:

	September 30, 2023						December 31, 2022
(dollars in thousands)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Customer lists	$	532,376	$	(365,853)	$	166,523	$	506,015	$	(340,579)	$	165,436
Trademarks	77,659		(42,135)		35,524		77,198		(37,519)		39,679
Non-compete agreement	3,969		(2,781)		1,188		3,179		(2,584)		595
Technology	261,573		(229,257)		32,316		246,220		(216,330)		29,890
Domain names	10,118		(5,187)		4,931		10,118		(4,682)		5,436
	$	885,695	$	(645,213)	$	240,482	$	842,730	$	(601,694)	$	241,036

15

Included within technology is $30.2 million and $28.1 million of internal-use software, net of accumulated amortization, as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023, $6.1 million of technology assets have not yet been put in service.

The Company capitalized $13.4 million of costs to develop internal-use software included in technology during the nine months ended September 30, 2023 (consisting of internal costs of $11.5 million and external costs of $1.8 million). The Company capitalized $11.7 million of costs to develop internal-use software included in technology during the nine months ended September 30, 2022 (consisting of internal costs of $9.4 million and external costs of $2.3 million).

For the three and nine months ended September 30, 2023, the Company recorded a write-down related to the impairment of capitalized software in the amount of less than $0.1 million and $0.2 million, respectively. For the three and nine months ended September 30, 2022, the Company recorded no write-down of capitalized software.

Amortization expense was $15.1 million and $15.5 million for the three months ended September 30, 2023 and 2022, respectively, and $44.3 million and $53.3 million for the nine months ended September 30, 2023 and 2022, respectively.

Except for the customer lists, which are amortized utilizing an accelerated method, all other intangible assets are amortized on a straight-line basis, which approximates the pattern in which economic benefits are consumed. Estimated amortization expense as of September 30, 2023 is as follows for each of the next five years:

(in thousands)
Year Ending December 31,
Remainder of fiscal year 2023	$	15,144
2024	52,636
2025	42,591
2026	32,526
2027	24,991
Thereafter	72,594
	$	240,482

7.    Accrued Expenses

Accrued expenses on the unaudited condensed consolidated balance sheets as of the periods presented consisted of the following:

(in thousands)	September 30, 2023		December 31, 2022
Accrued compensation	$	22,274	$	29,835
Accrued cost of revenues	21,721		15,721
Accrued interest	223		3,143
Other accrued expenses	16,169		18,348
Total accrued expenses	$	60,387	$	67,047

8.    Leases

Effective January 1, 2022 using the effective date method, the Company adopted the FASB’s Accounting Standards Update No. 2016-02, “Leases” (“ASC 842”), which requires the recognition of all leases, including operating leases on the unaudited condensed consolidated balance sheets by recording a right-of-use (“ROU”) asset and related liability, and elected to exclude short-term leases from adoption. The lease liability and ROU asset will be remeasured when there is a change in the lease term (or upon the occurrence of another reassessment trigger). Upon adoption on January 1, 2022, the Company recognized a ROU asset of $23.5 million and a lease liability of $23.8 million.

The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company’s leases generally do not provide an implicit rate and, therefore, the Company uses the interest rate on its term loan credit agreement as its incremental borrowing rate under ASC 842. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset

16

impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.

The Company leases real estate and equipment for use in its operations. The Company has 16 operating leases with remaining lease terms ranging from 1 to 64 months as of September 30, 2023. In connection with the real estate consolidation program, during the three months ended June 30, 2023, the Company exited additional offices including the Company’s former principal executive office and headquarters in New York. A reduction of the operating leases ROU asset of $5.3 million for impairment charges was recorded in impairments and disposals of long-lived assets in the unaudited condensed consolidated statements of operations and comprehensive income. The Company exercised termination options reducing the lease terms on certain operating leases and recorded lease remeasurements to the operating lease liability and corresponding reductions to the operating leases ROU asset in the amount of $4.7 million during the three months ended June 30, 2023. $1.5 million was recorded to de-recognize the operating lease ROU asset related to certain leases in selling, general and administrative expense due to abandonment, during the three months ended June 30, 2023.

The components of lease expense for the periods presented are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of total lease costs
Operating lease expense(1)	$	810	$	1,357	$	4,796	$	3,958
Sublease income	(278)		(216)		(843)		(504)
Total net lease costs	$	532	$	1,141	$	3,953	$	3,454

_________________________

(1)The nine months ended September 30, 2023 includes $1.5 million of lease expense to de-recognize certain operating ROU assets which were abandoned during the three months ended June 30, 2023.

Information related to the Company’s ROU assets and lease liabilities for the period presented is as follows:

(dollars in thousands)	September 30, 2023		December 31, 2022
Operating leases
Operating leases right-of-use asset	$	7,020	$	20,084
Operating leases liability, current portion	$	4,233	$	3,717
Long-term operating leases liability, net of current portion	8,834		16,835
Total operating leases liability	$	13,067	$	20,552

Weighted average remaining lease term in years - operating leases	3.7		4.8
Weighted average discount rate - operating leases	5.07	%	4.50	%

Total remaining lease payments under the Company’s operating leases for the period presented are as follows:

(in thousands)	September 30, 2023
Remainder of fiscal year 2023	$	1,229
2024	5,243
2025	2,337
2026	2,117
2027	2,149
Thereafter	1,113
Total future minimum lease payments	$	14,188
Less: imputed interest	(1,121)
Total	$	13,067

17

9.    Debt

On November 29, 2022, Sterling Infosystems, Inc. (the “Borrower”), a Delaware corporation and a subsidiary of the Company, entered into a credit agreement (the “2022 Credit Agreement”) by and among the Borrower, as borrower, Sterling Intermediate Corp., KeyBank National Association, as administrative agent (the “Administrative Agent”), certain guarantors party thereto and the lenders party thereto.

The 2022 Credit Agreement provides for aggregate principal borrowings of $700.0 million, comprised of $300.0 million aggregate principal amount of term loans (the “Term Loans”) and a $400.0 million revolving credit facility (the “Revolving Credit Facility”). The Term Loans and the Revolving Credit Facility mature on November 29, 2027.

The table below sets forth the Company’s long-term debt as presented in the unaudited condensed consolidated balance sheets for the periods presented:

(in thousands)	September 30, 2023		December 31, 2022
Current portion of long-term debt
Term Loans	$	13,125	$	7,500
Total current portion of long-term debt	$	13,125	$	7,500
Long-term debt
Term Loans, due November 29, 2027 (7.67% and 6.76% at September 30, 2023 and December 31, 2022, respectively)	281,250		292,500
Revolving Credit Facility	205,494		205,494
Unamortized discount and debt issuance costs	(3,410)		(4,004)
Total long-term debt, net	$	483,334	$	493,990

The estimated fair value of the Company’s 2022 Credit Agreement was $482.2 million and $487.1 million as of September 30, 2023 and December 31, 2022, respectively. These fair values were determined based on quoted prices in markets with similar instruments that are less active (Level 2 inputs as defined below) as an observable price of the 2022 Credit Agreement or similar liabilities is not readily available.

The Company was in compliance with all financial covenants under its credit agreement as of September 30, 2023.

10.    Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. An asset or liability’s level in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to measure fair value are as follows:

Level 1	Quoted prices in active markets for identical assets and liabilities.
Level 2	Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flows methodologies and similar techniques that use significant unobservable inputs.

The Company considers the recorded value of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses to approximate the fair value of the respective assets and liabilities as of September 30, 2023 and December 31, 2022 based upon the short-term nature of such assets and liabilities (Level 1). See Note 9, “Debt” for discussion of the fair value of the Company’s debt.

Interest rate swaps are measured at fair value on a recurring basis in the Company’s financial statements and are considered Level 2 financial instruments. Interest rate swaps are measured based on quoted prices for similar financial instruments and other observable inputs recognized. The currency forward agreements are typically cash settled in U.S. dollars for their fair value at or close to their settlement date.

Contingent consideration related to acquisitions is considered a Level 3 financial instrument. As of September 30, 2023, the fair value of contingent consideration related to the March 1, 2023 acquisition of A-Check

18

and the November 30, 2021 acquisition of EBI. As of December 31, 2022, the contingent consideration related to the acquisition of EBI. The contingent consideration consists of estimated future payments related to the Company’s acquisitions, based on metrics such as revenue retention and referral revenue. The fair value is determined using various assumptions and estimates, including revenue and customer projections to forecast a range of outcomes for the contingent consideration. The Company reassesses the estimated fair value of the contingent consideration at the end of each reporting period based on the information available at the time. Changes in the significant unobservable inputs used may result in a significantly higher or lower fair value measurement. Changes in fair value of contingent consideration are recorded in selling, general and administrative expense in the statement of operations and comprehensive income.

The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of the periods presented:

	September 30, 2023
(in thousands)	Level 1		Level 2		Level 3		Total
Assets
Interest rate swaps	$	—	$	3,073	$	—	$	3,073
Liabilities
Interest rate swaps	—		475		—		475
Contingent consideration	—		—		4,934		4,934

	December 31, 2022
(in thousands)	Level 1		Level 2		Level 3		Total
Liabilities
Contingent consideration	$	—	$	—	$	1,219	$	1,219

The following table summarizes the change in fair value of the Level 3 liabilities with significant unobservable inputs for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Fair value of contingent consideration, beginning of period	$	5,620	$	1,230	$	1,219	$	1,445
Acquired liabilities	—		—		4,706		—
Cash payments	—		(11)		(305)		(226)
Change in fair value of contingent consideration, net	(686)		—		(686)		—
Fair value of contingent consideration, end of period	$	4,934	$	1,219	$	4,934	$	1,219

During the three and nine months ended September 30, 2023 and 2022, the Company did not re-measure any financial assets or liabilities at fair value on a nonrecurring basis. There were no transfers between levels during the periods presented.

11.    Derivative Instruments and Hedging Activities

Interest Rate Swap Hedges

To reduce exposure to variability in expected future cash outflows on variable rate debt attributable to the changes in the applicable interest rates under the 2022 Credit Agreement, the Company entered into interest rate swaps to economically offset a portion of this risk.

For interest rate swap derivatives designated and that qualify as hedges for accounting purposes, the unrealized gain or loss on the derivative is initially recorded in OCI, reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item.

19

As of September 30, 2023, the Company had the following outstanding interest rate swap derivatives that were used to hedge its interest rate risks:

Product	Number of Instruments	Effective Date	Maturity Date	Current Notional(1)
Interest Rate Swaps	4	February 28, 2023	November 29, 2027	$300.0 million USD

_________________________

(1)The notional value steps down from $300.0 million to $150.0 million on February 27, 2026.

All financial derivative instruments are carried at their fair value on the balance sheet. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the unaudited condensed consolidated balance sheets as of the dates presented:

	Asset Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other current assets	$	3,073	Other current assets	$	—

	Liability Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other liabilities	$	475	Other liabilities	$	—

The tables below present the effect of cash flow hedge accounting on accumulated OCI for the periods presented:

	Three Months Ended September 30,					Three Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	3,910	$	—	Interest expense	$	761	$	—
	Nine Months Ended September 30,					Nine Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	4,008	$	—	Interest expense	$	1,410	$	—

The table below presents the effect of the Company’s cash flow hedge accounting on the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
(in thousands)	Interest Expense
Total amounts of income and expense line items in which the effects of cash flow hedges are recorded	$	9,305	$	7,764	$	26,903	$	20,719
Gain or (loss) on cash flow hedging relationships
Interest rate swaps:
Amount of gain or (loss) reclassified from accumulated OCI into income	$	761	$	—	$	1,410	$	—

20

Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. Based on current interest rates, during the next twelve months, the Company estimates that an additional $3.1 million net gain will be reclassified from accumulated OCI as a decrease to interest expense. No gain or loss was reclassified from accumulated OCI into earnings as a result of forecasted transactions that failed to occur during the periods presented.

Non-designated Derivatives

Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected to apply hedge accounting.

Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.

As of September 30, 2023, the Company did not have any outstanding derivatives not designated as a hedge in qualifying hedging relationships.

The table below presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments in the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

		Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)		2023		2022		2023		2022
Derivatives Not Designated as Hedging Instruments	Location of Gain or (Loss) Recognized in Income on Derivative	Amount of Gain or (Loss) Recognized in Income on Derivative
Interest rate swaps	Gain on interest rate swaps	$	—	$	—	$	—	$	296

12.    Income Taxes

The computation of the provision for or benefit from income taxes for interim periods is determined by applying the estimated annual effective tax rate to year-to-date income before tax and adjusting for discrete tax items recorded in the period, if any.

The Company recorded a tax provision of $4.0 million and $3.5 million for the three months ended September 30, 2023 and 2022, respectively, which resulted in an effective tax rate of 62.7% and 27.2%, respectively. The Company recorded a tax provision of $5.0 million and $13.0 million for the nine months ended September 30, 2023 and 2022, respectively, which resulted in an effective tax rate of 60.3% and 32.3%, respectively. For the three and nine months ended September 30, 2023 and 2022, the effective rate differs from the statutory rate mainly due to a jurisdictional mix of earnings and permanent items.

13.    Commitments and Contingencies

Litigation

The Company is party to both class actions and individual actions in the ordinary course of business. The matters typically allege violations of the Fair Credit Reporting Act (“FCRA”), as well as other claims. In addition, from time to time, the Company receives inquiries from regulatory bodies regarding its business. The Company accrues for the cost of resolving matters where it can be determined that a loss is both estimable and probable. Certain matters are in litigation and an estimate of the outcome and potential losses, if any, cannot be determined. Certain of these matters are covered by the Company’s insurance policies, subject to policy terms, including retentions. The Company does not believe that the resolution of current matters will result in a material adverse effect on the financial position, results of operations, or cash flows of the Company.

As of September 30, 2023, the Company had a legal settlement obligation of $7.2 million and an offsetting insurance receivable of $4.7 million for the settlement of legal matters. As of December 31, 2022, the Company had a legal settlement obligation of $4.2 million and an offsetting insurance receivable of $0.9 million for the settlement of legal matters.

Net legal settlement expense recorded in selling, general and administrative expense in the unaudited consolidated statements of operations and comprehensive income for the three months ended September 30, 2023 and 2022 totaled $0.5 million and $0.2 million, respectively, and $0.6 million and $0.5 million for the nine months ended September 30, 2023 and 2022, respectively.

21

14.    Equity

Under the Company’s Amended and Restated Certificate of Incorporation, a total of 1,100,000,000 shares of all classes of stock are authorized, divided as follows:

(i)1,000,000,000 shares of common stock, par value $0.01 per share (“common stock”); and

(ii)100,000,000 shares of undesignated preferred stock, par value $0.01 per share (“preferred stock”).

Each share of common stock is entitled to one vote on all matters on which holders of common stock are entitled to vote generally. Holders of common stock are entitled to be paid ratably any dividends as may be declared by the Board of Directors (in its sole discretion), subject to any preferential dividend rights of outstanding preferred stock (if any). No dividends have been declared or paid on the Company’s common stock through September 30, 2023.

The Board of Directors is authorized to direct the issuance of the undesignated preferred stock in one or more series and to fix the designation of such series, the powers (including voting powers), preferences and relative, participating, optional and other special rights, and the qualifications, limitations or restrictions thereof, of such series of preferred stock and the number of shares of such series.

On November 23, 2022, the Company’s board of directors authorized the repurchase of up to $100.0 million of the Company’s shares of common stock over a period through December 31, 2024. The share repurchase program is being executed on a discretionary basis through open market repurchases, private transactions, or other transactions, including through block trades and Rule 10b-18 and Rule 10b5-1 trading plans. The Company is not obligated to repurchase any specific number of shares, and the timing and amount of any share repurchases will be subject to several factors including share price, trading volume, market conditions and capital allocation priorities. The share repurchase program may be suspended, terminated or modified without notice at any time. For the three and nine months ended September 30, 2023, the Company repurchased 1,564,019 shares of its common stock for $20.7 million and 3,523,838 shares of its common stock for $46.0 million, respectively, inclusive of commissions and taxes.

On June 7, 2023, the Company entered into an Underwriting Agreement with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC as representatives of the several underwriters named therein (the “Underwriters”) and the selling stockholders (the “Selling Stockholders”), relating to the sale by the Selling Stockholders of 8,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Secondary Public Offering”). In connection with the Secondary Public Offering, the Selling Stockholders granted the Underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock of the Company, of which 1,145,486 shares were purchased. The Company did not sell any shares in the Secondary Public Offering and did not receive any proceeds from the sale of shares being sold by the Selling Stockholders in the Secondary Public Offering. In addition, the Company entered into an agreement with Broad Street Principal Investments, L.L.C. (“BSPI”), one of the Selling Stockholders, dated June 5, 2023, pursuant to which the Company repurchased from BSPI an aggregate of 1,000,000 shares of common stock of the Company for a total of $11.7 million pursuant to the Company’s share repurchase program at a price per share equal to the price paid by the Underwriters in the Secondary Public Offering.

15.    Stock-Based Compensation

Stock-based compensation expense is recognized in cost of revenues, corporate technology and production systems, and selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive income as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Stock-based compensation expense
Cost of revenues	$	396	$	384	$	1,218	$	1,208
Corporate technology and production systems	776		774		1,993		1,803
Selling, general and administrative	8,611		5,135		23,973		14,413
Total stock-based compensation expense	$	9,783	$	6,293	$	27,184	$	17,424

Prior to the IPO, all share-based awards were issued to employees under the Company’s 2015 Long-Term Equity Incentive Plan (the “2015 Plan”). Upon the adoption of the Sterling Check Corp. 2021 Omnibus Incentive

22

Plan (the “2021 Equity Plan”) on August 4, 2021 and as of September 22, 2021, all newly granted share-based awards have been issued under the 2021 Equity Plan.

As of September 30, 2023, the Company had approximately $90.1 million of unrecognized pre-tax non-cash stock-based compensation expense related to awards granted under the 2021 Equity Plan, consisting of approximately $28.5 million related to non-qualified stock options (“NQSOs”), $60.1 million related to restricted stock, and approximately $1.5 million related to restricted stock units (“RSUs”), all of which the Company expects to recognize over a weighted average period of 2.41 years.

2015 Long-Term Equity Incentive Plan

The table below provides a summary of service-based vesting options (“SVOs”) and performance-based stock options (“PSOs”) currently outstanding under the 2015 Plan for the nine months ended September 30, 2023:

	Outstanding SVOs						Outstanding PSOs
	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value		Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
(in thousands, except shares and per share amounts)
Balances at December 31, 2022	6,208,274	$	9.59	5.00	$	36,513	3,081,855	$	10.05	3.32	$	16,699
Granted	—	—					—	—
Forfeited / Expired	—	—					—	—
Exercised	(213,783)	9.44					(14,975)	9.68
Balances at September 30, 2023(1)	5,994,491	$	9.59	4.30	$	18,139	3,066,880	$	10.05	2.58	$	7,872

_________________________

(1)    All SVOs and PSOs are exercisable as of September 30, 2023.

On August 4, 2021, the Company amended each option outstanding under the 2015 Plan to (i) accelerate vesting upon an initial public offering and (ii) permit each option to be exercised following termination for any reason for the period set forth in the applicable award agreement or, if longer, an extended post-termination exercise period that would end on the date that is six months following the second anniversary of the effective date of the initial public offering, provided that if such date falls during a blackout period, the post-termination exercise period will be extended until the date that is thirty days after the commencement of the Company’s next open trading window. In connection with the option agreement amendments, the option holders agreed that any shares of common stock acquired by such individuals upon exercise of any options outstanding under the 2015 plan (the “LTIP Option Shares”) will be subject to the following transfer restrictions, in addition to any other lock-up restrictions, securities trading policies, and other limitations to which such individuals may be subject: (i) the holder will be able to transfer up to 25% of the LTIP Option Shares at any time after six months following the effectiveness of the registration statement of which the IPO Prospectus formed a part (or such earlier time as the transfer restrictions expire under the lock-up agreements described in the IPO Prospectus under “Shares Eligible for Future Sale—Lock-up Agreements”) but prior to the first anniversary of the effectiveness of the registration statement of which the IPO Prospectus formed a part; (ii) on or after the first anniversary but prior to the second anniversary of the effectiveness of the registration statement of which the IPO Prospectus formed a part, the holder will be able to transfer up to 50% of the LTIP Option Shares (reduced by any of the LTIP Option Shares sold prior to the first anniversary) and (iii) on or after the second anniversary of the effectiveness of the registration statement of which the IPO Prospectus forms a part, the holder will be able to transfer all of his or her LTIP Option Shares. The foregoing transfer restrictions will not apply to any shares of common stock held by any such individual that are not LTIP Option Shares.

2021 Omnibus Incentive Plan

On August 4, 2021, the Company’s Board of Directors adopted, and on August 13, 2021 the Company’s stockholders approved, the 2021 Equity Plan. Equity awards under the 2021 Equity Plan are intended to retain and motivate the Company’s officers and employees, consultants and non-employee directors and to promote the success of the Company’s business by providing such participating individuals with a proprietary interest in the performance of the Company. The 2021 Equity Plan will terminate on the tenth anniversary thereof, unless earlier terminated by the Board of Directors. Under the 2021 Equity Plan, the following types of awards can be granted to an eligible individual (as defined by the plan and to the extent permitted by applicable law): incentive stock options (“ISOs”) and NQSOs; stock appreciation rights (“SARs”); restricted stock; RSUs; performance awards; cash-based

23

awards and other share-based awards. Upon its adoption, the 2021 Equity Plan provided that up to 9,433,000 shares may be issued pursuant to awards granted under the 2021 Equity Plan (the “Share Limit”); provided, that, the Share Limit shall be automatically increased on the first day of each calendar year commencing on January 1, 2022 and ending on January 1, 2030 in an amount equal to the lesser of (x) 5% of the total number of shares outstanding on the last day of the immediately preceding calendar year, and (y) such number of shares as determined by the Board of Directors, and no more than 9,433,000 shares may be issued upon the exercise of ISOs. As of September 30, 2023, 8,303,713 shares were available for issuance pursuant to future granted awards under the 2021 Equity Plan.

Stock Options

Options issued under the 2021 Equity Plan generally vest on various schedules over one to four-year periods on the anniversary of the grant date, subject to continued employment with the Company through the applicable vesting date. Options issued under the 2021 Equity Plan generally expire ten years after the grant date.

The table below provides a summary of stock option activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding at December 31, 2022	4,387,501	$	22.91	8.81	$	—
Granted	909,431	12.77
Forfeited / Expired	—	—
Exercised	—	—
Outstanding at September 30, 2023	5,296,932	$	21.17	8.30	$	7,516
Exercisable at September 30, 2023	1,779,123	$	22.98	7.99	$	—

Restricted Stock

Restricted stock issued under the 2021 Equity Plan in connection with the Company’s initial public offering vests 50% on the second anniversary of the grant date and 25% on each of the third and fourth anniversaries of the grant date, subject to continued employment with the Company through the applicable vesting date. Other restricted stock grants issued under the 2021 Equity Plan vest on various schedules over one to four-year periods on the anniversary of the grant date, subject to the continued employment with the Company through the applicable vesting date. Holders of restricted stock are entitled to all rights of a common stockholder of the Company and are subject to restrictions on transfer.

The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	3,421,920	$	20.32
Granted	2,177,482	12.46
Forfeited / Cancelled	(306,240)	16.10
Vested	(792,403)	22.21
Unvested at September 30, 2023	4,500,759	$	16.48

Restricted Stock Units

Restricted stock units issued under the 2021 Equity Plan in connection with the Company’s initial public offering vest 50% on the second anniversary of the grant date and 25% on each of the third and fourth anniversaries of the grant date, subject to continued employment with the Company through the applicable vesting date. Additional grants of RSUs vest on various schedules over a one to four-year period on the anniversary of the grant date, subject to the continued employment with the Company through the applicable vesting date. Upon vesting, employees will receive shares of common stock in settlement of the units. The table below provides a summary of RSU activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

24

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	51,249	$	21.18
Granted	93,026	14.36
Forfeited / Cancelled	(3,287)	17.99
Vested	(17,177)	22.87
Unvested at September 30, 2023	123,811	$	15.79

Employee Stock Purchase Plan

The 2021 Employee Stock Purchase Plan (the “ESPP”) was launched on July 1, 2023. The ESPP allows eligible employees to voluntarily make after-tax contributions of up to 15% of such employee’s cash compensation for the purchase of the Company’s stock. Consecutive offering periods of six months in duration have been established, with the first one commencing on July 1, 2023. During each offering period, such contributions will be accumulated and applied to purchase shares at the end of the offering period. The purchase price for shares purchased in the initial offering period will be, and for subsequent offering periods will not be less than, 85% of the lesser of the closing price of the shares on the first day of the offering period or the last day of the offering period. During the three and nine months ended September 30, 2023, the amount the Company recorded for stock-based compensation expense associated with the ESPP was immaterial.

16.    Net Income Per Share

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except share and per share amounts)	2023		2022		2023		2022
Numerator:
Net income attributable to stockholders	$	2,354	$	9,303	$	3,268	$	27,110
Denominator:
Weighted average number of shares outstanding—basic	90,972,009		94,134,690		92,184,159		94,043,105
Weighted average additional shares assuming conversion of potential common shares	2,679,682		4,983,831		2,309,095		5,174,020
Weighted average common shares outstanding—diluted	93,651,691		99,118,521		94,493,254		99,217,125
Net income per share attributable to stockholders, basic	$	0.03	$	0.10	$	0.04	$	0.29
Net income per share attributable to stockholders, diluted	$	0.03	$	0.09	$	0.03	$	0.27

The following table summarizes the weighted average potentially dilutive securities that were excluded from the computation of diluted net income per share because their effect would have been anti-dilutive for the periods presented:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	5,296,932	8,964,397	5,064,658	8,964,397
Restricted stock	1,156,291	2,131,704	2,971,926	2,131,704
Restricted stock units	6,421	44,560	34,612	44,560

17.    Related Party Transactions

Goldman Sachs and some of its affiliates, each an affiliate of our Sponsor, are clients of the Company and the Company had sales to Goldman Sachs and some of its affiliates in the amount of $0.8 million and $1.2 million for

25

the three months ended September 30, 2023 and 2022, respectively, and $2.5 million and $4.8 million for the nine months ended September 30, 2023 and 2022, respectively. Outstanding accounts receivable from Goldman Sachs as of September 30, 2023 and December 31, 2022 were $0.4 million and $0.2 million, respectively. Additionally, the Company is currently a party to a $75.0 million notional value interest rate swap through November 29, 2027 with J. Aron & Company LLC, a wholly-owned subsidiary of Goldman Sachs.

During the three months ended June 30, 2023, in connection with the Secondary Public Offering, the Company repurchased 1,000,000 shares of common stock for $11.7 million directly from BSPI, an affiliate of Goldman Sachs. See Note 14, “Equity” for discussion of the Secondary Public Offering and the share repurchase.

An affiliate of certain stockholders that, to the Company’s knowledge, collectively own greater than 10% of the Company’s outstanding shares of common stock (the “Stockholders”) is a client of the Company, and the Company had sales to an affiliate of the Stockholders in the amount of $0.1 million for the three months ended September 30, 2023 and 2022, and $0.2 million for the nine months ended September 30, 2023 and 2022. Outstanding accounts receivable from an affiliate of the Stockholders were less than $0.1 million as of September 30, 2023 and December 31, 2022.

18.    Revenue

Performance Obligations

Substantially all of the Company’s revenues are recognized at a point in time as results from services are provided through a screening report and the customer takes control of the product when the report is completed. Accordingly, revenue is generally recognized at the point in time when the customer receives and can use the report.

For revenue arrangements containing multiple products or services, the Company accounts for the individual products or services as separate performance obligations if they are distinct, the product or service is separately identifiable from other terms in the contract, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. If these criteria are not met, the promised products or services are accounted for as a combined performance obligation. The Company allocates the contract price to each performance obligation based on the standalone selling prices of each distinct product or service in the contract.

Disaggregation of Revenues

The following tables set forth total revenue by type of service for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Screening services	$	178,809	$	197,870	$	544,330	$	591,900
Other services	1,757		1,429		5,894		4,962
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

The following table sets forth total revenue by geographic area in which the revenues and invoicing are recorded for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
United States	$	153,577	$	168,615	$	465,517	$	502,047
All other countries	26,989		30,684		84,707		94,815
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

Other than the U.S., no single country accounted for more than 10% of the Company’s total revenues during the three and nine months ended September 30, 2023 and 2022. Substantially all of the Company’s long-lived assets were located in the U.S. as of September 30, 2023 and December 31, 2022.

Contract Assets and Liabilities

Incremental costs of obtaining a contract with a customer are recognized as an asset if the benefit of such costs is expected to be longer than one year, with a majority of contracts being multi-year. Incremental costs include commissions to the sales force and are amortized over three years, as management estimates that this corresponds to the period over which a customer benefits from the contract. As of September 30, 2023 and

26

December 31, 2022, $3.3 million of deferred commissions are included in other current assets on the unaudited condensed consolidated balance sheets and approximately $2.8 million and $2.7 million, respectively, of deferred commissions are included in other noncurrent assets, net on the unaudited condensed consolidated balance sheets.

The Company did not have any material contract liabilities as of September 30, 2023 and December 31, 2022.

Concentrations

For the three and nine months ended September 30, 2023 and 2022, no single customer accounted for more than 10% of the Company’s revenue. No single customer had an accounts receivable balance greater than 10% of total accounts receivable as of September 30, 2023 and December 31, 2022.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes for the three and nine months ended September 30, 2023. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from the results described in or implied by the forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the sections titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 2, 2023 (“2022 Annual Report”) and in this Quarterly Report on Form 10-Q and “Cautionary Note Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q.

Basis of Presentation

As used in this Quarterly Report on Form 10-Q, unless the context otherwise requires, references to “Sterling,” “we,” “us,” “our,” the “Company,” and similar references refer to Sterling Check Corp.

Numerical figures included in this Quarterly Report on Form 10-Q have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them. In addition, we round certain percentages presented in this Quarterly Report on Form 10-Q to the nearest whole number. As a result, figures expressed as percentages in the text may not total 100% or, when aggregated, may not be the arithmetic aggregation of the percentages that precede them.

Overview

We are a leading global provider of technology-enabled background and identity verification services. We provide the foundation of trust and safety that our clients need to create great environments for their most essential resource—people. We offer a comprehensive hiring and risk management solution that begins with identity verification, followed by criminal background screening, credential verification, drug and health screening, processing of employee documentation required for onboarding and ongoing risk monitoring. Our services are generally delivered through our purpose-built, proprietary, cloud-based technology platform that empowers organizations with real-time and data-driven insights to conduct and manage their employment screening programs efficiently and effectively. Our clients face a dynamic and rapidly evolving global labor market with increasing complexity and regulatory requirements. We believe that our services and platform enable organizations to make more informed employment decisions, improve workplace safety, protect their brand and mitigate risk. As a result, we believe our solutions are mission-critical to our clients’ core human resources, risk management and compliance functions. During the twelve months ended December 31, 2022, we completed over 110 million searches for over 50,000 clients, including over 50% of the Fortune 100 and over 50% of the Fortune 500.

Our client-centric approach underpins everything we do. We serve a diverse and global client base in a wide range of industries, such as healthcare, gig economy, financial and business services, industrials, retail, contingent, technology, media and entertainment, transportation and logistics, hospitality, education and government. Employers are facing numerous challenges, including complex and changing legal and regulatory requirements, a rise in fraudulent job applications, a growing spotlight on reputation and a more complex global workforce. Successfully navigating these challenges requires an industry-specific perspective, given differing candidate profiles, economics, competitive dynamics and regulatory demands. To serve these differing needs, our sales and support delivery model is organized around teams dedicated to specific industries (“Verticals”) and geographic markets (“Regions”). Our delivery model provides our clients with both the personal touch and consultative partnership of a small boutique firm and the global reach, scale, innovation and resources of an industry leader. Additionally, this delivery model supports our principle of “Compliance by Design”, enabling clients to maintain compliance globally. We believe the combination of our deep market expertise from our sales and support combined with the flexibility of our proprietary technology platform enable us to deliver industry-relevant, highly specialized solutions to our clients in a scalable manner, driving growth and differentiating us from our competitors.

We offer an extensive suite of global products addressing a wide range of complex client needs, and we see compelling opportunities to continue extending our operating presence in other geographies. We believe we have a unique ability to translate client needs into superior local market solutions through a combination of portfolio depth and breadth, local know-how and language capabilities. Additionally, we view a targeted, disciplined approach to strategic mergers and acquisitions (“M&A”) as highly complementary to our other key growth objectives, compounding and/or accelerating related opportunities. Through our investments in technology, we have established a unified platform, allowing us to quickly integrate targets and drive synergies. Our core platform processes approximately 80% of our global revenue. We expect to continue to increase the revenue processed on

28

our core platform in 2023. We expect Sterling’s proven track record of M&A—with 12 acquisitions over the last 12 years—to continue to support and elevate the various layers of our future growth profile.

Throughout our more than 45-year operating history, innovation and self-disruption have been at the core of what we do every day. Our history of unique, industry-oriented market insights allows us to be at the forefront of innovation which includes multiple industry-leading solutions. For example, we pioneered criminal fulfillment technology (CourtDirect), arrest record and incarceration alert products, post-hire monitoring capabilities, artificial intelligence-enhanced record review and validation process and the industry’s only proprietary technology in a single-sourced U.S.-nationwide fingerprint network. Our commitment to innovation has continued with the recent development of enhanced global language support capabilities, a cloud-based operating platform, our exclusive partnership with the Financial Industry Regulatory Authority, Inc. serving as their fingerprint services provider, and a comprehensive global identity verification solution through our partnership with ID.me in the U.S. and Yoti internationally. Enabled by our market leadership and platform investments, we have established a foundation and roadmap for future innovation which includes industry-specific products, growing our Identity-as-a-Service capabilities and further geographic expansion.

As part of our journey of growth and optimization, we continue to refine our corporate strategy and are committed to our goal of delivering stockholder value by executing on the growth opportunities in front of us. We have a number of key execution elements to help us achieve our goals, including increasing our revenues with existing clients, acquiring new clients, growing market share internationally, and utilizing M&A to supplement our organic revenue growth. As part of our refreshed strategy, in 2022, we began executing on a restructuring program to realign senior leadership and functions, with the goal of elevating our go-to-market strategy and accelerating our technology and product innovation. We believe we are differentiated from competitors and well-positioned to achieve our goal of being the world’s most trusted background and identity services company due to our deep market expertise, unrivaled client service, best-in-class data, and seamless workflows. At the end of 2022, we also launched Project Nucleus, which we expect to drive meaningful cost savings and efficiency gains. The goal of this initiative is to enhance our organization by re-engineering processes, driving fulfillment cost reductions and identifying and executing on additional automation opportunities.

Trends and Other Factors Affecting Our Performance

Macroeconomic and Job Environment

Our business is impacted by the overall economic environment and our clients’ hiring volumes. In the latter half of the third quarter of 2022, base growth began to moderate due to macroeconomic uncertainty related to factors including inflation, monetary policy and fiscal policy. This moderation has continued throughout 2023 during which we experienced a year-over-year decline in base business with our existing clients that offset positive trends in other revenue drivers, including growth from new clients, up-sell and cross-sell and retention. The ongoing macroeconomic factors have caused uncertainty among our clients and general populace of a future economic downturn or recession. Given the uncertain conditions, it is challenging to predict the hiring and turnover trends of our clients.

Effects of Inflation

While inflation may impact our revenues and operating expenses, we believe the effects of inflation, if any, on our results of operations and financial condition have not been significant. However, if inflation continues or worsens, it could negatively impact us by increasing our operating expenses. For example, inflation may lead to cost increases in multiple areas across our business, including the cost of labor. Further, inflation may also cause our customers to reduce their use of our products and services. To the extent that we are unable to pass on these costs through increased prices, revised budget estimates or offset them otherwise, or that we experience lower demand from our customers due to inflation, the rising rate of inflation may adversely affect our business, results of operations and financial condition.

Recent Accounting Standards Updates

Emerging Growth Company

The Jumpstart Our Business Startups Act of 2021 permits us, as an “emerging growth company,” to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to use this extended transition period and, as a result, we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for private companies.

29

We will cease to be an emerging growth company upon the earliest of (a) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (b) the last day of our fiscal year following the fifth anniversary of the date of the initial public offering (“IPO”); (c) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (d) the date on which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur as of the last day of a fiscal year in which the market value of our common stock held by non-affiliates equals or exceeds $700 million as of the last business day of the second fiscal quarter of such fiscal year, which threshold was not exceeded as of June 30, 2023.

Refer to Note 3, “Recent Accounting Standards Updates” of the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for information about recent accounting pronouncements.

Components of Our Results of Operations

The following discussion summarizes the key components of our unaudited condensed consolidated statements of operations and comprehensive income. We have one operating and reportable segment.

Revenues

We generate revenue by providing identity verification and background services to our clients. We have an attractive business model underpinned by stable and highly recurring transactional revenues, significant operating leverage and low capital requirements that contribute to strong cash flow generation. We recognize revenue under the Financial Accounting Standards Board’s Accounting Standards Codification Topic No. 606, “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, we recognize revenue when control of the promised goods or services is transferred to clients, generally at a point in time, in an amount that reflects the consideration that we are entitled to for those goods or services. A majority of our enterprise client contracts are exclusive to Sterling or require Sterling to be used as the primary provider. Additionally, they are typically multi-year agreements with automatic renewal terms, no termination for convenience clauses and set pricing with Sterling’s right to increase prices annually upon notice, including the ability to increase pass-through costs to our clients with 30 days’ notice. The strength of our contracts combined with our high levels of client retention results in a high degree of revenue visibility.

Our revenue drivers are acquiring new clients (which we measure by new client growth, calculated as discussed in the following paragraph), and growth in existing client base through retaining existing clients (which we measure by gross retention rate, calculated as discussed in the following paragraph), and growing our existing client relationships through upselling, cross-selling, and organic and inorganic growth in our client’s operations that lead to an increase in hiring (which we measure by base business growth with existing clients, calculated as discussed in the following paragraph).

New client growth for the relevant period is calculated as revenues from clients that are in the first twelve months of billing with Sterling divided by total revenues from the prior period, expressed as a percentage. Existing client growth is defined as: (i) base business with existing clients due to increased or decreased volumes, which is calculated as change in revenues in the current period from clients that have been billing with us for longer than twelve calendar months, plus (ii) additional revenue from cross-sell and up-sell, net of (iii) attrition, which is the revenue impact from accounts considered lost. Existing client growth is expressed as a percentage, where the denominator is total revenues from the prior period. Gross retention rate is a percentage, the numerator of which is prior period revenues less the revenue impact from accounts considered lost and the denominator is prior period revenues. The revenue impact is calculated as revenue decline of lost accounts in the relevant period from the prior period for the months after they were considered lost. Therefore, the attrition impact of clients lost in the current year may be partially captured in both the current and following period’s retention rates depending on what point during the period they are lost. Our gross retention rate does not factor in the revenue impact, whether growth or decline, attributable to existing clients or the incremental revenue impact of new clients.

In addition to organic growth through the drivers mentioned above, we may from time to time consider acquisitions that drive growth in our business. In those instances, inorganic growth will refer to the revenue from acquisitions for the twelve months following an acquisition. Any incremental revenue generation thereafter will be considered organic growth.

Our revenues come from the following services which are sold as a bundle or individually, with revenue recognized at the time of delivery of background screening reports.

•Identity Verification - Leveraging innovative technologies in fingerprinting, facial recognition and ID validation to verify that candidates are who they say they are.

30

•Background Checks - County, state and federal criminal checks fulfilled through proprietary automation technology enabling global criminal screening capabilities in over 240 countries and territories. Other services include credit checks, civil checks, motor vehicle registration confirmation and social media checks.

•Credential Verification - Thorough employment and education verification services and licensing certification backed by a powerful fulfillment engine.

•Drug and Health Screening - Comprehensive, accurate and fast drug and health screening services through a network of over 20,000 collection sites supporting the Substance Abuse and Mental Health Services Administration in the U.S.

•Onboarding - Custom forms including I-9 and eVerify employment eligibility, tax withholding forms and Equal Employment Opportunity disclosure forms, with built-in compliance and dynamic validation.

•Post-Hire Monitoring - Continuous screening allowing for greater mobility and safety for remote, onsite and contingent jobs and also ensuring prompt risk warnings on any changes to an employee’s profile.

Operating Expenses

Our cost structure is flexible and provides us with operational leverage to be able to effectively adapt to changing client needs and broader economic events. Additionally, in 2021 and 2022, we implemented strategic structural changes in our business to improve operating leverage and accelerate modernizing our technological infrastructure including leveraging robotics process automation and artificial intelligence. We moved to a virtual-first strategy in 2020 and began to close or reduce the size of other offices globally and reduce our data center footprint as we executed moving our revenue to the cloud and streamlined our sales and operations organization for greater operational efficiency. Due to the success to date of the virtual-first strategy, we will continue our real estate consolidation efforts to exit or reduce the size of remaining offices during 2023. In the second quarter of 2023, we closed our former principal executive office and headquarters in New York and moved our headquarters to an existing administrative office in Ohio and closed or reduced the size of additional offices. As of September 30, 2023, we have closed or reduced the size of 23 offices globally since we launched our virtual first strategy.

As part of our refreshed strategy, in 2022, we began executing on a restructuring program to realign senior leadership and functions, with the goal of elevating our go-to-market strategy and accelerating our technology and product innovation. At the end of 2022, we also launched Project Nucleus which we expect to drive meaningful cost savings and efficiency gains in our cost of revenues. This initiative aims to enhance our organization by re-engineering processes, driving fulfillment cost reductions and identifying and executing on additional automation opportunities. In any given period, operating expenses are driven by the amount of revenue, mix of clients and products, and impact of automation, productivity and procurement initiatives. While we expect operating expenses to increase in absolute dollars to support our continued growth, we believe that operating expenses will decline gradually as a percentage of total revenues in the future as we expect our business to grow and our operating scale to continue to improve.

Operating expenses include the following costs:

Cost of Revenues

Cost of revenues includes costs related to delivery of services and includes third-party vendor costs associated with acquisition of data and to a lesser extent, costs related to our onshore and offshore fulfillment teams and facilities and hosting costs for our cloud-based platforms. Our ability to grow profitably depends on our ability to manage our cost structure. Our costs are affected by third-party costs including government fees and data vendor costs, as these third parties have discretion to adjust pricing.

Third-party data costs include amounts paid to third parties for access to government records, other third-party data and services, as well as costs related to our court runner network. Third-party costs of services are largely variable in nature. Where applicable, these are typically invoiced to our clients as direct pass-through costs.

Cost of revenues also includes salaries, benefits and stock-based compensation expense for personnel involved in the processing and fulfillment of our screening products and solutions, as well as our client care organization, and facilities costs for our onshore and offshore fulfillment centers. Additional vendor costs are third-party costs for robotics process automation related to fulfillment, and third-party costs related to hosting our fulfillment platforms in the cloud. We do not allocate depreciation and amortization to cost of revenues.

Corporate Technology and Production Systems

Included in this line item are costs related to maintaining our corporate information technology infrastructure and non-capitalizable costs to develop and maintain our production systems.

31

Corporate information technology expenses consist of personnel costs, including stock-based compensation, supporting internal operations such as information technology support and the maintenance of our information security and business continuity functions. Also included are third-party costs including cloud computing costs that support our corporate internal systems, software licensing and maintenance, telecommunications and other technology infrastructure costs.

Production systems costs consist of non-capitalizable personnel costs including contractor costs incurred for the development of platform and product initiatives, and production support and maintenance. Platform and product initiatives facilitate the development of our technology platform and the launch of new screening products. Production support and maintenance includes costs to support and maintain the technology underlying our existing screening products, and to enhance the ease of use for our cloud applications. Certain personnel costs related to new products and features are capitalized and amortization of these capitalized costs is included in the depreciation and amortization line item.

Included within Corporate technology and production systems are non-capitalizable production system and corporate information technology expenses related to Project Ignite, a three-phase strategic investment initiative. Phase one of Project Ignite modernized client and candidate experiences and is complete. Phase two of Project Ignite, which was completed in 2022, focused on decommissioning our on-premises data centers and migrating our production systems and corporate information technological infrastructure to a managed service provider in the cloud and resulted in approximately 98% of our revenue being processed through platforms hosted in the cloud and allows us to consistently maintain 99.9% platform availability while being prepared to scale into the future. Phase three of Project Ignite was decommissioning of platforms purchased over the prior ten years and the migration of the clients to one global platform. This third and final phase, which was completed in the first quarter of 2023, unified our clients onto a single global platform. Our core platform now processes approximately 80% of our global revenue. We expect to continue to increase the revenue processed on our core platform in 2023.

Selling, General and Administrative

Selling expenses consist of personnel costs, travel expenses and other expenses for our client success, sales and marketing teams. Additionally, selling expenses include the cost of marketing and promotional events, corporate communications and other brand-building activities. General and administrative expenses consist of personnel and related expenses for human resources, legal and compliance, finance, global shared services and executives. Additional costs include professional fees, stock-based compensation, insurance premiums and other corporate expenses.

While our selling, general and administrative (“SG&A”) expenses have increased over the last several years due to additional public company related reporting and compliance costs, we expect expenses to stabilize in the future as a result of strategic initiatives to drive operational efficiencies.

In addition, non-cash stock-based compensation expense associated with special one-time bonus grants in connection with the IPO of options and restricted stock under our Sterling Check Corp. 2021 Omnibus Incentive Plan (discussed in Note 15, “Stock-based Compensation” to our audited consolidated financial statements included in Part II, Item 8. “Financial Statements and Supplementary Data” of our 2022 Annual Report) began in the third quarter of 2021 and will continue over the following four years. Over the long term, we expect our SG&A expenses to decrease as a percentage of our revenue as we leverage our past investments.

Depreciation and Amortization

Definite-lived intangible assets consist of intangibles acquired through acquisition and the costs of developing internal-use software. They are amortized using a straight-line basis over their estimated useful lives except for customer lists, to which we apply an accelerated method of amortization. The costs of developing internal-use software are capitalized during the application development stage. Amortization commences when the software is placed into service and is computed using the straight-line method over the useful life of the underlying software of three years.

Depreciation of our property and equipment is computed on the straight-line basis over the estimated useful life of the assets, generally three to five years or, for leasehold improvements, the shorter of seven years or the term of the lease.

Impairment of Long-Lived Assets

Long-lived assets, such as property, equipment, operating leases right-of-use assets, and capitalized internal use software subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, such as (i) a significant adverse change in the

32

extent or manner in which it is being used or in its physical condition, (ii) a significant adverse change in legal factors or in business climate that could affect its value, or (iii) a current-period operation or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with its use. An asset is considered impaired if the carrying amount exceeds the undiscounted future net cash flows the asset is expected to generate. An impairment charge is recognized for the amount by which the carrying amount of the assets exceeds its fair value. The adjusted carrying amount of the asset becomes its new cost basis. For a depreciable long-lived asset, the new cost basis will be depreciated or amortized over the remaining useful life of that asset. Assets held for sale are reported at the lower of the carrying amount or fair value, less selling costs.

Interest Expense, Net

Interest expense consists of interest, the amortization of loan discount and deferred financing fees on the outstanding debt, and includes proceeds received or settlements paid on our designated interest rate swaps.

On February 28, 2023, we entered into amortizing $300.0 million notional value interest rate swaps. The notional value steps down from $300.0 million to $150.0 million on February 27, 2026. The swap provides for us to pay, as applied to the notional value, a fixed rate of interest of 4.26% monthly and receive, on a monthly basis, an amount equal to the greater of the one-month term Secured Overnight Financing Rate (“SOFR”) and a floor of (0.10%), as applied to the notional value (the “Floating Leg”). The interest rate swap matures on November 29, 2027.

Gain or Loss on Interest Rate Swaps

Gain on interest rate swaps consists of realized and unrealized gains or losses on our historical non-designated derivative interest rate swaps, which we entered into to reduce our exposure to variability in expected future cash flows on our previous credit agreement, which bore interest at a variable rate. Unrealized gains and losses result from changes in the fair value of the swap and realized gains and losses reflect the amounts payable or receivable between the fixed rate on the swap and the variable rate under the previous credit agreement. Our non-designated derivative interest rate swap expired in June 2022 and did not qualify for hedge accounting treatment.

Income Tax Provision or Benefit

Income tax provision consists of domestic and foreign corporate income taxes related to earnings from our sale of services, with statutory tax rates that differ by jurisdiction. We expect the income earned by our international entities to grow over time as a percentage of total income, which may impact our effective income tax rate. However, our effective tax rate will be affected by many other factors including changes in tax laws, regulations or rates, new interpretations of existing laws or regulations, shifts in the allocation of income earned throughout the world and changes in overall levels of income before tax. The computation of the provision for or benefit from income taxes for interim periods is determined by applying the estimated annual effective tax rate to year-to-date income or loss before tax and adjusting for discrete tax items recorded in the period, if any.

33

Results of Operations

Three Months Ended September 30, 2023 compared to the Three Months Ended September 30, 2022

The following table sets forth certain historical consolidated and comparative financial information for the periods presented:

	Three Months Ended September 30,						Increase/ (Decrease)
(dollars in thousands, except per share amounts)	2023			2022			$		%
Revenues	$	180,566		$	199,299		$	(18,733)	(9.4)	%
Cost of revenues (exclusive of depreciation and amortization below)	95,882			106,422			(10,540)		(9.9)	%
Corporate technology and production systems	11,329			13,715			(2,386)		(17.4)	%
Selling, general and administrative	42,382			42,411			(29)		(0.1)	%
Depreciation and amortization	15,875			16,570			(695)		(4.2)	%
Impairments and disposals of long-lived assets	48			193			(145)		(75.1)	%
Total operating expenses	165,516			179,311			(13,795)		(7.7)	%
Operating income	15,050			19,988			(4,938)		(24.7)	%
Interest expense, net	9,305			7,764			1,541		19.8	%
Other income	(561)			(560)			1		0.2	%
Total other expense, net	8,744			7,204			1,540		21.4	%
Income before income taxes	6,306			12,784			(6,478)		(50.7)	%
Income tax provision	3,952			3,481			471		13.5	%
Net income	$	2,354		$	9,303		$	(6,949)	(74.7)	%
Net income margin	1.3		%	4.7		%			(340) bps
Net income per share—basic	$	0.03		$	0.10		$	(0.07)	(70.0)	%
Net income per share—diluted	$	0.03		$	0.09		$	(0.06)	(66.7)	%

Revenues

Revenues decreased by 9.4%, or $18.7 million, from $199.3 million for the three months ended September 30, 2022 to $180.6 million for the three months ended September 30, 2023. The 9.4% decrease in revenue was driven by a 11.9% decrease in organic constant currency revenue partially offset by 2.4% inorganic growth from the acquisitions of Socrates Limited and its affiliates (“Socrates”) and A-Check Global (“A-Check”) and a 0.1% favorable impact from fluctuations in foreign currency. The organic revenue decrease reflected a decline in existing client business of approximately 17% including base, cross-sell and up-sell, and net of attrition offset by new client growth of approximately 5%. Year-over-year decline in base business was driven by lower hiring volumes by our clients due to macroeconomic uncertainty. Our investments in technology and products, coupled with our best-in-class turnaround times and customer-first focus, enabled our gross retention rate to remain strong at approximately 95% for the last twelve months ended September 30, 2023. Pricing was relatively stable across the periods and not meaningful to the change in revenues.

Total revenue in our U.S. business decreased 8.9% year-over-year. This decline is primarily driven by Financial and Business Services, Industrials, and Tech and Media Verticals. Our international business experienced total revenue decline of 12.0% driven by a decline in base business partially offset by favorable foreign exchange fluctuation.

Cost of Revenues

Cost of revenues decreased by 9.9%, or $10.5 million, from $106.4 million for the three months ended September 30, 2022 to $95.9 million for the three months ended September 30, 2023. This was primarily driven by a $10.0 million decrease due to decreased volume, with the remaining decrease due to lower payroll and related costs as a result of fulfillment optimization and lower facilities costs due to the closure of certain fulfillment centers in the second quarter of 2023.

34

Cost of revenues as a percentage of revenues decreased by 30 basis points from 53.4% for the three months ended September 30, 2022 to 53.1% for the three months ended September 30, 2023 driven by lower payroll and related costs and facilities costs as a percentage of revenue.

Corporate Technology and Production Systems

Corporate technology and production systems decreased by 17.4%, or $2.4 million, from $13.7 million for the three months ended September 30, 2022 to $11.3 million for the three months ended September 30, 2023. These expenses include costs related to maintaining our corporate information technology infrastructure and non-capitalizable costs to develop and maintain our production systems. Costs related to maintaining our corporate information technology infrastructure decreased by $2.3 million from $7.0 million for the three months ended September 30, 2022 to $4.7 million for the three months ended September 30, 2023 primarily due to lower payroll and related expenses, lower telecommunications, software licenses, software maintenance support, and other expenses as a result of restructuring efforts. Costs to develop platform and product initiatives remained flat at $4.4 million for the three months ended September 30, 2022 and September 30, 2023. Costs related to maintaining our production systems remained flat at $2.3 million for the three months ended September 30, 2022 and September 30, 2023.

These expenses also include non-capitalizable costs related to Project Ignite. We incurred $1.3 million related to phase two and $2.9 million related to phase three during the three months ended September 30, 2022. The third and final phase of Project Ignite was completed in the first quarter of 2023. For more information about Project Ignite, please see “—Components of our Results of Operations—Operating Expenses—Corporate Technology and Production Systems.”

For the three months ended September 30, 2023, corporate technology and production systems expenses also include $0.6 million of restructuring-related charges to support our strategy refresh and the execution against Project Nucleus.

Selling, General and Administrative

Selling, general and administrative expenses remained flat at $42.4 million for the three months ended September 30, 2022 and September 30, 2023. Year-over-year, there was an increase in stock-based compensation of $3.5 million and an increase of $2.9 million of restructuring related charges of which $2.7 million related to charges to support our strategy refresh and execution against Project Nucleus. These year-over-year increases were partially offset by a $3.2 million decrease in payroll, bonus, commissions and other employee related costs due to reduction in headcount from restructuring efforts, a $2.6 million decrease in insurance, marketing, professional fees and other operating expenses as a result of cost optimization efforts, and a $0.7 million decrease as a result of reassessing the estimated fair value of contingent consideration as of September 30, 2023.

Depreciation and Amortization

Depreciation and amortization expense decreased by 4.2%, or $0.7 million, from $16.6 million for the three months ended September 30, 2022 to $15.9 million for the three months ended September 30, 2023, primarily due to a $1.8 million decrease in intangible asset amortization resulting from assets being fully amortized and new intangible assets being added at lower rates compared to those which became fully amortized in the period. This year-over-year decrease was partially offset by a $1.3 million increase in amortization of intangible assets acquired from the Socrates and A-Check acquisitions.

Interest Expense, Net

Interest expense increased by 19.8%, or $1.5 million, from $7.8 million for the three months ended September 30, 2022 to $9.3 million for the three months ended September 30, 2023 primarily due to the increase in interest rates. The realized gain or loss on interest rate swaps designated as hedging instruments that we entered into in February 2023 is included in interest expense. This realized gain was $0.8 million and was recorded as a reduction to interest expense. Amortization of the loan discount and deferred financing fees resulted in expense of $0.5 million and $0.5 million for the three months ended September 30, 2023 and 2022, respectively.

Income Tax Provision

Income tax provision increased $0.5 million from $3.5 million for the three months ended September 30, 2022 to $4.0 million for the three months ended September 30, 2023, resulting in an effective tax rate of 27.2% and 62.7%, respectively. The increase in the income tax provision is primarily due to an increase in permanent items, offset by the decrease in income before taxes. Income before taxes decreased $6.5 million from $12.8 million for the three months ended September 30, 2022 to $6.3 million for the three months ended September 30, 2023. For

35

the three months ended September 30, 2023 and 2022, the effective rate differs from the statutory rate mainly due to a jurisdictional mix of earnings and permanent items.

Net Income and Net Income Margin

Net income decreased $6.9 million from $9.3 million for the three months ended September 30, 2022 to $2.4 million for the three months ended September 30, 2023. Net income margin decreased from 4.7% for the three months ended September 30, 2022 to 1.3% for the three months ended September 30, 2023.

The decrease in both net income and net income margin resulted primarily from lower revenues due to the macroeconomic environment, increased interest expense due to the rising interest rate environment, and increased income tax provision due to increase in permanent items.

Net Income per Share

Net income per share—basic decreased $0.07 per share from $0.10 per share for the three months ended September 30, 2022 to $0.03 per share for the three months ended September 30, 2023 and net income per share—diluted decreased $0.06 per share from $0.09 per share for the three months ended September 30, 2022 to $0.03 per share for the three months ended September 30, 2023 due to the decrease in net income.

Nine Months Ended September 30, 2023 compared to the Nine Months Ended September 30, 2022

The following table sets forth certain historical consolidated financial performance for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022.

	Nine Months Ended September 30,						Increase/ (Decrease)
(dollars in thousands, except per share amounts)	2023			2022			$		%
Revenues	$	550,224		$	596,862		$	(46,638)	(7.8)	%
Cost of revenues (exclusive of depreciation and amortization below)	292,692			314,954			(22,262)		(7.1)	%
Corporate technology and production systems	34,709			38,806			(4,097)		(10.6)	%
Selling, general and administrative	134,743			126,630			8,113		6.4	%
Depreciation and amortization	47,117			56,598			(9,481)		(16.8)	%
Impairments and disposals of long-lived assets	7,193			805			6,388		793.5	%
Total operating expenses	516,454			537,793			(21,339)		(4.0)	%
Operating income	33,770			59,069			(25,299)		(42.8)	%
Interest expense, net	26,903			20,719			6,184		29.8	%
Gain on interest rate swaps	—			(296)			296		N/M
Other income	(1,370)			(1,422)			(52)		(3.7)	%
Total other expense, net	25,533			19,001			6,532		34.4	%
Income before income taxes	8,237			40,068			(31,831)		(79.4)	%
Income tax provision	4,969			12,958			(7,989)		(61.7)	%
Net income	$	3,268		$	27,110		(23,842)		(87.9)	%
Net income margin	0.6		%	4.5		%			(390) bps
Net income per share—basic	$	0.04		$	0.29		$	(0.25)	(86.2)	%
Net income per share—diluted	$	0.03		$	0.27		$	(0.24)	(88.9)	%

_________________________

N/M—Not meaningful.

Revenues

Revenues decreased by 7.8%, or $46.6 million, from $596.9 million for the nine months ended September 30, 2022 to $550.2 million for the nine months ended September 30, 2023. The 7.8% decrease in revenue was driven by a 9.8% decrease in organic constant currency revenue and a 0.4% unfavorable impact from fluctuations in foreign currency partially offset by 2.4% inorganic growth from the acquisitions of Socrates and A-Check. The organic revenue decrease reflected a decline in existing client business of approximately 15% including base, cross-sell and up-sell, and net of attrition offset by new client growth of approximately 5%. Year-over-year decline in base business was driven by lower hiring volumes by our clients due to macroeconomic uncertainty. Our

36

investments in technology and products, coupled with our best-in-class turnaround times and customer-first focus, enabled our gross retention rate to remain strong at approximately 95% for the last twelve months ended September 30, 2023. Pricing was relatively stable across the periods and not meaningful to the change in revenues.

Total revenue in our U.S. business decreased 7.3% year-over-year. We experienced growth in our Healthcare Vertical, however, this growth was primarily offset by declines in our Financial and Business Services, Tech and Media, and Contingent Verticals. Our international business experienced total revenue decline of 10.7% driven by a decline in base business combined with the unfavorable foreign exchange fluctuation.

Cost of Revenues

Cost of revenues decreased by 7.1%, or $22.3 million, from $315.0 million for the nine months ended September 30, 2022 to $292.7 million for the nine months ended September 30, 2023. This was primarily driven by a $24.6 million decrease due to decreased volume partially offset by $2.3 million of higher costs of which $0.6 million was accelerated costs related to the completion of the Employment Background Investigations, Inc. (“EBI”) platform migration, and the remaining $1.7 million includes facilities costs due to accelerated rent for the closure of certain fulfillment centers in the second quarter of 2023 and higher third-party vendor and hosting costs as a percentage of revenue, because a proportion of costs are fixed.

Cost of revenues as a percentage of revenues increased by 40 basis points from 52.8% for the nine months ended September 30, 2022 to 53.2% for the nine months ended September 30, 2023 driven by the accelerated costs related to the completion of the EBI platform migration and rent recorded on decommissioned fulfillment centers and higher fulfillment and hosting costs as a percentage of revenue.

Corporate Technology and Production Systems

Corporate technology and production systems decreased by 10.6%, or $4.1 million, from $38.8 million for the nine months ended September 30, 2022 to $34.7 million for the nine months ended September 30, 2023. These expenses include costs related to maintaining our corporate information technology infrastructure and non-capitalizable costs to develop and maintain our production systems.

Costs related to maintaining our corporate information technology infrastructure decreased by $4.6 million from $19.4 million for the nine months ended September 30, 2022 to $14.9 million for the nine months ended September 30, 2023 primarily due to lower payroll and related expenses, lower telecommunications, software maintenance support, software licenses, and other expenses as a result of restructuring efforts. Costs to develop platform and product initiatives increased slightly from $12.8 million for the nine months ended September 30, 2022 to $13.1 million for the nine months ended September 30, 2023. Costs related to maintaining our production systems increased slightly from $6.6 million for the nine months ended September 30, 2022 to $6.8 million for the nine months ended September 30, 2023.

These expenses also include non-capitalizable costs related to Project Ignite. We incurred $3.7 million related to phase two and $7.5 million related to phase three during the nine months ended September 30, 2022, and $3.1 million related to phase three during the nine months ended September 30, 2023. The third and final phase of Project Ignite was completed in the first quarter of 2023. For more information about Project Ignite, please see “—Components of our Results of Operations—Operating Expenses—Corporate Technology and Production Systems.”

For the nine months ended September 30, 2023, corporate technology and production systems expenses also include $1.2 million of restructuring-related charges to support our strategy refresh and the execution against Project Nucleus.

Selling, General and Administrative

Selling, general and administrative expenses increased by 6.4%, or $8.1 million, from $126.6 million for the nine months ended September 30, 2022 to $134.7 million for the nine months ended September 30, 2023. The year-over-year increase was primarily driven by an increase in stock-based compensation of $9.6 million, a $8.9 million increase in restructuring related charges of which $7.5 million includes charges to support our strategy refresh and the execution against Project Nucleus, and $1.4 million relates to accelerated rent and facilities costs in connection with office closures. Additional year-over-year increases include $3.9 million in professional fees and transaction related expenses to support the Socrates and A-Check acquisitions as well as the secondary public offering executed in June 2023. These year-over-year increases were partially offset by a $9.9 million decrease in payroll, bonus, commissions and other employee related costs due to reduction in headcount from restructuring efforts and a $4.4 million decrease in insurance, marketing, other professional fees and other operating expenses as a result of cost optimization efforts, and a $0.7 million decrease as a result of reassessing the estimated fair value of contingent consideration as of September 30, 2023.

37

Depreciation and Amortization

Depreciation and amortization expense decreased by 16.8%, or $9.5 million, from $56.6 million for the nine months ended September 30, 2022 to $47.1 million for the nine months ended September 30, 2023, primarily due to a $12.4 million decrease in intangible asset amortization resulting from assets being fully amortized and new intangible assets being added at lower rates compared to those which became fully amortized in the period and a $0.2 million decrease in depreciation expense as a result of fixed asset disposals in connection with office closures. This year-over-year decrease was partially offset by a $3.5 million increase in amortization of intangible assets acquired from the Socrates and A-Check acquisitions.

Impairments and Disposals of Long-Lived Assets

Impairments and disposals of long-lived assets increased by $6.4 million from $0.8 million for the nine months ended September 30, 2022 to $7.2 million for the nine months ended September 30, 2023. The impairments and disposals of long-lived assets during the nine months ended September 30, 2023 primarily resulted from a $5.3 million impairment charge on ROU assets and $1.8 million of asset disposals in connection with our real estate consolidation efforts.

Interest Expense, Net

Interest expense increased by 29.8%, or $6.2 million, from $20.7 million for the nine months ended September 30, 2022 to $26.9 million for the nine months ended September 30, 2023 primarily due to the increase in interest rates. The realized gain or loss on interest rate swaps designated as hedging instruments that we entered into in February 2023 is included in interest expense. This realized gain was $1.4 million and was recorded as a reduction to interest expense. Amortization of the loan discount and deferred financing fees resulted in expense of $1.4 million for the nine months ended September 30, 2023 and 2022.

Gain on Interest Rate Swaps

Gain on interest rate swaps totaled $0.3 million for the nine months ended September 30, 2022 due to a mark-to-market gain of $4.1 million partially offset by a realized loss of $3.8 million. The historical non-designated derivative interest rate swaps expired in June 2022.

Income Tax Provision

Income tax provision decreased by $8.0 million from $13.0 million for the nine months ended September 30, 2022 to $5.0 million for the nine months ended September 30, 2023, resulting in an effective tax rate of 32.3% and 60.3%, respectively. The decrease in income tax provision is primarily due to the decrease in income before taxes. Income before taxes decreased $31.8 million from $40.1 million for the nine months ended September 30, 2022 to $8.2 million for the nine months ended September 30, 2023. For the nine months ended September 30, 2023 and 2022, the effective rate differs from the statutory rate mainly due to a jurisdictional mix of earnings and permanent items.

Net Income and Net Income Margin

Net income decreased by $23.8 million from $27.1 million for the nine months ended September 30, 2022 to $3.3 million for the nine months ended September 30, 2023. Net income margin decreased from 4.5% for the nine months ended September 30, 2022 to 0.6% for the nine months ended September 30, 2023.

The decrease in both net income and net income margin resulted primarily from lower revenues due to the macroeconomic environment, impairments of long-lived assets incurred in the second quarter due to office closures, restructuring and offering expenses, and increased interest expense due to the rising interest rate environment.

Net Income per Share

Net income per share—basic decreased $0.25 per share from $0.29 per share for the nine months ended September 30, 2022 to $0.04 per share for the nine months ended September 30, 2023 and net income per share—diluted decreased $0.24 per share from $0.27 per share for the nine months ended September 30, 2022 to $0.03 per share for the nine months ended September 30, 2023 due to the decrease in net income.

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q contains “non-GAAP financial measures,” which are financial measures that are not calculated and presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

38

Specifically, we make use of the non-GAAP financial measures “organic constant currency revenue growth (decline)”, “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Net Income,” “Adjusted Earnings Per Share” and “Free Cash Flow” to assess the performance of our business.

Organic constant currency revenue growth (decline) is calculated by adjusting for inorganic revenue growth (decline), which is defined as the impact to revenue growth (decline) in the current period from M&A activity that has occurred over the past twelve months, and converting the current period revenue at foreign currency exchange rates consistent with the prior period. For the three and nine months ended September 30, 2023, we have provided the impact of revenue from the acquisitions of Socrates and A-Check during the first quarter of 2023 and for the three and nine months ended September 30, 2022, we have provided the impact of revenue from the acquisition of EBI in November 2021. We present organic constant currency revenue growth (decline) because we believe it assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance; however, it has limitations as an analytical tool, and you should not consider such a measure either in isolation or as a substitute for analyzing our results as reported under GAAP. In particular, organic constant currency revenue growth (decline) does not reflect M&A activity or the impact of foreign currency exchange rate fluctuations.

Adjusted EBITDA is defined as net income (loss) adjusted for provision (benefit) for income taxes, interest expense, depreciation and amortization, stock-based compensation, transaction expenses related to the IPO, one-time public company transition expenses and costs associated with financing transactions, M&A activity, optimization and restructuring, technology transformation costs, foreign currency (gains) and losses and other costs affecting comparability. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by revenue for the applicable period. We present Adjusted EBITDA and Adjusted EBITDA Margin because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management and our board of directors use Adjusted EBITDA and Adjusted EBITDA Margin to evaluate the factors and trends affecting our business to assess our financial performance and in preparing and approving our annual budget and believe they are helpful in highlighting trends in our core operating performance. Further, our executive incentive compensation is based in part on components of Adjusted EBITDA. Adjusted EBITDA and Adjusted EBITDA Margin have limitations as analytical tools and should not be considered in isolation or as substitutes for our results as reported under GAAP. Adjusted EBITDA excludes items that can have a significant effect on our profit or loss and should, therefore, be considered only in conjunction with net income (loss) for the period. Because not all companies use identical calculations, these measures may not be comparable to other similarly titled measures of other companies.

Adjusted Net Income is a non-GAAP profitability measure. Adjusted Net Income is defined as net income (loss) adjusted for amortization of acquired intangible assets, stock-based compensation, transaction expenses related to the IPO, one-time public company transition expenses and costs associated with financing transactions, M&A activity, optimization and restructuring, technology transformation costs, and certain other costs affecting comparability, adjusted for the applicable tax rate. Adjusted Earnings Per Share is defined as Adjusted Net Income divided by diluted weighted average shares for the applicable period. We present Adjusted Net Income and Adjusted Earnings Per Share because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding certain material non-cash items and unusual items that we do not expect to continue at the same level in the future. Our management believes that the inclusion of supplementary adjustments to net income (loss) applied in presenting Adjusted Net Income provide additional information to investors about certain material non-cash items and about items that we do not expect to continue at the same level in the future. Adjusted Net Income and Adjusted Earnings Per Share have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing our results as reported under GAAP.

Free Cash Flow is defined as Net Cash provided by (used in) Operating Activities minus purchases of property and equipment and purchases of intangible assets and capitalized software. We present Free Cash Flow because we believe it provides cash available for strategic measures, after making necessary capital investments in property and equipment to support ongoing business operations, and provides investors with the same measures that management uses as the basis for making resource allocation decisions. Free Cash Flow has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under GAAP. Historically, we presented Adjusted Free Cash Flow, defined as Net Cash provided by (used in) Operating Activities minus purchases of property and equipment and purchases of intangible assets and capitalized software and reflecting adjustments for one-time, cash, non-operating expenses related to the IPO. As there are no adjustments related to the IPO for the three and nine months ended September 30, 2023 and 2022,

39

nor in the subsequent periods from such dates, management believes that Free Cash Flow is a more relevant measure.

Organic Constant Currency Revenue Growth (Decline)

The following table reconciles revenue growth (decline), the most directly comparable GAAP measure, to organic constant currency revenue growth (decline) for the periods presented. For the three and nine months ended September 30, 2022, we have provided the impact of revenue from the acquisition of EBI. For the three and nine months ended September 30, 2023, we have provided the impact of revenue from the acquisitions of Socrates and A-Check.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Reported revenue (decline) growth	(9.4)	%	17.5	%	(7.8)	%	27.5	%
Inorganic revenue growth(1)	2.4	%	6.7	%	2.4	%	7.4	%
Impact from foreign currency exchange(2)	0.1	%	(1.6)	%	(0.4)	%	(1.2)	%
Organic constant currency revenue (decline) growth	(11.9)	%	12.4	%	(9.8)	%	21.3	%

_________________________

(1)Impact to revenue growth (decline) in the current period from M&A activity that has occurred over the past twelve months.

(2)Impact to revenue growth (decline) in the current period from fluctuations in foreign currency exchange rates.

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA decreased by 10.4%, or $5.5 million, from $53.1 million for the three months ended September 30, 2022 to $47.6 million for the three months ended September 30, 2023. Adjusted EBITDA Margin decreased by 30 basis points year-over-year from 26.6% for the three months ended September 30, 2022 to 26.3% for the three months ended September 30, 2023. The decrease in Adjusted EBITDA and Adjusted EBITDA Margin was predominantly driven by a decline in revenues due to macroeconomic uncertainty resulting in moderation in our base revenue, partially offset by lower costs driven by volume and our cost optimization efforts.

Adjusted EBITDA decreased by 9.0%, or $14.1 million, from $157.2 million for the nine months ended September 30, 2022 to $143.1 million for the nine months ended September 30, 2023. Adjusted EBITDA Margin decreased by 30 basis points year-over-year from 26.3% for the nine months ended September 30, 2022 to 26.0% for the nine months ended September 30, 2023. The decrease in Adjusted EBITDA and Adjusted EBITDA Margin was predominantly driven by a decline in revenues due to macroeconomic uncertainty resulting in moderation in our base revenue, partially offset by lower costs driven by volume and our cost optimization efforts.

The following table reconciles net income, the most directly comparable GAAP measure, to Adjusted EBITDA for the periods presented:

	Three Months Ended September 30,						Nine Months Ended September 30,
(dollars in thousands)	2023			2022			2023			2022
Net income	$	2,354		$	9,303		$	3,268		$	27,110
Income tax provision	3,952			3,481			4,969			12,958
Interest expense, net	9,305			7,764			26,903			20,719
Depreciation and amortization	15,875			16,570			47,117			56,598
Stock-based compensation	9,783			6,293			27,184			17,424
Transaction expenses(1)	2,238			2,809			10,497			6,591
Restructuring(2)	4,018			2,730			18,781			3,912
Technology transformation(3)	256			4,767			3,668			13,066
Settlements impacting comparability(4)	—			213			—			213
Gain on interest rate swaps(5)	—			—			—			(296)
Other(6)	(225)			(832)			721			(1,089)
Adjusted EBITDA	$	47,556		$	53,098		$	143,108		$	157,206
Adjusted EBITDA Margin	26.3		%	26.6		%	26.0		%	26.3		%

_________________________

40

(1)Consists of transaction expenses related to M&A, associated earn-outs, costs related to the preparation of the IPO, one-time public company transition expenses and fees associated with financing transactions. For the three months ended September 30, 2023, costs consisted primarily of $1.5 million of M&A related costs for the acquisitions of Socrates and A-Check and $0.7 million of costs of one-time public company transition expenses and ancillary non-recurring public company expenses. For the three months ended September 30, 2022, costs consisted primarily of $1.3 million of one-time public company transition expenses and $1.5 million in costs related to M&A. For the nine months ended September 30, 2023, costs consisted primarily of $6.1 million of M&A related costs for the acquisitions of Socrates and A-Check, $1.2 million of M&A costs for the EBI acquisition primarily due to the acceleration of contract costs related to the completion of the EBI platform migration, and $3.2 million of registration statement costs, costs to support the secondary public offering in June 2023, one-time public company transition expenses and expenses related to executing our interest rate swap. For the nine months ended September 30, 2022, costs consisted primarily of $4.0 million of one-time public company transition expenses and $2.6 million in costs related to M&A.

(2)Consists of restructuring-related costs, including executive recruiting and severance charges, and lease termination costs and disposal of fixed assets related to our real estate consolidation efforts. Beginning in 2020, we began executing a virtual-first strategy, closing offices and reducing office space globally. In 2022, we began executing on a restructuring program to realign senior leadership and functions with the goal of elevating our go-to-market strategy and accelerating our technology and product innovation. At the end of 2022, we also launched Project Nucleus which we expect to drive meaningful cost savings and efficiency gains in our cost of revenues. For the three months ended September 30, 2023, costs consisted of $3.4 million of restructuring-related charges and $0.6 million in connection with executing against our real estate consolidation program. For the three months ended September 30, 2022, costs consisted of approximately $2.0 million of restructuring-related executive recruiting and severance charges as well as one one-time consulting and other costs and $0.7 million in expenses related to our real estate consolidation program primarily related to the exit of EBI’s office. For the nine months ended September 30, 2023, costs consisted of $9.9 million in connection with executing against our real estate consolidation program which included a $5.3 million impairment charge on ROU assets, $2.5 million of accelerated rent, facilities costs and other charges in connection with office closures, as well as $1.8 million of fixed asset disposals and $8.9 million of restructuring-related charges. For the nine months ended September 30, 2022, costs consisted of approximately $2.0 million of restructuring-related executive recruiting and severance charges as well as one one-time consulting and other costs and $1.7 million in expenses related to our real estate consolidation program, primarily due to the exit of EBI’s office.

(3)Includes costs related to technology modernization, as well as costs related to decommissioning of on-premise production systems and redundant fulfillment systems of acquired companies and the migration to our platform. We believe that these costs are discrete and non-recurring in nature, as they relate to a one-time restructuring and decommissioning of our on-premise production systems and corporate technological infrastructure and the move to a managed service provider, decommissioning redundant fulfillment systems and modernizing internal functional systems. As such, they are not normal, recurring operating expenses and are not reflective of ongoing trends in the cost of doing business. The significant majority of these are related to the last two phases of Project Ignite, a three-phase strategic investment initiative launched in 2019 to create an enterprise-class global platform, with the remainder related to an investment made to modernize internal functional systems in preparation for our public company infrastructure. Phase two of Project Ignite was completed in 2022 and phase three of Project Ignite was completed in the first quarter of 2023. For the three months ended September 30, 2023, $0.3 million related to decommissioning of the redundant production and fulfillment systems of A-Check and the redundant fulfillment systems of Socrates. For the three months ended September 30, 2022, investment related to Project Ignite was $4.2 million and the remaining $0.6 million related to costs for decommissioning of the on-premise production system and decommissioning of the redundant fulfillment system of EBI and migrating onto our platform. For the nine months ended September 30, 2023, investment related to the conclusion of Project Ignite was $3.1 million and the remaining $0.6 million related to costs for decommissioning of the on-premise production system and decommissioning of the redundant fulfillment system of EBI and migrating onto our platform and decommissioning costs of the A-Check and Socrates systems. For the nine months ended September 30, 2022, investment related to Project Ignite was $11.1 million and the remaining $1.9 million related to costs for decommissioning of the on-premise production system and decommissioning of the redundant fulfillment system of EBI and migrating onto our platform.

(4)Consists of non-recurring settlements and the related legal fees impacting comparability.

(5)Consists of gains or losses on historical non-designated derivative interest rate swaps. See Part I. Item 3. “Quantitative and Qualitative Disclosures about Market Risk—Interest Rate Risk” for additional information on interest rate swaps.

(6)Consists of gains or losses on foreign currency transactions and impairment of capitalized software.

The following table presents the calculation of Net income margin and Adjusted EBITDA Margin for the periods presented:

	Three Months Ended September 30,						Nine Months Ended September 30,
(dollars in thousands)	2023			2022			2023			2022
Net income	$	2,354		$	9,303		$	3,268		$	27,110
Adjusted EBITDA	$	47,556		$	53,098		$	143,108		$	157,206
Revenues	$	180,566		$	199,299		$	550,224		$	596,862
Net income margin	1.3		%	4.7		%	0.6		%	4.5		%
Adjusted EBITDA Margin	26.3		%	26.6		%	26.0		%	26.3		%

Adjusted Net Income and Adjusted Earnings Per Share

Adjusted Net Income decreased by 15.2%, or $4.4 million, from $29.2 million for the three months ended September 30, 2022 to $24.7 million for the three months ended September 30, 2023. Adjusted Earnings Per Share—basic decreased by 12.9%, or $0.04 per share, from $0.31 per share for the three months ended September 30, 2022 to $0.27 per share for the three months ended September 30, 2023. Adjusted Earnings Per Share—diluted decreased from $0.29 per share for the three months ended September 30, 2022 to $0.26 per share for the three

41

months ended September 30, 2023. The decrease in Adjusted Net Income, Adjusted Earnings Per Share—basic, and Adjusted Earnings Per Share—diluted was primarily driven by the decline in revenues due to macroeconomic uncertainty resulting in moderation in our base revenue, partially offset by lower costs driven by volume and our cost optimization efforts.

Adjusted Net Income decreased by 13.8%, or $11.8 million, from $86.1 million for the nine months ended September 30, 2022 to $74.2 million for the nine months ended September 30, 2023. Adjusted Earnings Per Share—basic decreased by 12.0%, or $0.11 per share, from $0.92 per share for the nine months ended September 30, 2022 to $0.81 per share for the nine months ended September 30, 2023. Adjusted Earnings Per Share—diluted decreased from $0.87 per share for the nine months ended September 30, 2022 to $0.79 per share for the nine months ended September 30, 2023. The decrease in Adjusted Net Income, Adjusted Earnings Per Share—basic, and Adjusted Earnings Per Share—diluted was primarily driven by the decline in revenues due to macroeconomic uncertainty resulting in moderation in our base revenue partially offset by lower costs driven by volume and our cost optimization efforts.

The following table reconciles net income, the most directly comparable GAAP measure, to Adjusted Net Income and Adjusted Earnings Per Share for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net income	$	2,354	$	9,303	$	3,268	$	27,110
Income tax provision	3,952		3,481		4,969		12,958
Income before income taxes	6,306		12,784		8,237		40,068
Amortization of acquired intangible assets	10,621		10,903		31,307		38,030
Stock-based compensation	9,783		6,293		27,184		17,424
Transaction expenses(1)	2,238		2,809		10,497		6,591
Restructuring(2)	4,018		2,730		18,781		3,912
Technology transformation(3)	256		4,767		3,668		13,066
Settlements impacting comparability(4)	—		213		—		213
Gain on interest rate swaps(5)	—		—		—		(296)
Other(6)	(225)		(832)		721		(1,089)
Adjusted Net Income before income tax effect	32,997		39,667		100,395		117,919
Income tax effect(7)	8,263		10,496		26,171		31,848
Adjusted Net Income	$	24,734	$	29,171	$	74,224	$	86,071
Net income per share—basic	$	0.03	$	0.10	$	0.04	$	0.29
Net income per share—diluted	$	0.03	$	0.09	$	0.03	$	0.27
Adjusted Earnings Per Share—basic	$	0.27	$	0.31	$	0.81	$	0.92
Adjusted Earnings Per Share—diluted	$	0.26	$	0.29	$	0.79	$	0.87

_________________________

(1)Consists of transaction expenses related to M&A, associated earn-outs, costs related to the preparation of the IPO, one-time public company transition expenses and fees associated with financing transactions.

(2)Consists of restructuring-related costs, including executive recruiting and severance charges, and lease termination costs and disposal of fixed assets related to our real estate consolidation efforts. Beginning in 2020, we began executing a virtual-first strategy, closing offices and reducing office space globally. In 2022, we began executing on a restructuring program to realign senior leadership and functions with the goal of elevating our go-to-market strategy and accelerating our technology and product innovation. At the end of 2022, we also launched Project Nucleus which we expect to drive meaningful cost savings and efficiency gains in our cost of revenues.

(3)Includes costs related to technology modernization, as well as costs related to decommissioning of on-premise production systems and redundant fulfillment systems of acquired companies and the migration to our platform. We believe that these costs are discrete and non-recurring in nature, as they relate to a one-time restructuring and decommissioning of our on-premise production systems and corporate technological infrastructure and the move to a managed service provider, decommissioning redundant fulfillment systems and modernizing internal functional systems. As such, they are not normal, recurring operating expenses and are not reflective of ongoing trends in the cost of doing business. The significant majority of these are related to the last two phases of Project Ignite, a three-phase strategic investment initiative launched in 2019 to create an enterprise-class global platform, with the remainder related to an investment made to modernize internal functional systems in preparation for our public company infrastructure. Phase two of Project Ignite was completed in 2022 and phase three of Project Ignite was completed in the first quarter of 2023.

(4)Consists of non-recurring settlements and the related legal fees impacting comparability.

42

(5)Consists of gains or losses on historical non-designated derivative interest rate swaps. See Part I. Item 3. “Quantitative and Qualitative Disclosures about Market Risk—Interest Rate Risk” for additional information on interest rate swaps.

(6)Consists of gains or losses on foreign currency transactions and impairment of capitalized software.

(7)Normalized effective tax rates of 25.0% and 26.5% have been used to compute Adjusted Net Income for the three months ended September 30, 2023 and 2022, respectively. Normalized effective tax rates of 26.1% and 27.0% have been used to compute Adjusted Net Income for the nine months ended September 30, 2023 and 2022, respectively. As of December 31, 2022, we had net operating loss carryforwards of approximately $16.3 million for federal income tax purposes and deferred tax assets of approximately $6.3 million related to state and foreign income tax loss carryforwards available to reduce future income subject to income taxes. The amount of actual cash taxes we pay for federal, state, and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP, and from the normalized rate shown above.

The following table reconciles net income per share, the most directly comparable GAAP measure, to Adjusted Earnings Per Share for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except share and per share amounts)	2023		2022		2023		2022
Net income	$	2,354	$	9,303	$	3,268	$	27,110
Weighted average number of shares outstanding—basic	90,972,009		94,134,690		92,184,159		94,043,105
Weighted average number of shares outstanding—diluted	93,651,691		99,118,521		94,493,254		99,217,125
Net income per share—basic	$	0.03	$	0.10	$	0.04	$	0.29
Net income per share—diluted	$	0.03	$	0.09	$	0.03	$	0.27
Adjusted Net Income	$	24,734	$	29,171	$	74,224	$	86,071
Weighted average number of shares outstanding—basic	90,972,009		94,134,690		92,184,159		94,043,105
Weighted average number of shares outstanding—diluted	93,651,691		99,118,521		94,493,254		99,217,125
Adjusted Earnings Per Share—basic	$	0.27	$	0.31	$	0.81	$	0.92
Adjusted Earnings Per Share—diluted	$	0.26	$	0.29	$	0.79	$	0.87

43

The following table presents the calculation of Adjusted Diluted Earnings Per Share for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net income per share—diluted	$	0.03	$	0.09	$	0.03	$	0.27
Adjusted Net Income adjustments per share
Income tax provision	0.04		0.04		0.06		0.13
Amortization of acquired intangible assets	0.11		0.11		0.33		0.38
Stock-based compensation	0.11		0.06		0.29		0.18
Transaction expenses(1)	0.02		0.03		0.11		0.07
Restructuring(2)	0.04		0.03		0.20		0.04
Technology transformation(3)	0.00		0.05		0.04		0.13
Settlements impacting comparability(4)	—		0.00		—		0.00
Gain on interest rate swaps(5)	—		—		—		0.00
Other(6)	0.00		(0.01)		0.01		(0.01)
Income tax effect(7)	(0.09)		(0.11)		(0.28)		(0.32)
Adjusted Earnings Per Share—diluted	$	0.26	$	0.29	$	0.79	$	0.87
Weighted average number of shares outstanding used in computation of Adjusted Diluted Earnings Per Share:
Weighted average number of shares outstanding—diluted (GAAP)	93,651,691		99,118,521		94,493,254		99,217,125
Options not included in weighted average number of shares outstanding—diluted (GAAP) (using treasury stock method)	—		—		—		—
Weighted average number of shares outstanding—diluted (non-GAAP) (using treasury stock method)	93,651,691		99,118,521		94,493,254		99,217,125

_________________________

(1)Consists of transaction expenses related to M&A, associated earn-outs, costs related to the preparation of the IPO, one-time public company transition expenses and fees associated with financing transactions.

(2)Consists of restructuring-related costs, including executive recruiting and severance charges, and lease termination costs and disposal of fixed assets related to our real estate consolidation efforts. Beginning in 2020, we began executing a virtual-first strategy, closing offices and reducing office space globally. In 2022, we began executing on a restructuring program to realign senior leadership and functions with the goal of elevating our go-to-market strategy and accelerating our technology and product innovation. At the end of 2022, we also launched Project Nucleus which we expect to drive meaningful cost savings and efficiency gains in our cost of revenues.

(3)Includes costs related to technology modernization, as well as costs related to decommissioning of on-premise production systems and redundant fulfillment systems of acquired companies and the migration to our platform. We believe that these costs are discrete and non-recurring in nature, as they relate to a one-time restructuring and decommissioning of our on-premise production systems and corporate technological infrastructure and the move to a managed service provider, decommissioning redundant fulfillment systems and modernizing internal functional systems. As such, they are not normal, recurring operating expenses and are not reflective of ongoing trends in the cost of doing business. The significant majority of these are related to the last two phases of Project Ignite, a three-phase strategic investment initiative launched in 2019 to create an enterprise-class global platform, with the remainder related to an investment made to modernize internal functional systems in preparation for our public company infrastructure. Phase two of Project Ignite was completed in 2022 and phase three of Project Ignite was completed in the first quarter of 2023.

(4)Consists of non-recurring settlements and the related legal fees impacting comparability.

(5)Consists of gains or losses on historical non-designated derivative interest rate swaps. See Part I. Item 3. “Quantitative and Qualitative Disclosures about Market Risk—Interest Rate Risk” for additional information on interest rate swaps.

(6)Consists of gains or losses on foreign currency transactions and impairment of capitalized software.

(7)Normalized effective tax rates of 25.0% and 26.5% have been used to compute Adjusted Net Income for the three months ended September 30, 2023 and 2022, respectively. Normalized effective tax rates of 26.1% and 27.0% have been used to compute Adjusted Net Income for the nine months ended September 30, 2023 and 2022, respectively. As of December 31, 2022, we had net operating loss carryforwards of approximately $16.3 million for federal income tax purposes and deferred tax assets of approximately $6.3 million related to state and foreign income tax loss carryforwards available to reduce future income subject to income taxes. The amount of actual cash taxes we pay for federal, state, and foreign income taxes differs significantly from the effective income tax rate computed in accordance with GAAP, and from the normalized rate shown above.

44

Liquidity and Capital Resources

Overview

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs to meet operating expenses, debt service, acquisitions, capital expenditures, other commitments and contractual obligations. We consider liquidity in terms of cash flows from operations and their sufficiency to fund our operating and investing activities.

Our primary liquidity requirements are for working capital, debt principal and interest obligations, continued investments in software development and other capital expenditures, and other strategic investments. In the third quarter of 2023, we fully utilized our remaining U.S. federal income tax net operating loss carryforwards. As a result, income taxes will become a material use of funds, depending on our future profitability, and future tax rates. Our liquidity needs are met primarily through existing balance sheet cash, cash flows from operations, as well as funds available under our revolving credit facility. Our cash flows from operations include cash received from customers, less cash costs to provide services to our customers, which includes general and administrative costs and interest payments.

Our capital expenditures can vary depending on the timing of the development of new products and services and technological enhancement-related investments. Capital expenditures, excluding acquisitions, for the nine months ended September 30, 2023 and 2022 were approximately $14.7 million and $15.7 million, respectively, primarily related to capitalizable software development.

We believe that our projected cash position and cash flows from operations will be sufficient to fund our liquidity requirements for at least the next twelve months. However, our future liquidity requirements could be higher than we currently expect as a result of various factors. For example, any future investments, acquisitions, joint ventures or other similar transactions may require additional capital. In addition, our ability to continue to meet our future liquidity requirements will depend on, among other things, our ability to achieve anticipated levels of revenues and cash flows from operations and our ability to manage costs and working capital successfully, all of which are subject to general economic, financial, competitive and other factors beyond our control. In the event we require any additional capital, it will take the form of equity or debt financing, or both, and there can be no assurance that we will be able to raise any such financing on terms acceptable to us or at all.

As of December 31, 2022, we had cash and cash equivalents of approximately $103.1 million. As of September 30, 2023, we had cash and cash equivalents of approximately $49.9 million. We used $49.2 million (net of cash acquired) primarily to purchase Socrates and A-Check and $46.0 million to repurchase shares of our common stock in the first nine months of 2023. All cash and cash equivalents are held with independent financial institutions with a minimum credit rating of “A” as defined by the three main credit rating agencies. As of September 30, 2023, all cash and cash equivalents were held in accounts with banks such that the funds are immediately available or in fixed term deposits with a maximum maturity of three months. The bank failures of Silicon Valley Bank, Signature Bank and First Republic Bank earlier this year created significant market disruption and uncertainty within the U.S. banking sector, in particular with respect to regional banks. We hold minimal cash balances with regional banks in the U.S. We have a robust and disciplined cash management process to protect our cash, maintain financial stability and diversify as we deem appropriate.

Credit Facility

On November 29, 2022 (the “Closing Date”), Sterling Infosystems, Inc. (the “Borrower”), a Delaware corporation and a subsidiary of the Company, entered into a credit agreement (the “2022 Credit Agreement”) by and among the Borrower, as borrower, Sterling Intermediate Corp. (“Parent”), KeyBank National Association, as administrative agent (the “Administrative Agent”), certain guarantors party thereto (the “Guarantors”) and the lenders party thereto.

The 2022 Credit Agreement provides for aggregate principal borrowings of $700.0 million, comprised of $300.0 million aggregate principal amount of term loans (the “Term Loans”) and a $400.0 million revolving credit facility (the “Revolving Credit Facility”). The Term Loans and the Revolving Credit Facility mature on November 29, 2027.

Amounts outstanding under the 2022 Credit Agreement bear interest under either of the following two rates, elected in advance by the Borrower: (1) a base rate (equal to the greatest of (a) the prime rate, (b) the federal funds rate plus 1⁄2 of 1% and (c) the one-month adjusted term SOFR rate plus 1%); or (2) an adjusted term SOFR rate (equal to the sum of (a) term SOFR plus (b) 0.10%), in each case, plus a tiered floating interest rate margin based on the net leverage ratio of the Borrower and its subsidiaries. Interest on adjusted term SOFR borrowings is payable on the last business day of the one, three or six-month interest period selected by the Borrower (except in the case

45

of a six-month election, in which case it is payable on the last business day of the third and sixth month). Interest on base rate borrowings is payable on the last business day of each quarter. The applicable interest rate at September 30, 2023 was 7.67%.

We, as borrower, will pay a quarterly unused commitment fee at a rate per annum ranging from 0.20% to 0.30%, on the unused portion of the Revolving Credit Facility based on the net leverage ratio of the Borrower and its subsidiaries. We can use available funding capacity under the Revolving Credit Facility to issue letters of credit, subject to a sublimit equal to the lesser of $40.0 million and amounts available for borrowing under the Revolving Credit Facility.

The Term Loans amortize quarterly in the following amounts: $1.875 million per quarter (for the first four full quarters ending after the Closing Date), $3.75 million per quarter (for the next eight quarters) and $5.625 million per quarter (for the next seven quarters).

The 2022 Credit Agreement contains covenants that, among other things, restrict our ability to: incur certain additional indebtedness; transfer money between various subsidiaries; pay dividends on, repurchase or make distributions with respect to subsidiaries’ capital stock or make other restricted payments; issue stock of subsidiaries; make certain investments, loans or advances; transfer and sell certain assets; create or permit liens on assets; consolidate, merge, sell or otherwise dispose of all or substantially all of our assets; enter into certain transactions with affiliates; and amend certain documents.

The 2022 Credit Agreement also contains financial covenants that require us to comply with (a) a maximum net leverage ratio of 4.00:1.00 (which may be increased to 4.50:1.00 for four quarters if the Borrower and its subsidiaries consummate acquisitions during any 6-month period for which the total aggregate cash consideration is greater than or equal to $75.0 million) and (b) a minimum interest coverage ratio of 3.00:1.00. Both financial covenants are tested quarterly. Since origination, we have been in compliance with all covenants under the 2022 Credit Agreement.

The Term Loans and the Revolving Credit Facility (and related revolving borrowings) are guaranteed by Parent and all of our material wholly owned domestic subsidiaries. Obligations under the 2022 Credit Agreement are collateralized by a first lien on substantially all of our assets and outstanding capital stock of our material domestic subsidiaries, subject to certain exceptions. The 2022 Credit Agreement also contains various events of default, including, without limitation, the failure to pay interest or principal when the same is due, cross default and cross acceleration provisions, the failure of representations and warranties contained therein to be true and certain insolvency events. If an event of default occurs and is continuing, the principal amounts outstanding under the 2022 Credit Agreement, together with all accrued and unpaid interest and other amounts owed thereunder, may be declared immediately due and payable by the lenders.

The net proceeds of the Term Loans, together with borrowings of approximately $223.0 million under the Revolving Credit Facility, were used to repay all outstanding indebtedness, including accrued and unpaid interest, in an aggregate amount of approximately $513.9 million, under that certain First Lien Credit Agreement, dated June 19, 2015 (as amended, the “2015 Credit Agreement”), by and among the Borrower, as borrower, the guarantors party thereto, KeyBank National Association, as administrative agent, and the lenders party thereto, and to pay related fees and expenses.

As of September 30, 2023, amounts outstanding under the 2022 Credit Agreement totaled $499.9 million and we had $194.5 million of capacity remaining under the Revolving Credit Facility and outstanding letters of credit in the amount of $0.7 million.

Off-Balance Sheet Arrangements

As of September 30, 2023, we did not have any off-balance sheet arrangements.

46

Cash Flows

The following table presents a summary and comparison of our condensed consolidated cash flows from operating, investing and financing activities for the periods presented:

	Nine Months Ended September 30,
(in thousands)	2023		2022
Net cash provided by operating activities	$	65,676	$	73,598
Net cash used in investing activities	(63,830)		(15,672)
Net cash used in financing activities	(53,572)		(3,009)
Effect of exchange rate changes on cash	(1,492)		(3,725)
Net change in cash and cash equivalents	(53,218)		51,192
Cash and cash equivalents at beginning of period	103,095		47,998
Cash and cash equivalents at end of period	$	49,877	$	99,190

Operating Activities

Net cash provided by operating activities of $65.7 million for the nine months ended September 30, 2023 reflects the adjustment to net income for non-cash charges totaling $83.0 million, primarily driven by $47.1 million of depreciation and amortization and $27.2 million of stock-based compensation. Changes in operating assets and liabilities for the nine months ended September 30, 2023 reduced cash flow from operating activities by $22.0 million.

Net cash provided by operating activities of $73.6 million for the nine months ended September 30, 2022 reflects the adjustment to net income for non-cash charges totaling $76.4 million, primarily driven by $56.6 million of depreciation and amortization, $17.4 million of stock-based compensation and $4.9 million of deferred income taxes partially offset by $4.1 million of changes in the fair value of derivatives and $1.8 million of unrealized translation gain on investment in foreign subsidiaries. Changes in operating assets and liabilities for the nine months ended September 30, 2022 reduced cash flow from operating activities by $29.9 million.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2023 and 2022 was $63.8 million and $15.7 million, respectively. Net cash used in investing activities for the nine months ended September 30, 2023 primarily consisted of $49.2 million of cash used for acquisitions, net of cash acquired, in addition to an $13.4 million investment in capitalized software. Net cash used in investing activities for the nine months ended September 30, 2022 consisted of a $11.7 million investment in capitalized software and $4.0 million in purchases of computer hardware and other property and equipment.

Financing Activities

Net cash used in financing activities for the nine months ended September 30, 2023 was $53.6 million consisting primarily of $46.0 million of share repurchases and $5.6 million of payments of long-term debt. Net cash used in financing activities for the nine months ended September 30, 2022 was $3.0 million.

Free Cash Flow

For the nine months ended September 30, 2023, we generated $50.9 million of Free Cash Flow compared to $57.9 million for the nine months ended September 30, 2022. The decrease in Free Cash Flow compared to the prior year period was driven by lower operating income and higher interest expense, partially offset by increased cash from interest rate swaps.

47

The following table reconciles net cash flow provided by operating activities, the most directly comparable GAAP measure, to Free Cash Flow for the periods presented:

	Nine Months Ended September 30,
(in thousands)	2023		2022
Net cash provided by operating activities	$	65,676	$	73,598
Purchases of intangible assets and capitalized software	(13,364)		(11,719)
Purchases of property and equipment	(1,377)		(3,978)
Free Cash Flow	$	50,935	$	57,901

Critical Accounting Estimates

The preparation of our consolidated financial statements in accordance with GAAP requires management to make estimates, assumptions and judgments about future events that can affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our 2022 Annual Report for a description of our critical accounting estimates and Note 2, “Summary of Significant Accounting Policies” to our 2022 consolidated financial statements in our 2022 Annual Report for our significant accounting policies. There were no significant changes to our critical accounting estimates for the nine months ended September 30, 2023.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency and Derivative Risk

We from time to time enter into foreign currency options and forward contracts to mitigate the foreign exchange risk on expected future cash outlays to fund our fulfillment centers. We have, in the past, hedged our Indian rupee denominated expenses through foreign exchange contracts. These contracts were designated as cash flow hedges and qualified for hedge accounting under GAAP. As of September 30, 2023 and December 31, 2022, we did not have any outstanding foreign currency options or forward contracts. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis. The earnings recognition of excluded components is also presented in the same line of the unaudited condensed consolidated statements of operations and comprehensive income as the earnings effect of the hedged transaction. During the three and nine months ended September 30, 2023 and 2022, there were no such gains or losses.

Credit Risk

As of September 30, 2023 and December 31, 2022, we had accounts receivable, net of allowance for expected credit losses, of $151.9 million and $139.6 million, respectively. For the three and nine months ended September 30, 2023 and 2022, no single client accounted for more than 3% of our revenue. No single client had an accounts receivable balance greater than 3% of total accounts receivable as of September 30, 2023 and December 31, 2022.

Interest Rate Risk

Our exposure to market risk is influenced by the changes in interest rates paid on any outstanding balance on our borrowings, under our 2015 Credit Agreement through November 2022 and under our 2022 Credit Agreement subsequent to the refinancing. Our 2015 Credit Agreement accrued interest at either (1) an applicable rate of 2.5% plus the greater of (a) the prime rate or (b) the federal funds rate plus 1/2 of 1% (c) the one-month LIBOR plus 1%, or (d) a 2% floor; (2) an applicable rate of 3.5% plus one-month LIBOR which is subject to a 1% floor. Amounts outstanding under the 2022 Credit Agreement bear interest under either of the following two rates, elected in advance by us: (1) a base rate (equal to the greatest of (a) the prime rate, (b) the federal funds rate plus 1⁄2 of 1% and (c) the one-month adjusted term SOFR rate plus 1%); or (2) an adjusted term SOFR rate (equal to the sum of (a) term SOFR plus (b) 0.10%), in each case, plus a tiered floating interest rate margin based on the net leverage ratio. Our borrowings as of September 30, 2023 and December 31, 2022 accrued interest at 7.67% and 6.76%, respectively, based on an adjusted term SOFR rate (equal to the sum of (a) term SOFR plus (b) 0.10%) plus a tiered floating interest rate margin based on our net leverage ratio.

We hedge against changes in the interest rates through interest rate swaps. As of December 31, 2022, we were not party to any outstanding interest rate swaps. On February 28, 2023, we entered into amortizing $300.0

48

million notional value interest rate swaps. The notional value steps down from $300.0 million to $150.0 million on February 27, 2026. The swap provides for us to pay, as applied to the notional value, a fixed rate of interest of 4.26% monthly and receive, on a monthly basis, an amount equal to the greater of the one-month term SOFR and a floor of (0.10%), as applied to the notional value (the “Floating Leg”). The interest rate swap matures on November 29, 2027. The interest expense related to the 2022 Credit Agreement will be offset by proceeds received or increased from settlements paid for the Floating Leg of the interest rate swap. As of September 30, 2023, we are currently party to four interest rate swaps which hedge the future cash flows on approximately 60% of the outstanding principal balance of the aggregate amounts due under our 2022 Credit Agreement.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, our management has evaluated, under the supervision and with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures as of September 30, 2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management of the company, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Based upon the evaluation of our disclosure controls and procedures as of September 30, 2023, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

49

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, we believe would individually or taken together have a material adverse effect on our business, financial condition, or liquidity.

For more information, see Note 13, “Commitments and Contingencies” to our unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Item 1A. Risk Factors.

There have been no material changes with respect to the risk factors as previously disclosed in our 2022 Annual Report, except as described below:

To the extent our clients reduce their operations, downsize their screening programs, or otherwise demand fewer of our products and solutions, our business could be materially adversely impacted.

Demand for our products and services is subject to our clients’ continual evaluation of their need for our products and services and is impacted by several factors, including their budget availability, hiring, and workforce needs, and a changing regulatory landscape. Demand for our offerings is also dependent on the size of our clients’ operations. Our clients could reduce their operations for a variety of reasons, including general economic slowdown, divestitures and spin-offs, business model disruption, poor financial performance, or as a result of increasing workforce automation, including artificial intelligence. Demand for drug screenings may decline as a result of evolving U.S. drug laws. For example, the legalization of cannabis in several U.S. states has led to a decrease in orders for marijuana screenings. Our revenues may be significantly reduced should our clients decide to downsize their screening programs or take such programs in-house.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

Period	Total Number of Shares Purchased(1) (a)	Average Price Paid per Share(1) (b)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) (c)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs(2) (d) (in thousands)
07/01/2023 to 07/31/2023	384,739	$	12.28	384,739	$	56,152
08/01/2023 to 08/31/2023	585,662	13.26		585,662	48,397
09/01/2023 to 09/30/2023	822,172	13.41		593,618	40,403
Total	1,792,573			1,564,019

_________________________

(1)During the three months ended September 30, 2023, we received 228,554 shares of our common stock that were surrendered by employees in payment for the minimum required withholding taxes due on the vesting of restricted stock awards. In the above table, these shares are included in columns (a) and (b), but excluded from columns (c) and (d). These shares do not reduce the number of shares that may yet be purchased under our share repurchase program.

(2)On November 23, 2022, our board of directors authorized the repurchase of up to $100.0 million of our shares of common stock over a period through December 31, 2024. The share repurchase program is expected to be funded through our existing cash and future free cash flow. The share repurchase program is being executed on a discretionary basis through open market repurchases, private transactions, or other transactions, including through block trades and Rule 10b-18 and Rule 10b5-1 trading plans. We are not obligated to repurchase any specific number of shares, and the timing and amount of any share repurchases will be subject to several factors including share price, trading volume, market conditions, and capital allocation priorities. The share repurchase program may be suspended, terminated or modified without notice at any time.

50

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Rule 10b5-1 Trading Arrangements and Non-Rule 10b5-1 Trading Arrangements

During the three months ended September 30, 2023, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits.

(a) Exhibits.

Exhibit No.	Exhibit Description
10.1*	Sterling Check Corp. Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on August 8, 2023).
31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

_________________________

* Filed herewith.

** Furnished herewith.

51

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

STERLING CHECK CORP.
By:	/s/ Joshua Peirez
	Joshua Peirez
	Chief Executive Officer
	(Principal Executive Officer)
Date: November 8, 2023
By:	/s/ Peter Walker
	Peter Walker
	Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)
Date: November 8, 2023

52

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joshua Peirez, certify that:

i.I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2023 of Sterling Check Corp.;

ii.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

iii.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

iv.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

i.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

ii.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

iii.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

iv.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

v.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

i.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

ii.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ JOSHUA PEIREZ
	Joshua Peirez
	Chief Executive Officer

Date: November 8, 2023

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peter Walker, certify that:

i.I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2023 of Sterling Check Corp.;

ii.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

iii.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

iv.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

i.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

ii.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

iii.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

iv.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

v.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

i.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

ii.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ PETER WALKER
	Peter Walker
	Executive Vice President and
	Chief Financial Officer

Date: November 8, 2023

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Sterling Check Corp. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joshua Peirez, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOSHUA PEIREZ
	Joshua Peirez
	Chief Executive Officer

November 8, 2023

EX-32.2

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Sterling Check Corp. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Walker, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ PETER WALKER
	Peter Walker
	Executive Vice President and
	Chief Financial Officer

November 8, 2023

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 01, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-40829
Entity Registrant Name	Sterling Check Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	37-1784336
Entity Address, Address Line One	6150 Oak Tree Boulevard
Entity Address, Address Line Two	Suite 490
Entity Address, City or Town	Independence
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44131
City Area Code	800
Local Phone Number	853-3228
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	STER
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		94,285,105
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001645070

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 49,877	$ 103,095
Accounts receivable (net of allowance for credit losses of $2,670 and $2,304 at September 30, 2023 and December 31, 2022, respectively)	151,935	139,579
Insurance receivable	4,689	921
Prepaid expenses	8,595	13,433
Other current assets	23,770	13,654
Total current assets	238,866	270,682
Property and equipment, net	7,330	10,341
Goodwill	878,390	849,609
Intangible assets, net	240,482	241,036
Deferred tax assets	4,328	4,452
Operating leases right-of-use asset	7,020	20,084
Other noncurrent assets, net	10,499	11,050
TOTAL ASSETS	1,386,915	1,407,254
CURRENT LIABILITIES:
Accounts payable	39,327	38,372
Litigation settlement obligation	7,178	4,165
Accrued expenses	60,387	67,047
Current portion of long-term debt	13,125	7,500
Operating leases liability, current portion	4,233	3,717
Other current liabilities	14,435	12,939
Total current liabilities	138,685	133,740
Long-term debt, net	483,334	493,990
Deferred tax liabilities	31,584	23,707
Long-term operating leases liability, net of current portion	8,834	16,835
Other liabilities	3,737	2,336
Total liabilities	666,174	670,608
COMMITMENTS AND CONTINGENCIES (NOTE 13)
STOCKHOLDERS’ EQUITY:
Preferred stock ($0.01 par value; 100,000,000 shares authorized; no shares issued or outstanding)	0	0
Common stock ($0.01 par value; 1,000,000,000 shares authorized; 99,889,227 shares issued and 95,045,289 shares outstanding at September 30, 2023; 97,765,120 shares issued and 96,717,883 shares outstanding at December 31, 2022)	97	76
Additional paid-in capital	971,950	942,789
Common stock held in treasury (4,843,938 and 1,047,237 shares at September 30, 2023 and December 31, 2022, respectively)	(64,499)	(14,859)
Accumulated deficit	(183,180)	(186,448)
Accumulated other comprehensive loss	(3,627)	(4,912)
Total stockholders’ equity	720,741	736,646
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 1,386,915	$ 1,407,254

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 2,670	$ 2,304
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	99,889,227	97,765,120
Common stock, shares outstanding (in shares)	95,045,289	96,717,883
Common stock held in treasury (in shares)	4,843,938	1,047,237

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
REVENUES	$ 180,566	$ 199,299	$ 550,224	$ 596,862
OPERATING EXPENSES:
Cost of revenues (exclusive of depreciation and amortization below)	95,882	106,422	292,692	314,954
Corporate technology and production systems	11,329	13,715	34,709	38,806
Selling, general and administrative	42,382	42,411	134,743	126,630
Depreciation and amortization	15,875	16,570	47,117	56,598
Impairments and disposals of long-lived assets	48	193	7,193	805
Total operating expenses	165,516	179,311	516,454	537,793
OPERATING INCOME	15,050	19,988	33,770	59,069
OTHER EXPENSE (INCOME):
Interest expense, net	9,305	7,764	26,903	20,719
Gain on interest rate swaps	0	0	0	(296)
Other income	(561)	(560)	(1,370)	(1,422)
Total other expense, net	8,744	7,204	25,533	19,001
INCOME BEFORE INCOME TAXES	6,306	12,784	8,237	40,068
Income tax provision	3,952	3,481	4,969	12,958
NET INCOME	2,354	9,303	3,268	27,110
Unrealized gain on hedged transactions, net of tax expense of $1,188, $0, $1,044 and $0, respectively	1,962	0	1,554	0
Foreign currency translation adjustments, net of tax of $0, $0, $0 and $0, respectively	(1,906)	(4,790)	(269)	(7,990)
Total other comprehensive income (loss)	56	(4,790)	1,285	(7,990)
COMPREHENSIVE INCOME	$ 2,410	$ 4,513	$ 4,553	$ 19,120
Net income per share attributable to stockholders
Basic (in USD per share)	$ 0.03	$ 0.10	$ 0.04	$ 0.29
Diluted (in USD per share)	$ 0.03	$ 0.09	$ 0.03	$ 0.27
Weighted average number of shares outstanding
Basic (in shares)	90,972,009	94,134,690	92,184,159	94,043,105
Diluted (in shares)	93,651,691	99,118,521	94,493,254	99,217,125

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Tax expense on unrealized gain on hedged transactions	$ 1,188	$ 0	$ 1,044	$ 0
Tax on foreign currency translation adjustments	$ 0	$ 0	$ 0	$ 0

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Common Shares Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	$ 709,624	$ (198)	$ 68	$ 916,578	$ (897)	$ (206,218)	$ (198)	$ 93
Beginning balance (in shares) at Dec. 31, 2021					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,112
Common stock issued for exercise of employee stock options (in shares)			8,486
Common stock issued for exercise of employee stock options	80			80
Issuance of restricted shares, net of forfeitures (in shares)			533,095
Issuance of restricted shares, net of forfeitures	0		$ 5	(5)
Stock-based compensation	5,108			5,108
Net income	6,236					6,236
Foreign currency translation adjustment, net of tax				(8)				283
Foreign currency translation adjustment, net of tax	275
Ending Balance (in shares) at Mar. 31, 2022			96,289,668
Ending Balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Ending balance (in shares) at Mar. 31, 2022					107,820
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	709,624	$ (198)	$ 68	916,578	$ (897)	(206,218)	$ (198)	93
Beginning balance (in shares) at Dec. 31, 2021					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	27,110
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(7,990)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	748,214		$ 75	936,239	$ (897)	(179,306)		(7,897)
Ending balance (in shares) at Sep. 30, 2022					107,820
Beginning balance (in shares) at Mar. 31, 2022			96,289,668
Beginning balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Beginning balance (in shares) at Mar. 31, 2022					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,812
Common stock issued for exercise of employee stock options (in shares)			76,399
Common stock issued for exercise of employee stock options	734			734
Issuance of restricted shares, net of forfeitures (in shares)			42,388
Stock-based compensation	6,023			6,023
Net income	11,571					11,571
Foreign currency translation adjustment, net of tax				(24)				(3,483)
Foreign currency translation adjustment, net of tax	(3,507)
Ending Balance (in shares) at Jun. 30, 2022			96,410,267
Ending Balance at Jun. 30, 2022	735,946		$ 73	928,486	$ (897)	(188,609)		(3,107)
Ending balance (in shares) at Jun. 30, 2022					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,604
Common stock issued for exercise of employee stock options (in shares)			159,350
Common stock issued for exercise of employee stock options	1,479		$ 2	1,477
Issuance of restricted shares, net of forfeitures (in shares)			(23,155)
Stock-based compensation	6,293			6,293
Net income	9,303					9,303
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(4,790)			(17)				(4,790)
Foreign currency translation adjustment, net of tax	(4,807)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	$ 748,214		$ 75	936,239	$ (897)	(179,306)		(7,897)
Ending balance (in shares) at Sep. 30, 2022					107,820
Beginning balance (in shares) at Dec. 31, 2022	96,717,883		96,717,883
Beginning balance at Dec. 31, 2022	$ 736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Beginning balance (in shares) at Dec. 31, 2022	1,047,237				1,047,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			4,567
Repurchases of common stock (in shares)			493,926		493,926
Repurchases of common stock	$ (7,712)				$ (7,712)
Issuance of restricted shares, net of forfeitures (in shares)			1,894,310
Issuance of restricted shares, net of forfeitures	0		$ 19	(19)
Shares withheld to cover restricted share vesting tax (in shares)			(37,128)		(37,128)
Shares withheld to cover restricted share vesting tax	(487)				$ (487)
Stock-based compensation	8,043			8,043
Net income	591					591
Unrealized gain (loss) on hedged transactions, net of tax	(5,159)							(5,159)
Foreign currency translation adjustment, net of tax	682							682
Ending Balance (in shares) at Mar. 31, 2023			98,085,706
Ending Balance at Mar. 31, 2023	$ 732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Ending balance (in shares) at Mar. 31, 2023					1,578,291
Beginning balance (in shares) at Dec. 31, 2022	96,717,883		96,717,883
Beginning balance at Dec. 31, 2022	$ 736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Beginning balance (in shares) at Dec. 31, 2022	1,047,237				1,047,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock (in shares)	3,523,838
Repurchases of common stock	$ (46,000)
Net income	3,268
Unrealized gain (loss) on hedged transactions, net of tax	1,554
Foreign currency translation adjustment, net of tax	$ (269)
Ending Balance (in shares) at Sep. 30, 2023	95,045,289		95,045,289
Ending Balance at Sep. 30, 2023	$ 720,741		$ 97	971,950	$ (64,499)	(183,180)		(3,627)
Ending balance (in shares) at Sep. 30, 2023	4,843,938				4,843,938
Beginning balance (in shares) at Mar. 31, 2023			98,085,706
Beginning balance at Mar. 31, 2023	$ 732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Beginning balance (in shares) at Mar. 31, 2023					1,578,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			2,363
Repurchases of common stock (in shares)			1,465,893		1,465,893
Repurchases of common stock	(17,630)				$ (17,630)
Common stock issued for exercise of employee stock options (in shares)			63,336
Common stock issued for exercise of employee stock options	611			611
Issuance of restricted shares, net of forfeitures (in shares)			80,331
Issuance of restricted shares, net of forfeitures	0		$ 1	(1)
Shares withheld to cover restricted share vesting tax (in shares)			(7,181)		(7,181)
Shares withheld to cover restricted share vesting tax	(85)				$ (85)
Stock-based compensation	9,358			9,358
Net income	323					323
Unrealized gain (loss) on hedged transactions, net of tax	4,751							4,751
Foreign currency translation adjustment, net of tax	955							955
Ending Balance (in shares) at Jun. 30, 2023			96,758,662
Ending Balance at Jun. 30, 2023	$ 730,887		$ 96	960,781	$ (40,773)	(185,534)		(3,683)
Ending balance (in shares) at Jun. 30, 2023					3,051,365
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock (in shares)	1,564,019		1,564,019		1,564,019
Repurchases of common stock	$ (20,701)				$ (20,701)
Common stock issued for exercise of employee stock options (in shares)			165,422
Common stock issued for exercise of employee stock options	1,387		$ 2	1,385
Issuance of restricted shares, net of forfeitures (in shares)			(86,222)
Issuance of restricted shares, net of forfeitures	0		$ (1)	1
Shares withheld to cover restricted share vesting tax (in shares)			(228,554)		(228,554)
Shares withheld to cover restricted share vesting tax	(3,025)				$ (3,025)
Stock-based compensation	9,783			9,783
Net income	2,354					2,354
Unrealized gain (loss) on hedged transactions, net of tax	1,962							1,962
Foreign currency translation adjustment, net of tax	$ (1,906)							(1,906)
Ending Balance (in shares) at Sep. 30, 2023	95,045,289		95,045,289
Ending Balance at Sep. 30, 2023	$ 720,741		$ 97	$ 971,950	$ (64,499)	$ (183,180)		$ (3,627)
Ending balance (in shares) at Sep. 30, 2023	4,843,938				4,843,938

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Accounting Standards Update 2016-13
Tax on cumulative effect adjustment for adoption of CECL	$ 56

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 3,268	$ 27,110
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	47,117	56,598
Deferred income taxes	(200)	4,885
Stock-based compensation	27,184	17,424
Impairments and disposals of long-lived assets	7,193	805
Provision for bad debts	556	1,016
Amortization of financing fees	808	327
Amortization of debt discount	594	1,444
Deferred rent	383	(170)
Unrealized translation loss (gain) on investment in foreign subsidiaries	94	(1,838)
Changes in fair value of derivatives	0	(4,102)
Change in fair value of contingent consideration, net	(686)	0
Interest rate swap settlements	1,323	0
Changes in operating assets and liabilities
Accounts receivable	(8,699)	(33,145)
Insurance receivable	(3,768)	0
Prepaid expenses	5,849	3,579
Other assets	(6,493)	(2,097)
Accounts payable	757	6,546
Litigation settlement obligation	3,013	0
Accrued expenses	(7,982)	84
Other liabilities	(4,635)	(4,868)
Net cash provided by operating activities	65,676	73,598
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(1,377)	(3,978)
Purchases of intangible assets and capitalized software	(13,364)	(11,719)
Acquisitions, net of cash acquired	(49,210)	0
Proceeds from disposition of property and equipment	121	25
Net cash used in investing activities	(63,830)	(15,672)
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock	1,998	2,291
Repurchases of common stock	(46,043)	0
Payments of initial public offering issuance costs	0	(225)
Cash paid for tax withholding on vesting of restricted shares	(3,597)	0
Payments of long-term debt	(5,625)	(4,846)
Payment of contingent consideration for acquisition	(305)	(226)
Payments of finance lease obligations	0	(3)
Net cash used in financing activities	(53,572)	(3,009)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(1,492)	(3,725)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(53,218)	51,192
Beginning of period	103,095	47,998
Cash and cash equivalents at end of period	49,877	99,190
Cash paid during the period for
Interest, net of capitalized amounts of $308 and $245 for the nine months ended September 30, 2023 and 2022, respectively	29,006	24,277
Income taxes	13,219	11,513
Noncash investing activities
Purchases of property and equipment in accounts payable and accrued expenses	400	8
Noncash purchase price of business combinations	$ 4,706	$ 0

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Statement of Cash Flows [Abstract]
Interest, capitalized amounts	$ 308	$ 245

XML

Description of Business

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Description of Business

Sterling Check Corp. (the “Company”), a Delaware corporation headquartered in Independence, Ohio, is a global provider of technology-enabled background and identity verification services. The Company provides the foundation of trust and safety its clients need to create effective environments for their most essential resource—people. The Company offers a comprehensive hiring and risk management solution that begins with identity verification, followed by criminal background screening, credential verification, drug and health screening, employee onboarding document processing and ongoing risk monitoring.

As of September 30, 2023, the Company is 52.4% owned by an investment group consisting of entities advised by or affiliated with The Goldman Sachs Group, Inc. (“Goldman Sachs”) and Caisse de dépôt et placement du Québec (“CDPQ” and, together with Goldman Sachs, our “Sponsor”). CDPQ owns its equity interest in the Company indirectly through a limited partnership controlled by Goldman Sachs.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

These unaudited condensed consolidated financial statements are unaudited; however, in the opinion of management, they reflect all adjustments consisting only of normal recurring adjustments necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with GAAP applicable to interim periods. The results of operations for the interim periods presented are not necessarily indicative of results for the full year or future periods. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of December 31, 2022 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2023.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that can affect the reported amount of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Significant estimates include the impairment of long-lived assets, goodwill impairment, the determination of the fair value of acquired assets and liabilities, collectability of receivables, the valuation of stock-based awards and stock-based compensation and sales and income tax liabilities. The Company also applies an estimated useful life of three years to internally developed software assets. This is based on the historical observed pace of change in the Company’s delivery, technology, and product offerings as well as market competition. The Company believes that the estimates used in the preparation of these unaudited condensed consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.

Segment Information

The Company has one operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance.

Cash and Cash Equivalents

Cash and cash equivalents of $49.9 million and $103.1 million as of September 30, 2023 and December 31, 2022, respectively, include money market instruments with maturities of three months or less. The Company maintained cash outside the U.S. as of September 30, 2023 of $33.4 million with the largest deposits being held in India and Canada, with balances of $4.1 million and $6.0 million, respectively. Cash outside the U.S. was $28.0 million as of December 31, 2022, with the largest deposits being held in Canada and India, with balances of $9.2 million and $5.1 million, respectively.

Foreign Currency

Assets and liabilities of operations having non-USD functional currencies are translated at period-end exchange rates, and income statement accounts are translated at weighted average exchange rates for the period. Gains or losses resulting from translating foreign currency financial statements, net of any related tax effects, are reflected in Accumulated Other Comprehensive Income or Loss (“OCI”), a separate component of stockholders’ equity on the unaudited condensed consolidated balance sheets. Gains or losses resulting from foreign currency transactions incurred in currencies other than the local functional currency are included in other income in the unaudited condensed consolidated statements of operations and comprehensive income. The cumulative translation adjustment resulted in losses of $5.5 million and $5.6 million as of September 30, 2023 and December 31, 2022, respectively.

Accounts Receivable and Allowance for Credit Losses

Accounts receivable balances consist of trade receivables that are recorded at the invoiced amount, net of allowances for expected credit losses and for potential sales credits and reserves. Sales credits and reserves were $0.7 million and $0.9 million as of September 30, 2023 and December 31, 2022, respectively.

The Company adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 326, Financial Instruments—Credit Losses (“CECL”) on January 1, 2022. The adoption of CECL resulted in a $0.3 million cumulative effect adjustment recorded in retained earnings as of January 1, 2022.

CECL requires an entity to utilize an impairment model to estimate its lifetime expected credit losses and record an allowance that, when deducted from the amortized cost basis of a financial asset, presents the net amount expected to be collected on the financial asset.

The Company maintains an allowance for expected credit losses in order to record accounts receivable at their net realizable value. Inherent in the assessment of the allowance for expected credit losses are certain judgments and estimates relating to, among other things, the Company’s customers’ access to capital, customers’ willingness and ability to pay, general economic conditions and the ongoing relationship with customers. Allowances have been recorded for receivables believed to be uncollectible, including amounts for the resolution of potential credit and other collection issues such as disputed invoices. The allowance for expected credit losses is determined by analyzing the Company’s historical write-offs, the current aging of receivables, the financial condition of customers and the general economic climate. Adjustments to the allowance may be required in future periods depending on how such potential issues are resolved or if the financial condition of the Company’s customers were to deteriorate resulting in an impairment of their ability to make payments. The Company has not historically had material write-offs due to uncollectible accounts receivable.

Allowances for expected credit losses were $2.7 million and $2.3 million as of September 30, 2023 and December 31, 2022, respectively. The following table summarizes changes in the allowance for expected credit losses for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Balance at beginning of period	$	2,658	$	2,161	$	2,304	$	2,949
Cumulative effect of accounting change upon adoption of CECL	—		—		—		254
Additions	97		351		556		1,010
Write-offs, net of recoveries	(82)		(36)		(190)		(1,727)
Foreign currency translation adjustment	(3)		(14)		—		(24)
Balance at end of period	$	2,670	$	2,462	$	2,670	$	2,462

Corporate Technology and Production Systems

Corporate technology and production systems includes costs related to maintaining the Company’s corporate information technology infrastructure and non-capitalizable costs to develop and maintain its production systems.

The following table sets forth expenses included in each category of corporate technology and production systems for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Corporate information technology	$	4,665	$	7,012	$	14,854	$	19,425
Development of platform and product initiatives	4,371		4,433		13,065		12,797
Production support and maintenance	2,293		2,270		6,790		6,584
Total production systems	6,664		6,703		19,855		19,381
Total corporate technology and production systems	$	11,329	$	13,715	$	34,709	$	38,806

Corporate information technology consists of salaries and benefits of personnel (including stock-based compensation expense) supporting internal operations such as information technology support and the maintenance of information security and business continuity functions. Also included are third-party costs including cloud computing costs that support the Company’s corporate internal systems, software licensing and maintenance, telecommunications and other technology infrastructure costs.

Production systems costs consist of non-capitalizable personnel costs including contractor costs incurred for the development of platform and product initiatives and production support and maintenance. Platform and product initiatives facilitate the development of the Company’s technology platform and the launch of new screening products. Production support and maintenance includes costs to support and maintain the technology underlying the Company’s existing screening products and to enhance the ease of use of the Company’s cloud applications. Certain personnel costs related to new products and features are capitalized and amortized to depreciation and amortization.

Included within corporate technology and production systems are non-capitalizable production system and corporate information technology expenses related to Project Ignite, a three-phase strategic investment initiative. Phase one of Project Ignite modernized client and candidate experiences and is complete. Phase two of Project Ignite focused on decommissioning the Company’s on-premises data centers and migrating the Company’s production systems and corporate information technological infrastructure to a managed service provider in the cloud. During the first half of 2021, the Company completed phase two initiatives related to the migration of its production and fulfillment systems to the cloud, and as a result, approximately 98% of revenue is processed through platforms hosted in the cloud. The Company incurred expenses related to phase two to complete the decommissioning of on-premises data centers for internal corporate technology infrastructure and migration to the cloud which was completed as of September 30, 2022. Phase three of Project Ignite was decommissioning of the platforms purchased over the prior ten years and the migration of the clients to one global platform. This third and final phase, which was completed in the first quarter of 2023, unified clients onto a single global platform. The Company’s core platform now processes approximately 80% of its global revenue.

XML

Recent Accounting Standards Updates

9 Months Ended

Sep. 30, 2023

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Standards Updates

Recent Accounting Standards Updates

The Company qualifies as an emerging growth company under the Jumpstart Our Business Startups Act (the “JOBS Act”). The JOBS Act permits extended transition periods for complying with new or revised accounting standards affecting public companies. The Company has elected to use the extended transition periods and is adopting new or revised accounting standards on the FASB’s non-public company timeline. As such, the Company’s financial statements may not be comparable to financial statements of public entities that comply with new or revised accounting standards on a non-delayed basis.

The Company will cease to be an emerging growth company upon the earliest of (a) the last day of the fiscal year in which it has total annual gross revenues of $1.235 billion or more; (b) the last day of its fiscal year following the fifth anniversary of the date of its initial public offering (“IPO”); (c) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years; or (d) the date on which it is deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur as of the last day of a fiscal year in which the market value of its common stock held by non-affiliates equals or exceeds $700 million as of the last business day of the second fiscal quarter of such fiscal year, which threshold was not exceeded as of June 30, 2023.

XML

Acquisitions

9 Months Ended

Sep. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Acquisitions

Acquisitions

Socrates and A-Check Acquisitions

On January 4, 2023, the Company acquired all of the outstanding shares of Socrates Limited and its affiliates (“Socrates”), a screening company in Latin America, pursuant to a share purchase agreement. The Socrates acquisition expands the Company’s global presence into Latin America to serve the rapidly growing regional hiring needs of both multi-national and local clients. On March 1, 2023, the Company acquired all of the outstanding shares of A-Check Global (“A-Check”), a U.S.-based employment screening organization, pursuant to a share purchase agreement. The A-Check acquisition provides the Company access to a high quality, enterprise-focused customer base diversified across verticals including healthcare and telecom. The aggregate purchase price for the acquisitions totaled approximately $66.2 million, was funded with available cash on hand and is subject to certain closing adjustments specified in the share purchase agreements and includes initial contingent consideration related to the A-Check acquisition of $4.7 million recorded at fair value. The contingent consideration will be determined based on actual future results. The initial fair value of the contingent consideration consisted of $2.6 million for an earn-out payable one year after the acquisition based upon revenue retention and a $2.1 million payable throughout the second and third year following the acquisition based on revenue retention and referral revenue. The Company recorded a preliminary allocation of the purchase price to assets acquired and liabilities assumed based on their estimated fair values as of their respective purchase dates. Additionally, in connection with the Socrates acquisition, $5.0 million is payable to certain senior employees two years after the acquisition date based on certain retention requirements.

The Company incurred approximately $2.0 million of transaction expenses related to the acquisitions during the nine months ended September 30, 2023.

The preliminary allocation of the purchase price is based on the fair value of assets acquired and liabilities assumed as of the applicable acquisition date. The following table summarizes the consideration paid and the amounts recognized for the assets acquired and liabilities assumed:

	Preliminary Purchase Price Allocation				Adjusted Purchase Price Allocation
(in thousands)	March 31, 2023		Purchase Price Adjustments		September 30, 2023
Consideration
Cash	$	11,935	$	—	$	11,935
Other current assets
Accounts receivable	4,279		(3)		4,276
Other current assets	805		447		1,252
Property and equipment	177		(1)		176
Intangible assets	32,141		(1,268)		30,873
Other long-term assets	6		—		6
Total assets acquired	$	49,343	$	(825)	$	48,518
Accounts payable and accrued expenses	1,156		94		1,250
Other current liabilities	1,291		(72)		1,219
Deferred tax liability	8,388		77		8,465
Other liabilities	2		—		2
Total liabilities assumed	$	10,837	$	99	$	10,936
Total identifiable net assets	38,506		(924)		37,582
Goodwill	27,352		1,218		28,570
Total consideration	$	65,858	$	294	$	66,152

Goodwill recognized is primarily attributable to assembled workforce and expected synergies and is not tax deductible in future years. Intangible assets acquired consist largely of customer lists in the amount of $28.0 million to be amortized over 15 years. The remaining intangible assets include trade names, developed technology and a non-compete agreement, which will be amortized over two years, eight years, and five years, respectively.

The acquisitions are not material to the Company's financial position as of September 30, 2023 or results of operations for the three and nine months ended September 30, 2023, and therefore, pro forma operating results and other disclosures for the acquisitions are not presented.

EBI Acquisition

On November 30, 2021, the Company acquired all of the outstanding shares of Employment Background Investigations, Inc. (“EBI”) for a purchase price of $67.8 million, consisting of $66.3 million of cash and $1.5 million of contingent consideration recorded at fair value. As of December 31, 2022, the purchase price was reduced by $0.3 million reflecting the final determination of the post-closing adjustment of the purchase price in accordance with the purchase agreement with EBI, resulting in an adjusted purchase price of $67.5 million. The receivable related to this adjustment was collected in February 2023.

XML

Property and Equipment, Net

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Property and Equipment, Net

(in thousands)	September 30, 2023		December 31, 2022
Furniture and fixtures	$	1,621	$	2,568
Computers and equipment	37,763		41,084
Leasehold improvements	2,048		6,565
	41,432		50,217
Less: Accumulated depreciation	(34,102)		(39,876)
Total property and equipment, net	$	7,330	$	10,341

Depreciation expense on property and equipment was $0.8 million and $1.1 million during the three months ended September 30, 2023 and 2022, respectively, and $2.8 million and $3.3 million for the nine months ended September 30, 2023 and 2022, respectively. Write down of abandoned property and equipment no longer in use totaled less than $0.1 million and $1.7 million during the three and nine months ended September 30, 2023, respectively. Write down of abandoned property and equipment no longer in use was $0.2 million and $0.8 million for the three and nine months ended September 30, 2022, respectively.

XML

Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill

The changes in the carrying amount of goodwill for the periods presented were as follows:

(in thousands)
Goodwill at December 31, 2022	$	849,609
Acquisitions	28,570
Foreign currency translation adjustment	211
Goodwill at September 30, 2023	$	878,390

Intangible Assets

Intangible assets, net consisted of the following for the periods presented:

	September 30, 2023						December 31, 2022
(dollars in thousands)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Customer lists	$	532,376	$	(365,853)	$	166,523	$	506,015	$	(340,579)	$	165,436
Trademarks	77,659		(42,135)		35,524		77,198		(37,519)		39,679
Non-compete agreement	3,969		(2,781)		1,188		3,179		(2,584)		595
Technology	261,573		(229,257)		32,316		246,220		(216,330)		29,890
Domain names	10,118		(5,187)		4,931		10,118		(4,682)		5,436
	$	885,695	$	(645,213)	$	240,482	$	842,730	$	(601,694)	$	241,036

Included within technology is $30.2 million and $28.1 million of internal-use software, net of accumulated amortization, as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023, $6.1 million of technology assets have not yet been put in service.

The Company capitalized $13.4 million of costs to develop internal-use software included in technology during the nine months ended September 30, 2023 (consisting of internal costs of $11.5 million and external costs of $1.8 million). The Company capitalized $11.7 million of costs to develop internal-use software included in technology during the nine months ended September 30, 2022 (consisting of internal costs of $9.4 million and external costs of $2.3 million).

For the three and nine months ended September 30, 2023, the Company recorded a write-down related to the impairment of capitalized software in the amount of less than $0.1 million and $0.2 million, respectively. For the three and nine months ended September 30, 2022, the Company recorded no write-down of capitalized software.

Amortization expense was $15.1 million and $15.5 million for the three months ended September 30, 2023 and 2022, respectively, and $44.3 million and $53.3 million for the nine months ended September 30, 2023 and 2022, respectively.

Except for the customer lists, which are amortized utilizing an accelerated method, all other intangible assets are amortized on a straight-line basis, which approximates the pattern in which economic benefits are consumed. Estimated amortization expense as of September 30, 2023 is as follows for each of the next five years:

(in thousands)
Year Ending December 31,
Remainder of fiscal year 2023	$	15,144
2024	52,636
2025	42,591
2026	32,526
2027	24,991
Thereafter	72,594
	$	240,482

XML

Accrued Expenses

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Accrued Expenses

Accrued Expenses

Accrued expenses on the unaudited condensed consolidated balance sheets as of the periods presented consisted of the following:

(in thousands)	September 30, 2023		December 31, 2022
Accrued compensation	$	22,274	$	29,835
Accrued cost of revenues	21,721		15,721
Accrued interest	223		3,143
Other accrued expenses	16,169		18,348
Total accrued expenses	$	60,387	$	67,047

XML

Leases

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Leases

Leases

Effective January 1, 2022 using the effective date method, the Company adopted the FASB’s Accounting Standards Update No. 2016-02, “Leases” (“ASC 842”), which requires the recognition of all leases, including operating leases on the unaudited condensed consolidated balance sheets by recording a right-of-use (“ROU”) asset and related liability, and elected to exclude short-term leases from adoption. The lease liability and ROU asset will be remeasured when there is a change in the lease term (or upon the occurrence of another reassessment trigger). Upon adoption on January 1, 2022, the Company recognized a ROU asset of $23.5 million and a lease liability of $23.8 million.

The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company’s leases generally do not provide an implicit rate and, therefore, the Company uses the interest rate on its term loan credit agreement as its incremental borrowing rate under ASC 842. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset

impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.

The Company leases real estate and equipment for use in its operations. The Company has 16 operating leases with remaining lease terms ranging from 1 to 64 months as of September 30, 2023. In connection with the real estate consolidation program, during the three months ended June 30, 2023, the Company exited additional offices including the Company’s former principal executive office and headquarters in New York. A reduction of the operating leases ROU asset of $5.3 million for impairment charges was recorded in impairments and disposals of long-lived assets in the unaudited condensed consolidated statements of operations and comprehensive income. The Company exercised termination options reducing the lease terms on certain operating leases and recorded lease remeasurements to the operating lease liability and corresponding reductions to the operating leases ROU asset in the amount of $4.7 million during the three months ended June 30, 2023. $1.5 million was recorded to de-recognize the operating lease ROU asset related to certain leases in selling, general and administrative expense due to abandonment, during the three months ended June 30, 2023.

The components of lease expense for the periods presented are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of total lease costs
Operating lease expense(1)	$	810	$	1,357	$	4,796	$	3,958
Sublease income	(278)		(216)		(843)		(504)
Total net lease costs	$	532	$	1,141	$	3,953	$	3,454

_________________________

(1)The nine months ended September 30, 2023 includes $1.5 million of lease expense to de-recognize certain operating ROU assets which were abandoned during the three months ended June 30, 2023.

Information related to the Company’s ROU assets and lease liabilities for the period presented is as follows:

(dollars in thousands)	September 30, 2023		December 31, 2022
Operating leases
Operating leases right-of-use asset	$	7,020	$	20,084
Operating leases liability, current portion	$	4,233	$	3,717
Long-term operating leases liability, net of current portion	8,834		16,835
Total operating leases liability	$	13,067	$	20,552

Weighted average remaining lease term in years - operating leases	3.7		4.8
Weighted average discount rate - operating leases	5.07	%	4.50	%

Total remaining lease payments under the Company’s operating leases for the period presented are as follows:

(in thousands)	September 30, 2023
Remainder of fiscal year 2023	$	1,229
2024	5,243
2025	2,337
2026	2,117
2027	2,149
Thereafter	1,113
Total future minimum lease payments	$	14,188
Less: imputed interest	(1,121)
Total	$	13,067

XML

Debt

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Debt

Debt

On November 29, 2022, Sterling Infosystems, Inc. (the “Borrower”), a Delaware corporation and a subsidiary of the Company, entered into a credit agreement (the “2022 Credit Agreement”) by and among the Borrower, as borrower, Sterling Intermediate Corp., KeyBank National Association, as administrative agent (the “Administrative Agent”), certain guarantors party thereto and the lenders party thereto.

The 2022 Credit Agreement provides for aggregate principal borrowings of $700.0 million, comprised of $300.0 million aggregate principal amount of term loans (the “Term Loans”) and a $400.0 million revolving credit facility (the “Revolving Credit Facility”). The Term Loans and the Revolving Credit Facility mature on November 29, 2027.

The table below sets forth the Company’s long-term debt as presented in the unaudited condensed consolidated balance sheets for the periods presented:

(in thousands)	September 30, 2023		December 31, 2022
Current portion of long-term debt
Term Loans	$	13,125	$	7,500
Total current portion of long-term debt	$	13,125	$	7,500
Long-term debt
Term Loans, due November 29, 2027 (7.67% and 6.76% at September 30, 2023 and December 31, 2022, respectively)	281,250		292,500
Revolving Credit Facility	205,494		205,494
Unamortized discount and debt issuance costs	(3,410)		(4,004)
Total long-term debt, net	$	483,334	$	493,990

The estimated fair value of the Company’s 2022 Credit Agreement was $482.2 million and $487.1 million as of September 30, 2023 and December 31, 2022, respectively. These fair values were determined based on quoted prices in markets with similar instruments that are less active (Level 2 inputs as defined below) as an observable price of the 2022 Credit Agreement or similar liabilities is not readily available.

The Company was in compliance with all financial covenants under its credit agreement as of September 30, 2023.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. An asset or liability’s level in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to measure fair value are as follows:

Level 1	Quoted prices in active markets for identical assets and liabilities.
Level 2	Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flows methodologies and similar techniques that use significant unobservable inputs.

The Company considers the recorded value of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses to approximate the fair value of the respective assets and liabilities as of September 30, 2023 and December 31, 2022 based upon the short-term nature of such assets and liabilities (Level 1). See Note 9, “Debt” for discussion of the fair value of the Company’s debt.

Interest rate swaps are measured at fair value on a recurring basis in the Company’s financial statements and are considered Level 2 financial instruments. Interest rate swaps are measured based on quoted prices for similar financial instruments and other observable inputs recognized. The currency forward agreements are typically cash settled in U.S. dollars for their fair value at or close to their settlement date.

Contingent consideration related to acquisitions is considered a Level 3 financial instrument. As of September 30, 2023, the fair value of contingent consideration related to the March 1, 2023 acquisition of A-Check

and the November 30, 2021 acquisition of EBI. As of December 31, 2022, the contingent consideration related to the acquisition of EBI. The contingent consideration consists of estimated future payments related to the Company’s acquisitions, based on metrics such as revenue retention and referral revenue. The fair value is determined using various assumptions and estimates, including revenue and customer projections to forecast a range of outcomes for the contingent consideration. The Company reassesses the estimated fair value of the contingent consideration at the end of each reporting period based on the information available at the time. Changes in the significant unobservable inputs used may result in a significantly higher or lower fair value measurement. Changes in fair value of contingent consideration are recorded in selling, general and administrative expense in the statement of operations and comprehensive income.

The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of the periods presented:

	September 30, 2023
(in thousands)	Level 1		Level 2		Level 3		Total
Assets
Interest rate swaps	$	—	$	3,073	$	—	$	3,073
Liabilities
Interest rate swaps	—		475		—		475
Contingent consideration	—		—		4,934		4,934

	December 31, 2022
(in thousands)	Level 1		Level 2		Level 3		Total
Liabilities
Contingent consideration	$	—	$	—	$	1,219	$	1,219

The following table summarizes the change in fair value of the Level 3 liabilities with significant unobservable inputs for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Fair value of contingent consideration, beginning of period	$	5,620	$	1,230	$	1,219	$	1,445
Acquired liabilities	—		—		4,706		—
Cash payments	—		(11)		(305)		(226)
Change in fair value of contingent consideration, net	(686)		—		(686)		—
Fair value of contingent consideration, end of period	$	4,934	$	1,219	$	4,934	$	1,219

During the three and nine months ended September 30, 2023 and 2022, the Company did not re-measure any financial assets or liabilities at fair value on a nonrecurring basis. There were no transfers between levels during the periods presented.

XML

Derivative Instruments and Hedging Activities

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

Derivative Instruments and Hedging Activities

Interest Rate Swap Hedges

To reduce exposure to variability in expected future cash outflows on variable rate debt attributable to the changes in the applicable interest rates under the 2022 Credit Agreement, the Company entered into interest rate swaps to economically offset a portion of this risk.

For interest rate swap derivatives designated and that qualify as hedges for accounting purposes, the unrealized gain or loss on the derivative is initially recorded in OCI, reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item.

As of September 30, 2023, the Company had the following outstanding interest rate swap derivatives that were used to hedge its interest rate risks:

Product	Number of Instruments	Effective Date	Maturity Date	Current Notional(1)
Interest Rate Swaps	4	February 28, 2023	November 29, 2027	$300.0 million USD

_________________________

(1)The notional value steps down from $300.0 million to $150.0 million on February 27, 2026.

All financial derivative instruments are carried at their fair value on the balance sheet. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the unaudited condensed consolidated balance sheets as of the dates presented:

	Asset Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other current assets	$	3,073	Other current assets	$	—

	Liability Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other liabilities	$	475	Other liabilities	$	—

The tables below present the effect of cash flow hedge accounting on accumulated OCI for the periods presented:

	Three Months Ended September 30,					Three Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	3,910	$	—	Interest expense	$	761	$	—
	Nine Months Ended September 30,					Nine Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	4,008	$	—	Interest expense	$	1,410	$	—

The table below presents the effect of the Company’s cash flow hedge accounting on the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
(in thousands)	Interest Expense
Total amounts of income and expense line items in which the effects of cash flow hedges are recorded	$	9,305	$	7,764	$	26,903	$	20,719
Gain or (loss) on cash flow hedging relationships
Interest rate swaps:
Amount of gain or (loss) reclassified from accumulated OCI into income	$	761	$	—	$	1,410	$	—

Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. Based on current interest rates, during the next twelve months, the Company estimates that an additional $3.1 million net gain will be reclassified from accumulated OCI as a decrease to interest expense. No gain or loss was reclassified from accumulated OCI into earnings as a result of forecasted transactions that failed to occur during the periods presented.

Non-designated Derivatives

Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected to apply hedge accounting.

Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.

As of September 30, 2023, the Company did not have any outstanding derivatives not designated as a hedge in qualifying hedging relationships.

The table below presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments in the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

		Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)		2023		2022		2023		2022
Derivatives Not Designated as Hedging Instruments	Location of Gain or (Loss) Recognized in Income on Derivative	Amount of Gain or (Loss) Recognized in Income on Derivative
Interest rate swaps	Gain on interest rate swaps	$	—	$	—	$	—	$	296

XML

Income Taxes

9 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The computation of the provision for or benefit from income taxes for interim periods is determined by applying the estimated annual effective tax rate to year-to-date income before tax and adjusting for discrete tax items recorded in the period, if any.

The Company recorded a tax provision of $4.0 million and $3.5 million for the three months ended September 30, 2023 and 2022, respectively, which resulted in an effective tax rate of 62.7% and 27.2%, respectively. The Company recorded a tax provision of $5.0 million and $13.0 million for the nine months ended September 30, 2023 and 2022, respectively, which resulted in an effective tax rate of 60.3% and 32.3%, respectively. For the three and nine months ended September 30, 2023 and 2022, the effective rate differs from the statutory rate mainly due to a jurisdictional mix of earnings and permanent items.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Litigation

The Company is party to both class actions and individual actions in the ordinary course of business. The matters typically allege violations of the Fair Credit Reporting Act (“FCRA”), as well as other claims. In addition, from time to time, the Company receives inquiries from regulatory bodies regarding its business. The Company accrues for the cost of resolving matters where it can be determined that a loss is both estimable and probable. Certain matters are in litigation and an estimate of the outcome and potential losses, if any, cannot be determined. Certain of these matters are covered by the Company’s insurance policies, subject to policy terms, including retentions. The Company does not believe that the resolution of current matters will result in a material adverse effect on the financial position, results of operations, or cash flows of the Company.

As of September 30, 2023, the Company had a legal settlement obligation of $7.2 million and an offsetting insurance receivable of $4.7 million for the settlement of legal matters. As of December 31, 2022, the Company had a legal settlement obligation of $4.2 million and an offsetting insurance receivable of $0.9 million for the settlement of legal matters.

Net legal settlement expense recorded in selling, general and administrative expense in the unaudited consolidated statements of operations and comprehensive income for the three months ended September 30, 2023 and 2022 totaled $0.5 million and $0.2 million, respectively, and $0.6 million and $0.5 million for the nine months ended September 30, 2023 and 2022, respectively.

XML

Equity

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Equity

Equity

Under the Company’s Amended and Restated Certificate of Incorporation, a total of 1,100,000,000 shares of all classes of stock are authorized, divided as follows:

(i)1,000,000,000 shares of common stock, par value $0.01 per share (“common stock”); and

(ii)100,000,000 shares of undesignated preferred stock, par value $0.01 per share (“preferred stock”).

Each share of common stock is entitled to one vote on all matters on which holders of common stock are entitled to vote generally. Holders of common stock are entitled to be paid ratably any dividends as may be declared by the Board of Directors (in its sole discretion), subject to any preferential dividend rights of outstanding preferred stock (if any). No dividends have been declared or paid on the Company’s common stock through September 30, 2023.

The Board of Directors is authorized to direct the issuance of the undesignated preferred stock in one or more series and to fix the designation of such series, the powers (including voting powers), preferences and relative, participating, optional and other special rights, and the qualifications, limitations or restrictions thereof, of such series of preferred stock and the number of shares of such series.

On November 23, 2022, the Company’s board of directors authorized the repurchase of up to $100.0 million of the Company’s shares of common stock over a period through December 31, 2024. The share repurchase program is being executed on a discretionary basis through open market repurchases, private transactions, or other transactions, including through block trades and Rule 10b-18 and Rule 10b5-1 trading plans. The Company is not obligated to repurchase any specific number of shares, and the timing and amount of any share repurchases will be subject to several factors including share price, trading volume, market conditions and capital allocation priorities. The share repurchase program may be suspended, terminated or modified without notice at any time. For the three and nine months ended September 30, 2023, the Company repurchased 1,564,019 shares of its common stock for $20.7 million and 3,523,838 shares of its common stock for $46.0 million, respectively, inclusive of commissions and taxes.

On June 7, 2023, the Company entered into an Underwriting Agreement with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC as representatives of the several underwriters named therein (the “Underwriters”) and the selling stockholders (the “Selling Stockholders”), relating to the sale by the Selling Stockholders of 8,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Secondary Public Offering”). In connection with the Secondary Public Offering, the Selling Stockholders granted the Underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock of the Company, of which 1,145,486 shares were purchased. The Company did not sell any shares in the Secondary Public Offering and did not receive any proceeds from the sale of shares being sold by the Selling Stockholders in the Secondary Public Offering. In addition, the Company entered into an agreement with Broad Street Principal Investments, L.L.C. (“BSPI”), one of the Selling Stockholders, dated June 5, 2023, pursuant to which the Company repurchased from BSPI an aggregate of 1,000,000 shares of common stock of the Company for a total of $11.7 million pursuant to the Company’s share repurchase program at a price per share equal to the price paid by the Underwriters in the Secondary Public Offering.

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Stock-based compensation expense is recognized in cost of revenues, corporate technology and production systems, and selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive income as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Stock-based compensation expense
Cost of revenues	$	396	$	384	$	1,218	$	1,208
Corporate technology and production systems	776		774		1,993		1,803
Selling, general and administrative	8,611		5,135		23,973		14,413
Total stock-based compensation expense	$	9,783	$	6,293	$	27,184	$	17,424

Prior to the IPO, all share-based awards were issued to employees under the Company’s 2015 Long-Term Equity Incentive Plan (the “2015 Plan”). Upon the adoption of the Sterling Check Corp. 2021 Omnibus Incentive

Plan (the “2021 Equity Plan”) on August 4, 2021 and as of September 22, 2021, all newly granted share-based awards have been issued under the 2021 Equity Plan.

As of September 30, 2023, the Company had approximately $90.1 million of unrecognized pre-tax non-cash stock-based compensation expense related to awards granted under the 2021 Equity Plan, consisting of approximately $28.5 million related to non-qualified stock options (“NQSOs”), $60.1 million related to restricted stock, and approximately $1.5 million related to restricted stock units (“RSUs”), all of which the Company expects to recognize over a weighted average period of 2.41 years.

2015 Long-Term Equity Incentive Plan

The table below provides a summary of service-based vesting options (“SVOs”) and performance-based stock options (“PSOs”) currently outstanding under the 2015 Plan for the nine months ended September 30, 2023:

	Outstanding SVOs						Outstanding PSOs
	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value		Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
(in thousands, except shares and per share amounts)
Balances at December 31, 2022	6,208,274	$	9.59	5.00	$	36,513	3,081,855	$	10.05	3.32	$	16,699
Granted	—	—					—	—
Forfeited / Expired	—	—					—	—
Exercised	(213,783)	9.44					(14,975)	9.68
Balances at September 30, 2023(1)	5,994,491	$	9.59	4.30	$	18,139	3,066,880	$	10.05	2.58	$	7,872

_________________________

(1)    All SVOs and PSOs are exercisable as of September 30, 2023.

On August 4, 2021, the Company amended each option outstanding under the 2015 Plan to (i) accelerate vesting upon an initial public offering and (ii) permit each option to be exercised following termination for any reason for the period set forth in the applicable award agreement or, if longer, an extended post-termination exercise period that would end on the date that is six months following the second anniversary of the effective date of the initial public offering, provided that if such date falls during a blackout period, the post-termination exercise period will be extended until the date that is thirty days after the commencement of the Company’s next open trading window. In connection with the option agreement amendments, the option holders agreed that any shares of common stock acquired by such individuals upon exercise of any options outstanding under the 2015 plan (the “LTIP Option Shares”) will be subject to the following transfer restrictions, in addition to any other lock-up restrictions, securities trading policies, and other limitations to which such individuals may be subject: (i) the holder will be able to transfer up to 25% of the LTIP Option Shares at any time after six months following the effectiveness of the registration statement of which the IPO Prospectus formed a part (or such earlier time as the transfer restrictions expire under the lock-up agreements described in the IPO Prospectus under “Shares Eligible for Future Sale—Lock-up Agreements”) but prior to the first anniversary of the effectiveness of the registration statement of which the IPO Prospectus formed a part; (ii) on or after the first anniversary but prior to the second anniversary of the effectiveness of the registration statement of which the IPO Prospectus formed a part, the holder will be able to transfer up to 50% of the LTIP Option Shares (reduced by any of the LTIP Option Shares sold prior to the first anniversary) and (iii) on or after the second anniversary of the effectiveness of the registration statement of which the IPO Prospectus forms a part, the holder will be able to transfer all of his or her LTIP Option Shares. The foregoing transfer restrictions will not apply to any shares of common stock held by any such individual that are not LTIP Option Shares.

2021 Omnibus Incentive Plan

On August 4, 2021, the Company’s Board of Directors adopted, and on August 13, 2021 the Company’s stockholders approved, the 2021 Equity Plan. Equity awards under the 2021 Equity Plan are intended to retain and motivate the Company’s officers and employees, consultants and non-employee directors and to promote the success of the Company’s business by providing such participating individuals with a proprietary interest in the performance of the Company. The 2021 Equity Plan will terminate on the tenth anniversary thereof, unless earlier terminated by the Board of Directors. Under the 2021 Equity Plan, the following types of awards can be granted to an eligible individual (as defined by the plan and to the extent permitted by applicable law): incentive stock options (“ISOs”) and NQSOs; stock appreciation rights (“SARs”); restricted stock; RSUs; performance awards; cash-based

awards and other share-based awards. Upon its adoption, the 2021 Equity Plan provided that up to 9,433,000 shares may be issued pursuant to awards granted under the 2021 Equity Plan (the “Share Limit”); provided, that, the Share Limit shall be automatically increased on the first day of each calendar year commencing on January 1, 2022 and ending on January 1, 2030 in an amount equal to the lesser of (x) 5% of the total number of shares outstanding on the last day of the immediately preceding calendar year, and (y) such number of shares as determined by the Board of Directors, and no more than 9,433,000 shares may be issued upon the exercise of ISOs. As of September 30, 2023, 8,303,713 shares were available for issuance pursuant to future granted awards under the 2021 Equity Plan.

Stock Options

Options issued under the 2021 Equity Plan generally vest on various schedules over one to four-year periods on the anniversary of the grant date, subject to continued employment with the Company through the applicable vesting date. Options issued under the 2021 Equity Plan generally expire ten years after the grant date.

The table below provides a summary of stock option activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding at December 31, 2022	4,387,501	$	22.91	8.81	$	—
Granted	909,431	12.77
Forfeited / Expired	—	—
Exercised	—	—
Outstanding at September 30, 2023	5,296,932	$	21.17	8.30	$	7,516
Exercisable at September 30, 2023	1,779,123	$	22.98	7.99	$	—

Restricted Stock

Restricted stock issued under the 2021 Equity Plan in connection with the Company’s initial public offering vests 50% on the second anniversary of the grant date and 25% on each of the third and fourth anniversaries of the grant date, subject to continued employment with the Company through the applicable vesting date. Other restricted stock grants issued under the 2021 Equity Plan vest on various schedules over one to four-year periods on the anniversary of the grant date, subject to the continued employment with the Company through the applicable vesting date. Holders of restricted stock are entitled to all rights of a common stockholder of the Company and are subject to restrictions on transfer.

The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	3,421,920	$	20.32
Granted	2,177,482	12.46
Forfeited / Cancelled	(306,240)	16.10
Vested	(792,403)	22.21
Unvested at September 30, 2023	4,500,759	$	16.48

Restricted Stock Units

Restricted stock units issued under the 2021 Equity Plan in connection with the Company’s initial public offering vest 50% on the second anniversary of the grant date and 25% on each of the third and fourth anniversaries of the grant date, subject to continued employment with the Company through the applicable vesting date. Additional grants of RSUs vest on various schedules over a one to four-year period on the anniversary of the grant date, subject to the continued employment with the Company through the applicable vesting date. Upon vesting, employees will receive shares of common stock in settlement of the units. The table below provides a summary of RSU activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	51,249	$	21.18
Granted	93,026	14.36
Forfeited / Cancelled	(3,287)	17.99
Vested	(17,177)	22.87
Unvested at September 30, 2023	123,811	$	15.79

Employee Stock Purchase Plan

The 2021 Employee Stock Purchase Plan (the “ESPP”) was launched on July 1, 2023. The ESPP allows eligible employees to voluntarily make after-tax contributions of up to 15% of such employee’s cash compensation for the purchase of the Company’s stock. Consecutive offering periods of six months in duration have been established, with the first one commencing on July 1, 2023. During each offering period, such contributions will be accumulated and applied to purchase shares at the end of the offering period. The purchase price for shares purchased in the initial offering period will be, and for subsequent offering periods will not be less than, 85% of the lesser of the closing price of the shares on the first day of the offering period or the last day of the offering period. During the three and nine months ended September 30, 2023, the amount the Company recorded for stock-based compensation expense associated with the ESPP was immaterial.

XML

Net Income per Share

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Net Income per Share

Net Income Per Share

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except share and per share amounts)	2023		2022		2023		2022
Numerator:
Net income attributable to stockholders	$	2,354	$	9,303	$	3,268	$	27,110
Denominator:
Weighted average number of shares outstanding—basic	90,972,009		94,134,690		92,184,159		94,043,105
Weighted average additional shares assuming conversion of potential common shares	2,679,682		4,983,831		2,309,095		5,174,020
Weighted average common shares outstanding—diluted	93,651,691		99,118,521		94,493,254		99,217,125
Net income per share attributable to stockholders, basic	$	0.03	$	0.10	$	0.04	$	0.29
Net income per share attributable to stockholders, diluted	$	0.03	$	0.09	$	0.03	$	0.27

The following table summarizes the weighted average potentially dilutive securities that were excluded from the computation of diluted net income per share because their effect would have been anti-dilutive for the periods presented:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	5,296,932	8,964,397	5,064,658	8,964,397
Restricted stock	1,156,291	2,131,704	2,971,926	2,131,704
Restricted stock units	6,421	44,560	34,612	44,560

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Related Party Transactions

Related Party TransactionsGoldman Sachs and some of its affiliates, each an affiliate of our Sponsor, are clients of the Company and the Company had sales to Goldman Sachs and some of its affiliates in the amount of $0.8 million and $1.2 million for

the three months ended September 30, 2023 and 2022, respectively, and $2.5 million and $4.8 million for the nine months ended September 30, 2023 and 2022, respectively. Outstanding accounts receivable from Goldman Sachs as of September 30, 2023 and December 31, 2022 were $0.4 million and $0.2 million, respectively. Additionally, the Company is currently a party to a $75.0 million notional value interest rate swap through November 29, 2027 with J. Aron & Company LLC, a wholly-owned subsidiary of Goldman Sachs.

During the three months ended June 30, 2023, in connection with the Secondary Public Offering, the Company repurchased 1,000,000 shares of common stock for $11.7 million directly from BSPI, an affiliate of Goldman Sachs. See Note 14, “Equity” for discussion of the Secondary Public Offering and the share repurchase.

An affiliate of certain stockholders that, to the Company’s knowledge, collectively own greater than 10% of the Company’s outstanding shares of common stock (the “Stockholders”) is a client of the Company, and the Company had sales to an affiliate of the Stockholders in the amount of $0.1 million for the three months ended September 30, 2023 and 2022, and $0.2 million for the nine months ended September 30, 2023 and 2022. Outstanding accounts receivable from an affiliate of the Stockholders were less than $0.1 million as of September 30, 2023 and December 31, 2022.

XML

Revenue

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Performance Obligations

Substantially all of the Company’s revenues are recognized at a point in time as results from services are provided through a screening report and the customer takes control of the product when the report is completed. Accordingly, revenue is generally recognized at the point in time when the customer receives and can use the report.

For revenue arrangements containing multiple products or services, the Company accounts for the individual products or services as separate performance obligations if they are distinct, the product or service is separately identifiable from other terms in the contract, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. If these criteria are not met, the promised products or services are accounted for as a combined performance obligation. The Company allocates the contract price to each performance obligation based on the standalone selling prices of each distinct product or service in the contract.

Disaggregation of Revenues

The following tables set forth total revenue by type of service for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Screening services	$	178,809	$	197,870	$	544,330	$	591,900
Other services	1,757		1,429		5,894		4,962
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

The following table sets forth total revenue by geographic area in which the revenues and invoicing are recorded for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
United States	$	153,577	$	168,615	$	465,517	$	502,047
All other countries	26,989		30,684		84,707		94,815
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

Other than the U.S., no single country accounted for more than 10% of the Company’s total revenues during the three and nine months ended September 30, 2023 and 2022. Substantially all of the Company’s long-lived assets were located in the U.S. as of September 30, 2023 and December 31, 2022.

Contract Assets and Liabilities

Incremental costs of obtaining a contract with a customer are recognized as an asset if the benefit of such costs is expected to be longer than one year, with a majority of contracts being multi-year. Incremental costs include commissions to the sales force and are amortized over three years, as management estimates that this corresponds to the period over which a customer benefits from the contract. As of September 30, 2023 and

December 31, 2022, $3.3 million of deferred commissions are included in other current assets on the unaudited condensed consolidated balance sheets and approximately $2.8 million and $2.7 million, respectively, of deferred commissions are included in other noncurrent assets, net on the unaudited condensed consolidated balance sheets.

The Company did not have any material contract liabilities as of September 30, 2023 and December 31, 2022.

Concentrations

For the three and nine months ended September 30, 2023 and 2022, no single customer accounted for more than 10% of the Company’s revenue. No single customer had an accounts receivable balance greater than 10% of total accounts receivable as of September 30, 2023 and December 31, 2022.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income	$ 2,354	$ 323	$ 591	$ 9,303	$ 11,571	$ 6,236	$ 3,268	$ 27,110

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation and ConsolidationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include accounts of the Company and its wholly-owned subsidiaries.These unaudited condensed consolidated financial statements are unaudited; however, in the opinion of management, they reflect all adjustments consisting only of normal recurring adjustments necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with GAAP applicable to interim periods. The results of operations for the interim periods presented are not necessarily indicative of results for the full year or future periods. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of December 31, 2022 and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2023.

Consolidation

All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that can affect the reported amount of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Significant estimates include the impairment of long-lived assets, goodwill impairment, the determination of the fair value of acquired assets and liabilities, collectability of receivables, the valuation of stock-based awards and stock-based compensation and sales and income tax liabilities. The Company also applies an estimated useful life of three years to internally developed software assets. This is based on the historical observed pace of change in the Company’s delivery, technology, and product offerings as well as market competition. The Company believes that the estimates used in the preparation of these unaudited condensed consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.

Segment Information

Segment InformationThe Company has one operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents of $49.9 million and $103.1 million as of September 30, 2023 and December 31, 2022, respectively, include money market instruments with maturities of three months or less. The Company maintained cash outside the U.S. as of September 30, 2023 of $33.4 million with the largest deposits being held in India and Canada, with balances of $4.1 million and $6.0 million, respectively. Cash outside the U.S. was $28.0 million as of December 31, 2022, with the largest deposits being held in Canada and India, with balances of $9.2 million and $5.1 million, respectively.

Foreign Currency

Foreign CurrencyAssets and liabilities of operations having non-USD functional currencies are translated at period-end exchange rates, and income statement accounts are translated at weighted average exchange rates for the period. Gains or losses resulting from translating foreign currency financial statements, net of any related tax effects, are reflected in Accumulated Other Comprehensive Income or Loss (“OCI”), a separate component of stockholders’ equity on the unaudited condensed consolidated balance sheets. Gains or losses resulting from foreign currency transactions incurred in currencies other than the local functional currency are included in other income in the unaudited condensed consolidated statements of operations and comprehensive income.

Accounts Receivable and Allowance for Credit Losses

Accounts Receivable and Allowance for Credit Losses

Accounts receivable balances consist of trade receivables that are recorded at the invoiced amount, net of allowances for expected credit losses and for potential sales credits and reserves. Sales credits and reserves were $0.7 million and $0.9 million as of September 30, 2023 and December 31, 2022, respectively.

The Company adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 326, Financial Instruments—Credit Losses (“CECL”) on January 1, 2022. The adoption of CECL resulted in a $0.3 million cumulative effect adjustment recorded in retained earnings as of January 1, 2022.

CECL requires an entity to utilize an impairment model to estimate its lifetime expected credit losses and record an allowance that, when deducted from the amortized cost basis of a financial asset, presents the net amount expected to be collected on the financial asset.

The Company maintains an allowance for expected credit losses in order to record accounts receivable at their net realizable value. Inherent in the assessment of the allowance for expected credit losses are certain judgments and estimates relating to, among other things, the Company’s customers’ access to capital, customers’ willingness and ability to pay, general economic conditions and the ongoing relationship with customers. Allowances have been recorded for receivables believed to be uncollectible, including amounts for the resolution of potential credit and other collection issues such as disputed invoices. The allowance for expected credit losses is determined by analyzing the Company’s historical write-offs, the current aging of receivables, the financial condition of customers and the general economic climate. Adjustments to the allowance may be required in future periods depending on how such potential issues are resolved or if the financial condition of the Company’s customers were to deteriorate resulting in an impairment of their ability to make payments. The Company has not historically had material write-offs due to uncollectible accounts receivable.

Corporate Technology and Production Systems

Corporate Technology and Production Systems

Corporate technology and production systems includes costs related to maintaining the Company’s corporate information technology infrastructure and non-capitalizable costs to develop and maintain its production systems.

Corporate information technology consists of salaries and benefits of personnel (including stock-based compensation expense) supporting internal operations such as information technology support and the maintenance of information security and business continuity functions. Also included are third-party costs including cloud computing costs that support the Company’s corporate internal systems, software licensing and maintenance, telecommunications and other technology infrastructure costs.

Production systems costs consist of non-capitalizable personnel costs including contractor costs incurred for the development of platform and product initiatives and production support and maintenance. Platform and product initiatives facilitate the development of the Company’s technology platform and the launch of new screening products. Production support and maintenance includes costs to support and maintain the technology underlying the Company’s existing screening products and to enhance the ease of use of the Company’s cloud applications. Certain personnel costs related to new products and features are capitalized and amortized to depreciation and amortization.

Included within corporate technology and production systems are non-capitalizable production system and corporate information technology expenses related to Project Ignite, a three-phase strategic investment initiative. Phase one of Project Ignite modernized client and candidate experiences and is complete. Phase two of Project Ignite focused on decommissioning the Company’s on-premises data centers and migrating the Company’s production systems and corporate information technological infrastructure to a managed service provider in the cloud. During the first half of 2021, the Company completed phase two initiatives related to the migration of its production and fulfillment systems to the cloud, and as a result, approximately 98% of revenue is processed through platforms hosted in the cloud. The Company incurred expenses related to phase two to complete the decommissioning of on-premises data centers for internal corporate technology infrastructure and migration to the cloud which was completed as of September 30, 2022. Phase three of Project Ignite was decommissioning of the platforms purchased over the prior ten years and the migration of the clients to one global platform. This third and final phase, which was completed in the first quarter of 2023, unified clients onto a single global platform. The Company’s core platform now processes approximately 80% of its global revenue.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Schedule of Accounts Receivable, Allowance for Credit Losses

The following table summarizes changes in the allowance for expected credit losses for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Balance at beginning of period	$	2,658	$	2,161	$	2,304	$	2,949
Cumulative effect of accounting change upon adoption of CECL	—		—		—		254
Additions	97		351		556		1,010
Write-offs, net of recoveries	(82)		(36)		(190)		(1,727)
Foreign currency translation adjustment	(3)		(14)		—		(24)
Balance at end of period	$	2,670	$	2,462	$	2,670	$	2,462

Summary of Corporate Technology and Production Systems Expense

The following table sets forth expenses included in each category of corporate technology and production systems for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Corporate information technology	$	4,665	$	7,012	$	14,854	$	19,425
Development of platform and product initiatives	4,371		4,433		13,065		12,797
Production support and maintenance	2,293		2,270		6,790		6,584
Total production systems	6,664		6,703		19,855		19,381
Total corporate technology and production systems	$	11,329	$	13,715	$	34,709	$	38,806

XML

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the consideration paid and the amounts recognized for the assets acquired and liabilities assumed:

	Preliminary Purchase Price Allocation				Adjusted Purchase Price Allocation
(in thousands)	March 31, 2023		Purchase Price Adjustments		September 30, 2023
Consideration
Cash	$	11,935	$	—	$	11,935
Other current assets
Accounts receivable	4,279		(3)		4,276
Other current assets	805		447		1,252
Property and equipment	177		(1)		176
Intangible assets	32,141		(1,268)		30,873
Other long-term assets	6		—		6
Total assets acquired	$	49,343	$	(825)	$	48,518
Accounts payable and accrued expenses	1,156		94		1,250
Other current liabilities	1,291		(72)		1,219
Deferred tax liability	8,388		77		8,465
Other liabilities	2		—		2
Total liabilities assumed	$	10,837	$	99	$	10,936
Total identifiable net assets	38,506		(924)		37,582
Goodwill	27,352		1,218		28,570
Total consideration	$	65,858	$	294	$	66,152

XML

Property and Equipment, Net (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment, net

(in thousands)	September 30, 2023		December 31, 2022
Furniture and fixtures	$	1,621	$	2,568
Computers and equipment	37,763		41,084
Leasehold improvements	2,048		6,565
	41,432		50,217
Less: Accumulated depreciation	(34,102)		(39,876)
Total property and equipment, net	$	7,330	$	10,341

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill for the periods presented were as follows:

(in thousands)
Goodwill at December 31, 2022	$	849,609
Acquisitions	28,570
Foreign currency translation adjustment	211
Goodwill at September 30, 2023	$	878,390

Summary of Intangible Assets

Intangible assets, net consisted of the following for the periods presented:

	September 30, 2023						December 31, 2022
(dollars in thousands)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Customer lists	$	532,376	$	(365,853)	$	166,523	$	506,015	$	(340,579)	$	165,436
Trademarks	77,659		(42,135)		35,524		77,198		(37,519)		39,679
Non-compete agreement	3,969		(2,781)		1,188		3,179		(2,584)		595
Technology	261,573		(229,257)		32,316		246,220		(216,330)		29,890
Domain names	10,118		(5,187)		4,931		10,118		(4,682)		5,436
	$	885,695	$	(645,213)	$	240,482	$	842,730	$	(601,694)	$	241,036

Summary of Estimated Future Amortization Expense

Estimated amortization expense as of September 30, 2023 is as follows for each of the next five years:

(in thousands)
Year Ending December 31,
Remainder of fiscal year 2023	$	15,144
2024	52,636
2025	42,591
2026	32,526
2027	24,991
Thereafter	72,594
	$	240,482

XML

Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Summary of Accrued Expenses

Accrued expenses on the unaudited condensed consolidated balance sheets as of the periods presented consisted of the following:

(in thousands)	September 30, 2023		December 31, 2022
Accrued compensation	$	22,274	$	29,835
Accrued cost of revenues	21,721		15,721
Accrued interest	223		3,143
Other accrued expenses	16,169		18,348
Total accrued expenses	$	60,387	$	67,047

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Schedule of Lease Expense

The components of lease expense for the periods presented are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of total lease costs
Operating lease expense(1)	$	810	$	1,357	$	4,796	$	3,958
Sublease income	(278)		(216)		(843)		(504)
Total net lease costs	$	532	$	1,141	$	3,953	$	3,454

_________________________

(1)The nine months ended September 30, 2023 includes $1.5 million of lease expense to de-recognize certain operating ROU assets which were abandoned during the three months ended June 30, 2023.

Schedule of Right-of-Use Assets and Lease Liabilities

Information related to the Company’s ROU assets and lease liabilities for the period presented is as follows:

(dollars in thousands)	September 30, 2023		December 31, 2022
Operating leases
Operating leases right-of-use asset	$	7,020	$	20,084
Operating leases liability, current portion	$	4,233	$	3,717
Long-term operating leases liability, net of current portion	8,834		16,835
Total operating leases liability	$	13,067	$	20,552

Weighted average remaining lease term in years - operating leases	3.7		4.8
Weighted average discount rate - operating leases	5.07	%	4.50	%

Schedule of Remaining Lease Payments

Total remaining lease payments under the Company’s operating leases for the period presented are as follows:

(in thousands)	September 30, 2023
Remainder of fiscal year 2023	$	1,229
2024	5,243
2025	2,337
2026	2,117
2027	2,149
Thereafter	1,113
Total future minimum lease payments	$	14,188
Less: imputed interest	(1,121)
Total	$	13,067

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Summary of Company's Long-term Debt

The table below sets forth the Company’s long-term debt as presented in the unaudited condensed consolidated balance sheets for the periods presented:

(in thousands)	September 30, 2023		December 31, 2022
Current portion of long-term debt
Term Loans	$	13,125	$	7,500
Total current portion of long-term debt	$	13,125	$	7,500
Long-term debt
Term Loans, due November 29, 2027 (7.67% and 6.76% at September 30, 2023 and December 31, 2022, respectively)	281,250		292,500
Revolving Credit Facility	205,494		205,494
Unamortized discount and debt issuance costs	(3,410)		(4,004)
Total long-term debt, net	$	483,334	$	493,990

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis

The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of the periods presented:

	September 30, 2023
(in thousands)	Level 1		Level 2		Level 3		Total
Assets
Interest rate swaps	$	—	$	3,073	$	—	$	3,073
Liabilities
Interest rate swaps	—		475		—		475
Contingent consideration	—		—		4,934		4,934

	December 31, 2022
(in thousands)	Level 1		Level 2		Level 3		Total
Liabilities
Contingent consideration	$	—	$	—	$	1,219	$	1,219

Schedule of Fair Value of the Level 3 Liabilities with Significant Unobservable Inputs

The following table summarizes the change in fair value of the Level 3 liabilities with significant unobservable inputs for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Fair value of contingent consideration, beginning of period	$	5,620	$	1,230	$	1,219	$	1,445
Acquired liabilities	—		—		4,706		—
Cash payments	—		(11)		(305)		(226)
Change in fair value of contingent consideration, net	(686)		—		(686)		—
Fair value of contingent consideration, end of period	$	4,934	$	1,219	$	4,934	$	1,219

XML

Derivative Instruments and Hedging Activities (Tables)

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Company's Outstanding Derivatives

As of September 30, 2023, the Company had the following outstanding interest rate swap derivatives that were used to hedge its interest rate risks:

Product	Number of Instruments	Effective Date	Maturity Date	Current Notional(1)
Interest Rate Swaps	4	February 28, 2023	November 29, 2027	$300.0 million USD

_________________________

(1)The notional value steps down from $300.0 million to $150.0 million on February 27, 2026.

Summary of Fair Value of Derivative Financial Instruments

All financial derivative instruments are carried at their fair value on the balance sheet. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the unaudited condensed consolidated balance sheets as of the dates presented:

	Asset Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other current assets	$	3,073	Other current assets	$	—

	Liability Derivatives
	September 30, 2023			December 31, 2022
(in thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Other liabilities	$	475	Other liabilities	$	—

Schedule of Effect of Cash Flow Hedges on Accumulated OCI

The tables below present the effect of cash flow hedge accounting on accumulated OCI for the periods presented:

	Three Months Ended September 30,					Three Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	3,910	$	—	Interest expense	$	761	$	—
	Nine Months Ended September 30,					Nine Months Ended September 30,
(in thousands)	2023		2022			2023		2022
Derivatives designated as hedging instruments:	Amount of Gain or (Loss) Recognized in OCI on Derivative				Location of Gain or (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Interest rate swaps	$	4,008	$	—	Interest expense	$	1,410	$	—

Schedule of Derivative Instruments on Statements of Operations and Comprehensive Income

The table below presents the effect of the Company’s cash flow hedge accounting on the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
(in thousands)	Interest Expense
Total amounts of income and expense line items in which the effects of cash flow hedges are recorded	$	9,305	$	7,764	$	26,903	$	20,719
Gain or (loss) on cash flow hedging relationships
Interest rate swaps:
Amount of gain or (loss) reclassified from accumulated OCI into income	$	761	$	—	$	1,410	$	—

The table below presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments in the unaudited condensed consolidated statements of operations and comprehensive income for the periods presented:

		Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)		2023		2022		2023		2022
Derivatives Not Designated as Hedging Instruments	Location of Gain or (Loss) Recognized in Income on Derivative	Amount of Gain or (Loss) Recognized in Income on Derivative
Interest rate swaps	Gain on interest rate swaps	$	—	$	—	$	—	$	296

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Summary Of Stock-Based Compensation Expense

Stock-based compensation expense is recognized in cost of revenues, corporate technology and production systems, and selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive income as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Stock-based compensation expense
Cost of revenues	$	396	$	384	$	1,218	$	1,208
Corporate technology and production systems	776		774		1,993		1,803
Selling, general and administrative	8,611		5,135		23,973		14,413
Total stock-based compensation expense	$	9,783	$	6,293	$	27,184	$	17,424

Schedule of Share-based Payment Arrangement, Option, Activity

The table below provides a summary of service-based vesting options (“SVOs”) and performance-based stock options (“PSOs”) currently outstanding under the 2015 Plan for the nine months ended September 30, 2023:

	Outstanding SVOs						Outstanding PSOs
	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value		Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
(in thousands, except shares and per share amounts)
Balances at December 31, 2022	6,208,274	$	9.59	5.00	$	36,513	3,081,855	$	10.05	3.32	$	16,699
Granted	—	—					—	—
Forfeited / Expired	—	—					—	—
Exercised	(213,783)	9.44					(14,975)	9.68
Balances at September 30, 2023(1)	5,994,491	$	9.59	4.30	$	18,139	3,066,880	$	10.05	2.58	$	7,872

_________________________

(1)    All SVOs and PSOs are exercisable as of September 30, 2023.

The table below provides a summary of stock option activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding at December 31, 2022	4,387,501	$	22.91	8.81	$	—
Granted	909,431	12.77
Forfeited / Expired	—	—
Exercised	—	—
Outstanding at September 30, 2023	5,296,932	$	21.17	8.30	$	7,516
Exercisable at September 30, 2023	1,779,123	$	22.98	7.99	$	—

Schedule of Share-based Payment Arrangement, Restricted Stock Activity

The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	3,421,920	$	20.32
Granted	2,177,482	12.46
Forfeited / Cancelled	(306,240)	16.10
Vested	(792,403)	22.21
Unvested at September 30, 2023	4,500,759	$	16.48

The table below provides a summary of RSU activity under the 2021 Equity Plan for the nine months ended September 30, 2023:

	Number of Shares	Weighted Average Fair Value (per share)
Unvested at December 31, 2022	51,249	$	21.18
Granted	93,026	14.36
Forfeited / Cancelled	(3,287)	17.99
Vested	(17,177)	22.87
Unvested at September 30, 2023	123,811	$	15.79

XML

Net Income per Share (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except share and per share amounts)	2023		2022		2023		2022
Numerator:
Net income attributable to stockholders	$	2,354	$	9,303	$	3,268	$	27,110
Denominator:
Weighted average number of shares outstanding—basic	90,972,009		94,134,690		92,184,159		94,043,105
Weighted average additional shares assuming conversion of potential common shares	2,679,682		4,983,831		2,309,095		5,174,020
Weighted average common shares outstanding—diluted	93,651,691		99,118,521		94,493,254		99,217,125
Net income per share attributable to stockholders, basic	$	0.03	$	0.10	$	0.04	$	0.29
Net income per share attributable to stockholders, diluted	$	0.03	$	0.09	$	0.03	$	0.27

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the weighted average potentially dilutive securities that were excluded from the computation of diluted net income per share because their effect would have been anti-dilutive for the periods presented:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	5,296,932	8,964,397	5,064,658	8,964,397
Restricted stock	1,156,291	2,131,704	2,971,926	2,131,704
Restricted stock units	6,421	44,560	34,612	44,560

XML

Revenue (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following tables set forth total revenue by type of service for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Screening services	$	178,809	$	197,870	$	544,330	$	591,900
Other services	1,757		1,429		5,894		4,962
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

Schedule of Revenue from External Customers by Geographic Areas

The following table sets forth total revenue by geographic area in which the revenues and invoicing are recorded for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
United States	$	153,577	$	168,615	$	465,517	$	502,047
All other countries	26,989		30,684		84,707		94,815
Total revenue	$	180,566	$	199,299	$	550,224	$	596,862

XML

Description of Business (Details)	Sep. 30, 2023
Sterling Check Corp.
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Ownership percentage	52.40%

XML

Summary of Significant Accounting Policies - Additional information (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($) Segment	Dec. 31, 2022 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jan. 01, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2021
Accounting Policies [Line Items]
Number of operating segments | Segment	1
Cash and cash equivalents	$ 49,877	$ 103,095
Cumulative translation adjustment losses	(5,500)	(5,600)
Sales credits and reserves	700	900
Allowance for expected credit losses	$ 2,670	2,304	$ 2,658	$ 2,462	$ 2,161		$ 2,949
Percentage of cloud-hosted revenue platforms	80.00%							98.00%
Cumulative Effect, Period of Adoption, Adjustment
Accounting Policies [Line Items]
Allowance for expected credit losses		0	$ 0		$ 0		$ 254
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-13
Accounting Policies [Line Items]
Retained earnings						$ 300
Outside US
Accounting Policies [Line Items]
Cash	$ 33,400	28,000
India
Accounting Policies [Line Items]
Cash	4,100	5,100
Canada
Accounting Policies [Line Items]
Cash	$ 6,000	$ 9,200
Internally Developed Software Assets
Accounting Policies [Line Items]
Estimated useful life	3 years

XML

Summary of Significant Accounting Policies - Schedule of Accounts Receivable, Allowance for Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ 2,658	$ 2,161	$ 2,304	$ 2,949
Additions	97	351	556	1,010
Write-offs, net of recoveries	(82)	(36)	(190)	(1,727)
Foreign currency translation adjustment	(3)	(14)	0	(24)
Balance at end of period	2,670	2,462	2,670	2,462
Cumulative Effect, Period of Adoption, Adjustment
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ 0	$ 0	$ 0	$ 254

XML

Summary of Significant Accounting Policies - Summary of Corporate Technology and Production Systems Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Corporate information technology	$ 4,665	$ 7,012	$ 14,854	$ 19,425
Development of platform and product initiatives	4,371	4,433	13,065	12,797
Production support and maintenance	2,293	2,270	6,790	6,584
Total production systems	6,664	6,703	19,855	19,381
Total corporate technology and production systems	$ 11,329	$ 13,715	$ 34,709	$ 38,806

XML

Acquisitions - Additional Information (Details) - USD ($)				6 Months Ended	9 Months Ended		13 Months Ended
	Mar. 01, 2023	Dec. 31, 2022	Nov. 30, 2021	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Contingent consideration					$ 4,706,000	$ 0
Socrates and A-Check
Business Acquisition [Line Items]
Purchase price	$ 66,200,000
Transaction expenses					$ 2,000,000
Tax deductible goodwill	0
Total consideration, purchase price adjustment				$ (294,000)
Socrates and A-Check | Customer lists
Business Acquisition [Line Items]
Finite lived assets acquired	$ 28,000,000
Useful life of assets acquired	15 years
Socrates and A-Check | Trade Names
Business Acquisition [Line Items]
Useful life of assets acquired	2 years
Socrates and A-Check | Developed Technology
Business Acquisition [Line Items]
Useful life of assets acquired	8 years
Socrates and A-Check | Non-compete agreement
Business Acquisition [Line Items]
Useful life of assets acquired	5 years
A-Check Global
Business Acquisition [Line Items]
Contingent consideration	$ 4,700,000
Current portion of contingent consideration	$ 2,600,000
Contingent consideration period	1 year
Noncurrent portion of contingent consideration	$ 2,100,000
Socrates
Business Acquisition [Line Items]
Retention requirements payable	$ 5,000,000
Period of retention requirements payable	2 years
Contingent consideration
Business Acquisition [Line Items]
Purchase price		$ 67,500,000	$ 67,800,000
Contingent consideration			1,500,000
Cash purchase price			$ 66,300,000
Total consideration, purchase price adjustment							$ (300,000)

XML

Acquisitions - Assets and Liabilities Assumed (Details) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Other current assets
Goodwill	$ 878,390		$ 849,609
Socrates and A-Check
Consideration
Cash	11,935	$ 11,935
Other current assets
Accounts receivable	4,276	4,279
Other current assets	1,252	805
Property and equipment	176	177
Intangible assets	30,873	32,141
Other long-term assets	6	6
Total assets acquired	48,518	49,343
Accounts payable and accrued expenses	1,250	1,156
Other current liabilities	1,219	1,291
Deferred tax liability	8,465	8,388
Other liabilities	2	2
Total liabilities assumed	10,936	10,837
Total identifiable net assets	37,582	38,506
Goodwill	28,570	27,352
Total consideration	66,152	$ 65,858
Purchase Price Adjustments
Accounts receivable	(3)
Other current assets	447
Property and equipment	(1)
Intangible assets	(1,268)
Total assets acquired	(825)
Accounts payable and accrued expenses	94
Other current liabilities	(72)
Deferred tax liability	77
Total liabilities assumed	99
Total identifiable net assets	(924)
Goodwill	1,218
Total consideration	$ 294

XML

Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 41,432	$ 50,217
Less: Accumulated depreciation	(34,102)	(39,876)
Total property and equipment, net	7,330	10,341
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,621	2,568
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	37,763	41,084
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,048	$ 6,565

XML

Property and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.8	$ 1.1	$ 2.8	$ 3.3
Write down no longer use in property and equipment	$ 0.1	$ 0.2	$ 1.7	$ 0.8

XML

Goodwill and Intangible Assets - Summary of Changes in Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 849,609
Acquisitions	28,570
Foreign currency translation adjustment	211
Goodwill, ending balance	$ 878,390

XML

Goodwill and Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 885,695	$ 842,730
Accumulated Amortization	(645,213)	(601,694)
Net	240,482	241,036
Customer lists
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	532,376	506,015
Accumulated Amortization	(365,853)	(340,579)
Net	166,523	165,436
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	77,659	77,198
Accumulated Amortization	(42,135)	(37,519)
Net	35,524	39,679
Non-compete agreement
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,969	3,179
Accumulated Amortization	(2,781)	(2,584)
Net	1,188	595
Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	261,573	246,220
Accumulated Amortization	(229,257)	(216,330)
Net	32,316	29,890
Domain names
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	10,118	10,118
Accumulated Amortization	(5,187)	(4,682)
Net	$ 4,931	$ 5,436

XML

Goodwill and Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Indefinite-lived Intangible Assets [Line Items]
Net intangibles	$ 240,482,000		$ 240,482,000		$ 241,036,000
Capitalized computer software, impairments	100,000	$ 0	200,000	$ 0
Amortization of intangible assets	15,100,000	$ 15,500,000	44,300,000	53,300,000
Software and Software Development Costs
Indefinite-lived Intangible Assets [Line Items]
Net intangibles	30,200,000		30,200,000		$ 28,100,000
Finite lived intangible assets, not yet in service	$ 6,100,000		6,100,000
Capitalized computer software, additions			13,400,000	11,700,000
Software and Software Development Costs | Internal Cost
Indefinite-lived Intangible Assets [Line Items]
Capitalized computer software, additions			11,500,000	9,400,000
Software and Software Development Costs | External Cost
Indefinite-lived Intangible Assets [Line Items]
Capitalized computer software, additions			$ 1,800,000	$ 2,300,000

XML

Goodwill and Intangible Assets - Summary of Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of fiscal year 2023	$ 15,144
2024	52,636
2025	42,591
2026	32,526
2027	24,991
Thereafter	72,594
Net	$ 240,482	$ 241,036

XML

Accrued Expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued compensation	$ 22,274	$ 29,835
Accrued cost of revenues	21,721	15,721
Accrued interest	223	3,143
Other accrued expenses	16,169	18,348
Total accrued expenses	$ 60,387	$ 67,047

XML

Leases - Additional Information (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) lease	Dec. 31, 2022 USD ($)	Jan. 01, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Right-of-use asset		$ 7,020	$ 20,084
Lease liability		$ 13,067	$ 20,552
Number of operating leases | lease		16
Reduction of operating leases ROU asset for impairment charges	$ 5,300
Increase to lease liability resulting from lease remeasurement	4,700
Reduction to operating ROU asset resulting from lease remeasurement	4,700
De-recognition of operating lease ROU asset related to certain leases due to abandonment	$ 1,500
Minimum
Lessee, Lease, Description [Line Items]
Remaining operating lease term		1 month
Maximum
Lessee, Lease, Description [Line Items]
Remaining operating lease term		64 months
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Right-of-use asset				$ 23,500
Lease liability				$ 23,800

XML

Leases - Schedule of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Components of total lease costs
Operating lease expense	$ 810		$ 1,357	$ 4,796	$ 3,958
Sublease income	(278)		(216)	(843)	(504)
Total net lease costs	$ 532		$ 1,141	$ 3,953	$ 3,454
Lease expense to de-recognized certain operating ROU assets abandoned		$ 1,500

XML

Leases - Schedule of Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Operating leases right-of-use asset	$ 7,020	$ 20,084
Operating leases liability, current portion	4,233	3,717
Long-term operating leases liability, net of current portion	8,834	16,835
Total operating leases liability	$ 13,067	$ 20,552
Weighted average remaining lease term in years - operating leases	3 years 8 months 12 days	4 years 9 months 18 days
Weighted average discount rate - operating leases	5.07%	4.50%

XML

Leases - Schedule of Remaining Lease Payments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Remainder of fiscal year 2023	$ 1,229
2024	5,243
2025	2,337
2026	2,117
2027	2,149
Thereafter	1,113
Total future minimum lease payments	14,188
Less: imputed interest	(1,121)
Total	$ 13,067	$ 20,552

XML

Debt - Additional Information (Details) - Line of Credit - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Nov. 29, 2022
Debt Instrument [Line Items]
Aggregate amount of borrowings permitted			$ 700,000,000
Level 2
Debt Instrument [Line Items]
Estimated fair value	$ 482,200,000	$ 487,100,000
Secured Debt | Term Loans
Debt Instrument [Line Items]
Aggregate amount of borrowings permitted			300,000,000
Revolving Credit Facility
Debt Instrument [Line Items]
Aggregate amount of borrowings permitted			$ 400,000,000

XML

Debt - Summary of Company's Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current portion of long-term debt
Total current portion of long-term debt	$ 13,125	$ 7,500
Long-term debt
Unamortized discount and debt issuance costs	(3,410)	(4,004)
Total long-term debt, net	483,334	493,990
Line of Credit | Secured Debt | Term Loans
Current portion of long-term debt
Total current portion of long-term debt	13,125	7,500
Long-term debt
Long-term debt, gross	$ 281,250	$ 292,500
Interest rates	7.67%	6.76%
Line of Credit | Revolving Credit Facility
Long-term debt
Long-term debt, gross	$ 205,494	$ 205,494

XML

Fair Value of Financial Instruments - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Liabilities
Contingent consideration	$ 4,934	$ 1,219
Interest rate swaps
Assets
Interest rate swaps	3,073
Liabilities
Interest rate swaps	475
Level 1
Liabilities
Contingent consideration	0	0
Level 1 | Interest rate swaps
Assets
Interest rate swaps	0
Liabilities
Interest rate swaps	0
Level 2
Liabilities
Contingent consideration	0	0
Level 2 | Interest rate swaps
Assets
Interest rate swaps	3,073
Liabilities
Interest rate swaps	475
Level 3
Liabilities
Contingent consideration	4,934	$ 1,219
Level 3 | Interest rate swaps
Assets
Interest rate swaps	0
Liabilities
Interest rate swaps	$ 0

XML

Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in fair value of contingent consideration, net			$ (686)	$ 0
Contingent Consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value of contingent consideration, beginning of period	$ 5,620	$ 1,230	1,219	1,445
Acquired liabilities	0	0	4,706	0
Cash payments	0	(11)	(305)	(226)
Change in fair value of contingent consideration, net	(686)	0	(686)	0
Fair value of contingent consideration, end of period	$ 4,934	$ 1,219	$ 4,934	$ 1,219

XML

Derivative Instruments and Hedging Activities - Summary of Company's Outstanding Derivatives (Details) - Interest rate swaps $ in Millions	Feb. 27, 2026 USD ($)	Sep. 30, 2023 USD ($) instrument
Derivative [Line Items]
Number of Instruments | instrument		4
Current Notional		$ 300.0
Forecast
Derivative [Line Items]
Current Notional	$ 150.0

XML

Derivative Instruments and Hedging Activities - Summary of Fair Value of Derivative Financial Instruments (Details) - Derivatives designated as hedging instruments: - Interest rate swaps - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Other current assets
Derivative [Line Items]
Asset Derivatives	$ 3,073	$ 0
Other liabilities
Derivative [Line Items]
Liability Derivatives	$ 475	$ 0

XML

Derivative Instruments and Hedging Activities - Summary of Effect of Cash Flow Hedge Accounting on Accumulated OCI (Loss) (Details) - Derivatives designated as hedging instruments: - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Interest expense
Derivative [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income	$ 761	$ 0	$ 1,410	$ 0
Interest rate swaps
Derivative [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative	$ 3,910	$ 0	$ 4,008	$ 0

XML

Derivative Instruments and Hedging Activities - Impact Of The Companies Derivative Financial Instruments On The Consolidated Statement Of Operations And Comprehensive Income Statement (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative [Line Items]
Interest expense, net	$ 9,305	$ 7,764	$ 26,903	$ 20,719
Cash Flow Hedging | Interest rate swaps | Interest expense
Derivative [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income	761	0	1,410	0
Derivatives designated as hedging instruments: | Interest expense
Derivative [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income	761	0	1,410	0
Derivatives designated as hedging instruments: | Cash Flow Hedging
Derivative [Line Items]
Interest expense, net	$ 9,305	$ 7,764	$ 26,903	$ 20,719

XML

Derivative Instruments and Hedging Activities - Additional Information (Details)	9 Months Ended
	Sep. 30, 2023 USD ($) instrument
Derivative [Line Items]
Estimated reclassification from other comprehensive income during next twelve months	$ 3,100,000
Gain (loss) reclassified from accumulated OCI into earnings from forecasted transaction that failed to occur	$ 0
Derivatives designated as hedging instruments:
Derivative [Line Items]
Number of Instruments | instrument	0

XML

Derivative Instruments and Hedging Activities - Summary of Derivative Financial Instruments that are Not Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivatives designated as hedging instruments: | Interest rate swaps | Gain on interest rate swaps
Derivative [Line Items]
Amount of Gain or (Loss) Recognized in Income on Derivative	$ 0	$ 0	$ 0	$ 296

XML

Income Taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income tax provision	$ 3,952	$ 3,481	$ 4,969	$ 12,958
Effective tax rate	62.70%	27.20%	60.30%	32.30%

XML

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Litigation settlement obligation	$ 7,178		$ 7,178		$ 4,165
Insurance receivable	4,700		4,700		$ 900
Net legal settlement expense	$ 500	$ 200	$ 600	$ 500

XML

Equity (Details)		3 Months Ended			9 Months Ended
	Jun. 07, 2023 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) vote $ / shares shares	Jun. 30, 2023 USD ($) shares	Mar. 31, 2023 USD ($) shares	Sep. 30, 2023 USD ($) vote $ / shares shares	Dec. 31, 2022 $ / shares shares	Nov. 23, 2022 USD ($)
Class of Stock [Line Items]
Total shares authorized (in shares)		1,100,000,000			1,100,000,000
Common stock, shares authorized (in shares)		1,000,000,000			1,000,000,000	1,000,000,000
Common stock, par value (in USD per share) | $ / shares		$ 0.01			$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)		100,000,000			100,000,000	100,000,000
Preferred stock, par value (in USD per share) | $ / shares		$ 0.01			$ 0.01	$ 0.01
Number of votes entitled to each share of common stock | vote		1			1
Dividends declared (in USD per share) | $ / shares					$ 0
Authorized common stock repurchase amount | $							$ 100,000,000
Common stock repurchased (in shares)		1,564,019			3,523,838
Value of common stock repurchased | $		$ 20,701,000	$ 17,630,000	$ 7,712,000	$ 46,000,000
Common Shares Held in Treasury
Class of Stock [Line Items]
Common stock repurchased (in shares)		1,564,019	1,465,893	493,926
Value of common stock repurchased | $		$ 20,701,000	$ 17,630,000	$ 7,712,000
BSPI | Common Shares Held in Treasury
Class of Stock [Line Items]
Common stock repurchased (in shares)			1,000,000
Value of common stock repurchased | $			$ 11,700,000
Secondary Public Offering | Underwriters
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)	0
Proceeds from sale of stock | $	$ 0
Secondary Public Offering | Selling Stockholders
Class of Stock [Line Items]
Common stock, par value (in USD per share) | $ / shares	$ 0.01
Number of shares issued in transaction (in shares)	8,000,000
Over-Allotment Option | Selling Stockholders | Underwriters
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)	1,145,486
Period for option to purchase additional shares	30 days
Over-Allotment Option | Selling Stockholders | Underwriters | Maximum
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)	1,200,000

XML

Stock-Based Compensation - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 9,783	$ 6,293	$ 27,184	$ 17,424
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	396	384	1,218	1,208
Corporate technology and production systems
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	776	774	1,993	1,803
Selling, general and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 8,611	$ 5,135	$ 23,973	$ 14,413

XML

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Millions			3 Months Ended	9 Months Ended
	Jul. 01, 2023	Aug. 04, 2021	Sep. 30, 2023	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized share-based compensation expense			$ 90.1	$ 90.1
Weighted average period of recognition				2 years 4 months 28 days
2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Post-termination exercise period		6 months
Extended post-termination exercise period		30 days
Maximum threshold percentage transfer of long term option shares within one year		25.00%
Effectiveness period of transfer of long term option shares within one year		6 months
Maximum threshold percentage transfer of long term option shares after one year		50.00%
2021 Equity Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award expiration term		10 years
Share-based compensation arrangement by share-based payment award, shares issued in period (in shares)		9,433,000
Percentage of outstanding stock maximum		5.00%
Share based compensation by share based award number of shares authorized for issuance (in shares)		9,433,000
Share based compensation by share based award number of shares available for grant (in shares)			8,303,713	8,303,713
NQSOs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized share-based compensation expense related to options			$ 28.5	$ 28.5
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized share-based compensation expense related to restricted stock			60.1	$ 60.1
Restricted stock | 2021 Equity Plan | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				2 years
Share based compensation by share based award vesting percentage				50.00%
Restricted stock | 2021 Equity Plan | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				3 years
Share based compensation by share based award vesting percentage				25.00%
Restricted stock | 2021 Equity Plan | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				4 years
Share based compensation by share based award vesting percentage				25.00%
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized share-based compensation expense related to restricted stock			$ 1.5	$ 1.5
Restricted stock units | 2021 Equity Plan | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				2 years
Share based compensation by share based award vesting percentage				50.00%
Restricted stock units | 2021 Equity Plan | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				3 years
Share based compensation by share based award vesting percentage				25.00%
Restricted stock units | 2021 Equity Plan | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				4 years
Share based compensation by share based award vesting percentage				25.00%
Restricted stock units | 2021 Equity Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				1 year
Restricted stock units | 2021 Equity Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				4 years
Stock Options | 2021 Equity Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award expiration term				10 years
Stock Options | 2021 Equity Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				1 year
Stock Options | 2021 Equity Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				4 years
Other Restricted Stock | 2021 Equity Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				1 year
Other Restricted Stock | 2021 Equity Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based award vesting term				4 years
Employee Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, maximum employee subscription rate	15.00%
Share-based compensation arrangement by share based payment award, offering period	6 months
Share-based compensation arrangement by share based payment award, purchase price of common stock, percent			85.00%

XML

Stock-Based Compensation - Summary of Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
2015 Plan | Service-Based Vesting Stock Options
Number of Shares
Balance at beginning of period (in shares) | shares	6,208,274
Granted (in shares) | shares	0
Forfeited / Expired (in shares) | shares	0
Exercised (in shares) | shares	(213,783)
Balance at end of period (in shares) | shares	5,994,491	6,208,274
Weighted Average Exercise Price
Balance at beginning of period (in USD per share) | $ / shares	$ 9.59
Granted (in USD per share) | $ / shares	0
Forfeited / Expired (in USD per share) | $ / shares	0
Exercised (in USD per share) | $ / shares	9.44
Balance at end of period (in USD per share) | $ / shares	$ 9.59	$ 9.59
Weighted Average Remaining Contractual Life (years)
Weighted average contractual term of options outstanding	4 years 3 months 18 days	5 years
Aggregate Intrinsic Value
Balance at beginning of period | $	$ 36,513
Exercised | $
Balance at beginning of period | $	$ 18,139	$ 36,513
2015 Plan | Performance-Based Stock Options
Number of Shares
Balance at beginning of period (in shares) | shares	3,081,855
Granted (in shares) | shares	0
Forfeited / Expired (in shares) | shares	0
Exercised (in shares) | shares	(14,975)
Balance at end of period (in shares) | shares	3,066,880	3,081,855
Weighted Average Exercise Price
Balance at beginning of period (in USD per share) | $ / shares	$ 10.05
Granted (in USD per share) | $ / shares	0
Forfeited / Expired (in USD per share) | $ / shares	0
Exercised (in USD per share) | $ / shares	9.68
Balance at end of period (in USD per share) | $ / shares	$ 10.05	$ 10.05
Weighted Average Remaining Contractual Life (years)
Weighted average contractual term of options outstanding	2 years 6 months 29 days	3 years 3 months 25 days
Aggregate Intrinsic Value
Balance at beginning of period | $	$ 16,699
Exercised | $
Balance at beginning of period | $	$ 7,872	$ 16,699
2021 Equity Plan
Number of Shares
Balance at beginning of period (in shares) | shares	4,387,501
Granted (in shares) | shares	909,431
Forfeited / Expired (in shares) | shares	0
Exercised (in shares) | shares	0
Balance at end of period (in shares) | shares	5,296,932	4,387,501
Exercisable (in shares) | shares	1,779,123
Weighted Average Exercise Price
Balance at beginning of period (in USD per share) | $ / shares	$ 22.91
Granted (in USD per share) | $ / shares	12.77
Forfeited / Expired (in USD per share) | $ / shares	0
Exercised (in USD per share) | $ / shares	0
Balance at end of period (in USD per share) | $ / shares	21.17	$ 22.91
Exercisable (in USD per share) | $ / shares	$ 22.98
Weighted Average Remaining Contractual Life (years)
Weighted average contractual term of options outstanding	8 years 3 months 18 days	8 years 9 months 21 days
Weighted average contractual term of options exercisable	7 years 11 months 26 days
Aggregate Intrinsic Value
Balance at beginning of period | $	$ 0
Exercised | $
Balance at beginning of period | $	7,516	$ 0
Aggregate intrinsic value of options exercisable | $	$ 0

XML

Stock-Based Compensation - Summary of Restricted Stock Activity (Details) - 2021 Equity Plan	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Restricted stock
Number of Shares
Balance at beginning of period (in shares) | shares	3,421,920
Granted (in shares) | shares	2,177,482
Forfeited / cancelled (in shares) | shares	(306,240)
Vested (in shares) | shares	(792,403)
Balance at end of period (in shares) | shares	4,500,759
Weighted Average Fair Value (per share)
Balance at beginning of period (in USD per share) | $ / shares	$ 20.32
Granted (in USD per share) | $ / shares	12.46
Forfeited / cancelled (in USD per share) | $ / shares	16.10
Vested (in USD per share) | $ / shares	22.21
Balance at end of period (in USD per share) | $ / shares	$ 16.48
Restricted stock units
Number of Shares
Balance at beginning of period (in shares) | shares	51,249
Granted (in shares) | shares	93,026
Forfeited / cancelled (in shares) | shares	(3,287)
Vested (in shares) | shares	(17,177)
Balance at end of period (in shares) | shares	123,811
Weighted Average Fair Value (per share)
Balance at beginning of period (in USD per share) | $ / shares	$ 21.18
Granted (in USD per share) | $ / shares	14.36
Forfeited / cancelled (in USD per share) | $ / shares	17.99
Vested (in USD per share) | $ / shares	22.87
Balance at end of period (in USD per share) | $ / shares	$ 15.79

XML

Net Income per Share - Schedule of Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net income attributable to stockholders	$ 2,354	$ 323	$ 591	$ 9,303	$ 11,571	$ 6,236	$ 3,268	$ 27,110
Denominator:
Weighted average number of shares outstanding, basic (in shares)	90,972,009			94,134,690			92,184,159	94,043,105
Weighted average additional shares assuming conversion of potential common shares (in shares)	2,679,682			4,983,831			2,309,095	5,174,020
Weighted average shares of common stock outstanding - diluted (in shares)	93,651,691			99,118,521			94,493,254	99,217,125
Net income per share attributable to stockholders, basic (in USD per share)	$ 0.03			$ 0.10			$ 0.04	$ 0.29
Net income per share attributable to stockholders, diluted (in USD per share)	$ 0.03			$ 0.09			$ 0.03	$ 0.27

XML

Net Income per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,296,932	8,964,397	5,064,658	8,964,397
Restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,156,291	2,131,704	2,971,926	2,131,704
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,421	44,560	34,612	44,560

XML

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Sales to related parties	$ 180,566			$ 199,299	$ 550,224	$ 596,862
Accounts receivable from related parties	$ 151,935				$ 151,935		$ 139,579
Common stock repurchased (in shares)	1,564,019				3,523,838
Value of common stock repurchased	$ 20,701	$ 17,630	$ 7,712		$ 46,000
Common Shares Held in Treasury
Related Party Transaction [Line Items]
Common stock repurchased (in shares)	1,564,019	1,465,893	493,926
Value of common stock repurchased	$ 20,701	$ 17,630	$ 7,712
Interest rate swaps
Related Party Transaction [Line Items]
Notional value interest rate swap with related party	300,000				300,000
BSPI | Common Shares Held in Treasury
Related Party Transaction [Line Items]
Common stock repurchased (in shares)		1,000,000
Value of common stock repurchased		$ 11,700
Goldman Sachs
Related Party Transaction [Line Items]
Sales to related parties	800			1,200	2,500	4,800
Accounts receivable from related parties	400				400		200
Goldman Sachs | J. Aron & Company LLC | Interest rate swaps
Related Party Transaction [Line Items]
Notional value interest rate swap with related party	75,000				75,000
Stockholders
Related Party Transaction [Line Items]
Sales to related parties	100			$ 100	200	$ 200
Stockholders | Maximum
Related Party Transaction [Line Items]
Accounts receivable from related parties	$ 100				$ 100		$ 100

XML

Revenue - Summary of Total Revenue by Type of Service (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 180,566	$ 199,299	$ 550,224	$ 596,862
Screening services
Disaggregation of Revenue [Line Items]
Total revenue	178,809	197,870	544,330	591,900
Other services
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,757	$ 1,429	$ 5,894	$ 4,962

XML

Revenue - Summary of Total Revenue by Geographic Area Based on the Billing Address of its Customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 180,566	$ 199,299	$ 550,224	$ 596,862
United States
Disaggregation of Revenue [Line Items]
Total revenue	153,577	168,615	465,517	502,047
All other countries
Disaggregation of Revenue [Line Items]
Total revenue	$ 26,989	$ 30,684	$ 84,707	$ 94,815

XML

Revenue - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred commissions, amortization period	3 years
Deferred commissions, current	$ 3.3	$ 3.3
Deferred commissions, non-current	$ 2.8	$ 2.7

XML

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]